_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,orig_e1,orig_e2,expertdecision,relation,sent_id,orig_sentence,term1,term2
503350516,7/15/2014 22:06:43,,1323865117,7/15/2014 22:06:22,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,102-114-117-126-130,combination of ATROPINE and tertatolol,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:07:47,,1323865572,7/15/2014 22:07:24,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,81-117,"bradycardia, ATROPINE","Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:08:19,,1323865888,7/15/2014 22:07:54,clixsense,1,15189335,GBR,H9,London,188.29.165.113,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,117,ATROPINE,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:08:47,,1323866080,7/15/2014 22:08:27,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,117,ATROPINE,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:21:48,,1323871856,7/15/2014 22:21:01,clixsense,1,19803139,NLD,06,Veldhoven,212.61.84.196,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,117,ATROPINE,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:22:53,,1323872383,7/15/2014 22:22:40,clixsense,1,23585686,GBR,H9,London,31.51.221.173,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,117,ATROPINE,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:40:38,,1323881307,7/15/2014 22:40:36,coinworker,1,26727958,USA,OH,Cleveland,99.108.68.152,81,117,,,92,125,BRADYCARDIA,ATROPINE,"only reduced the BRADYCARDIA, but the combination",64-69-77-81-94-98-102,98-102-114-117-126-130-141,the combination of ATROPINE and tertatolol suppressed,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:48:25,,1323884688,7/15/2014 22:48:00,clixsense,1,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,117-130,ATROPINE tertatolol,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:52:16,,1323886782,7/15/2014 22:50:39,prizerebel,1,21325389,USA,NY,Queens Village,108.30.3.50,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,117,ATROPINE,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350516,7/15/2014 22:57:30,,1323889298,7/15/2014 22:57:14,prodege,1,22124564,GBR,N5,Lowestoft,90.220.97.157,81,117,,,92,125,BRADYCARDIA,ATROPINE,"BRADYCARDIA,",81,117,ATROPINE,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia.",81,117,81,117,92,125,1,RO-may_treat,908049,"Bilateral vagotomy also inhibited both effects whereas atropine only reduced the bradycardia, but the combination of atropine and tertatolol suppressed the bradycardia",bradycardia,atropine
503350517,7/15/2014 22:10:55,,1323867116,7/15/2014 22:10:10,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,70,42,,,78,47,NONLUPUS,LUPUS,haplotype matched NONLUPUS,52-62-70,30-32-37-42-26,Igh V loci from LUPUS,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 22:21:26,,1323871689,7/15/2014 22:21:02,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,70,42,,,78,47,NONLUPUS,LUPUS,haplotype matched NONLUPUS,52-62-70,42,LUPUS,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 22:29:45,,1323875720,7/15/2014 22:29:28,clixsense,1,21034659,AUS,04,Brisbane,49.189.2.107,70,42,,,78,47,NONLUPUS,LUPUS,NONLUPUS,70,42,LUPUS,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 22:36:32,,1323879268,7/15/2014 22:35:55,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,70,42,,,78,47,NONLUPUS,LUPUS,haplotype matched NONLUPUS,52-62-70,42,LUPUS,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 22:38:24,,1323880212,7/15/2014 22:38:08,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,70,42,,,78,47,NONLUPUS,LUPUS,NONLUPUS,70,42,LUPUS,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 22:41:49,,1323881781,7/15/2014 22:41:47,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,70,42,,,78,47,NONLUPUS,LUPUS,and haplotype matched NONLUPUS mice resulted in,48-52-62-70-79-84-93,30-32-37-42-48-52-62,V loci from LUPUS and haplotype matched,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 22:58:14,,1323889629,7/15/2014 22:57:50,clixsense,1,24896327,GBR,V2,Glasgow,94.2.231.4,70,42,,,78,47,NONLUPUS,LUPUS,NONLUPUS,70,42,LUPUS,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 23:03:53,,1323892874,7/15/2014 23:03:34,tremorgames,1,21788954,GBR,E3,Enfield,82.45.226.44,70,42,,,78,47,NONLUPUS,LUPUS,NONLUPUS,70,42-48-52,LUPUS and haplotype,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 23:14:02,,1323898858,7/15/2014 23:13:35,elite,1,28397222,GBR,Y4,Usk,31.50.223.75,70,42,,,78,47,NONLUPUS,LUPUS,NONLUPUS,70,42,LUPUS,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350517,7/15/2014 23:15:34,,1323899598,7/15/2014 23:15:02,instagc,1,21551272,GBR,E6,Chipping Campden,78.145.193.123,70,42,,,78,47,NONLUPUS,LUPUS,haplotype matched NONLUPUS,52-70-62,42,LUPUS,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease.",70,42,70,42,78,47,-1,RO-cause_of,900206,"Our study showed that the Igh-V loci from lupus and haplotype-matched nonlupus mice resulted in essentially identical restriction fragment patterns, a finding which suggests that the Igh-V gene complex does not carry a primary defect responsible for autoimmune disease",nonlupus,lupus
503350518,7/15/2014 22:04:23,,1323863986,7/15/2014 22:04:11,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,MAGNESIUM DEFICIENCY,17-27,107,MAGNESIUM,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:07:26,,1323865409,7/15/2014 22:07:06,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,MAGNESIUM DEFICIENCY,17-27,107-117-127,MAGNESIUM tolerance test,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:15:04,,1323868834,7/15/2014 22:14:50,elite,1,28503042,USA,OK,Watonga,65.255.78.241,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,MAGNESIUM DEFICIENCY,17-27,107-117-127,MAGNESIUM tolerance test,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:15:55,,1323869260,7/15/2014 22:15:36,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,MAGNESIUM DEFICIENCY,17-27,107,MAGNESIUM,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:24:00,,1323872927,7/15/2014 22:23:38,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,MAGNESIUM DEFICIENCY,17-27,27-107-17,magnesium deficiency MAGNESIUM,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:31:51,,1323876625,7/15/2014 22:31:29,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,The diagnosis of MAGNESIUM DEFICIENCY is usually made,0-4-14-17-27-38-41-49,79-94-103-107-117-127-132,"concentration, although the MAGNESIUM tolerance test may","The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:35:08,,1323878561,7/15/2014 22:34:53,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,MAGNESIUM DEFICIENCY,17-27,107-117-127,MAGNESIUM tolerance test,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:36:37,,1323879303,7/15/2014 22:36:24,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,MAGNESIUM DEFICIENCY,17-27,79-94-103-107-117-127-132,"concentration, although the MAGNESIUM tolerance test may","The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:38:08,,1323880102,7/15/2014 22:38:03,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,The diagnosis of MAGNESIUM DEFICIENCY is usually made,0-4-14-17-27-38-41-49,79-94-103-107-117-127-132,"concentration, although the MAGNESIUM tolerance test may","The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350518,7/15/2014 22:41:55,,1323881811,7/15/2014 22:41:53,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,17,107,,,37,116,MAGNESIUM DEFICIENCY,MAGNESIUM,The diagnosis of MAGNESIUM DEFICIENCY is usually made,0-4-14-17-27-38-41-49,79-94-103-107-117-127-132,"concentration, although the MAGNESIUM tolerance test may","The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states.",17 27,107,17,107,37,116,1,RO-may_prevent,907157,"The diagnosis of magnesium deficiency is usually made by a low-serum magnesium concentration, although the magnesium tolerance test may be more indicative of low magnesium states",magnesium deficiency,magnesium
503350519,7/15/2014 22:00:32,,1323862319,7/15/2014 22:00:21,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,"psychosis (i.e., fewer HALLUCINATIONS and delusions and",42-52-59-65-80-84-94,0-4-11-25-33-35,1 Simple SCHIZOPHRENIA denotes a milder,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 22:00:45,,1323862452,7/15/2014 22:00:36,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,HALLUCINATIONS,65,11,SCHIZOPHRENIA,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 22:14:39,,1323868613,7/15/2014 22:14:25,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,HALLUCINATIONS,65,11,SCHIZOPHRENIA,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 22:30:57,,1323876260,7/15/2014 22:30:42,instagc,1.0,13763729,USA,"","",75.182.89.225,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,HALLUCINATIONS,65,11,SCHIZOPHRENIA,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 22:34:00,,1323877866,7/15/2014 22:33:46,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,HALLUCINATIONS,65,11,SCHIZOPHRENIA,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 22:37:26,,1323879697,7/15/2014 22:37:10,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,HALLUCINATIONS delusions and,65-94-84,4-11,Simple SCHIZOPHRENIA,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 22:38:40,,1323880380,7/15/2014 22:38:33,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,"psychosis (i.e., fewer HALLUCINATIONS and delusions and",42-52-59-65-80-84-94,0-4-11-25-33-35,1 Simple SCHIZOPHRENIA denotes a milder,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 22:54:22,,1323887871,7/15/2014 22:53:43,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,"psychosis (i.e., fewer HALLUCINATIONS and delusions",42-52-59-65-80-84,0-4-11-25-33-35-42-52-59-65-80-84,"1 Simple SCHIZOPHRENIA denotes a milder psychosis (i.e., fewer hallucinations and delusions","1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 23:07:14,,1323895012,7/15/2014 23:06:48,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,HALLUCINATIONS,65,11,SCHIZOPHRENIA,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350519,7/15/2014 23:09:20,,1323896235,7/15/2014 23:09:04,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,65,11,,,79,24,HALLUCINATIONS,SCHIZOPHRENIA,"(i.e., HALLUCINATIONS",52-65,11,SCHIZOPHRENIA,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement.",65,11,65,11,79,24,1,RO-has_manifestation,906248,"1   Simple schizophrenia denotes a milder psychosis (i.e., fewer hallucinations and delusions and less disorganization), with cases typically featuring a schizoid lifestyle of reduced emotional experience and expression and reduced social drive and engagement",hallucinations,schizophrenia
503350520,7/15/2014 21:57:57,,1323861030,7/15/2014 21:57:53,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,90,117,,,95,130,FEVER,MONONUCLEOSIS,"brucellosis includes enteric FEVER, malaria, infectious mononucleosis",61-73-82-90-97-106-117,90-97-106-117-140-145,"fever, malaria, infectious MONONUCLEOSIS Barr virus","11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 22:03:11,,1323863547,7/15/2014 22:02:38,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,90,117,,,95,130,FEVER,MONONUCLEOSIS,"enteric FEVER,",82-90,106-117-131-140-145-151-157,"infectious MONONUCLEOSIS (Epstein Barr virus [EBV] infection),","11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 22:12:13,,1323867655,7/15/2014 22:09:54,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,90,117,,,95,130,FEVER,MONONUCLEOSIS,"enteric FEVER,",82-90,106-117,infectious MONONUCLEOSIS,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 22:26:40,,1323874189,7/15/2014 22:26:21,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,90,117,,,95,130,FEVER,MONONUCLEOSIS,"enteric FEVER,",82-90,106-117,infectious MONONUCLEOSIS,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 22:33:46,,1323877712,7/15/2014 22:33:27,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,90,117,,,95,130,FEVER,MONONUCLEOSIS,"enteric FEVER,",82-90,106-117-131-140-145-151-157,"infectious MONONUCLEOSIS (Epstein Barr virus [EBV] infection),","11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 22:36:19,,1323879183,7/15/2014 22:36:14,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,90,117,,,95,130,FEVER,MONONUCLEOSIS,"brucellosis includes enteric FEVER, malaria, infectious mononucleosis",61-73-82-90-97-106-117,90-97-106-117-140-145,"fever, malaria, infectious MONONUCLEOSIS Barr virus","11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 22:44:27,,1323883045,7/15/2014 22:44:00,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,90,117,,,95,130,FEVER,MONONUCLEOSIS,"FEVER,",90,117-106,infectious MONONUCLEOSIS,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 23:00:21,,1323890571,7/15/2014 23:00:08,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,90,117,,,95,130,FEVER,MONONUCLEOSIS,"enteric FEVER, malaria, infectious mononucleosis",82-90-97-106-117,90-97-106-117,"fever, malaria, infectious MONONUCLEOSIS","11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 23:00:36,,1323890716,7/15/2014 23:00:13,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,90,117,,,95,130,FEVER,MONONUCLEOSIS,"enteric FEVER,",82-90,106-117-131-140-145-151-157,"infectious MONONUCLEOSIS (Epstein Barr virus [EBV] infection),","11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350520,7/15/2014 23:05:49,,1323894175,7/15/2014 23:05:21,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,90,117,,,95,130,FEVER,MONONUCLEOSIS,"enteric FEVER,",82-90,106-117-131-140-145-151-157,"infectious MONONUCLEOSIS (Epstein Barr virus [EBV] infection),","11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar.",90,117,90,117,95,130,-1,RO-disease_has_finding,901702,"11,12  DIFFERENTIAL DIAGNOSIS  The differential diagnosis of brucellosis includes enteric fever, malaria, infectious mononucleosis (Epstein-Barr virus [EBV] infection), atypical mononucleosis (cytomegalovirus infection), Q fever, miliary tuberculosis, subacute bacterial endocarditis, HIV infection, and visceral leishmaniasis (kala-azar",fever,mononucleosis
503350521,7/15/2014 21:58:22,,1323861186,7/15/2014 21:58:16,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS.,121,4-15,"TUBERCULIN response,","The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 22:02:07,,1323863054,7/15/2014 22:01:51,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,cellular immunity against TUBERCULOSIS.,95-104-113-121,0-4-15-25-31,"The TUBERCULIN response, which is","The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 22:05:18,,1323864424,7/15/2014 22:05:05,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS.,121,4-15,"TUBERCULIN response,","The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 22:15:52,,1323869228,7/15/2014 22:15:44,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS.,121,4-15,"TUBERCULIN response,","The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 22:20:09,,1323871167,7/15/2014 22:19:56,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS.,121,4-15,"TUBERCULIN response,","The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 22:43:02,,1323882382,7/15/2014 22:42:31,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS.,121,4,TUBERCULIN,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 22:43:59,,1323882837,7/15/2014 22:43:45,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS.,121,4-15,"TUBERCULIN response,","The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 22:54:44,,1323888051,7/15/2014 22:54:23,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,indicates the status cellular immunity against TUBERCULOSIS.,71-85-95-104-113-121-81,0-4-15-25-31-36-44,"The TUBERCULIN response, which is delayed hypersensitivity","The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 23:02:09,,1323891595,7/15/2014 23:01:25,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,cellular immunity against TUBERCULOSIS.,95-104-113-121,0-4-15,"The TUBERCULIN response,","The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350521,7/15/2014 23:14:00,,1323898846,7/15/2014 23:13:47,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,121,4,,,133,14,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS.,121,4,TUBERCULIN,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis.",121,4,121,4,133,14,1,RO-may_diagnose,906700,"The tuberculin response, which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against tuberculosis",tuberculosis,tuberculin
503350522,7/15/2014 21:58:02,,1323861047,7/15/2014 21:57:58,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,183,157,,,201,161,MICROCALCIFICATION,DCIS,(P=0.03) and between MICROCALCIFICATION on previous films,162-171-175-183-202-205-214,135-146-154-157-171-175,subsequent finding of DCIS and between,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:01:26,,1323862778,7/15/2014 22:01:01,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,183,157,,,201,161,MICROCALCIFICATION,DCIS,MICROCALCIFICATION,183,157-162,DCIS (P=0.03),"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:06:07,,1323864772,7/15/2014 22:05:45,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,183,157,,,201,161,MICROCALCIFICATION,DCIS,MICROCALCIFICATION ductal carcinomas,183-244-251,157-244-251,DCIS ductal carcinomas,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:06:51,,1323865177,7/15/2014 22:06:40,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,183,157,,,201,161,MICROCALCIFICATION,DCIS,MICROCALCIFICATION,183,157,DCIS,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:15:35,,1323869049,7/15/2014 22:15:18,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,183,157,,,201,161,MICROCALCIFICATION,DCIS,MICROCALCIFICATION,183,157,DCIS,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:16:42,,1323869617,7/15/2014 22:16:12,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,183,157,,,201,161,MICROCALCIFICATION,DCIS,MICROCALCIFICATION,183,157,DCIS,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:22:51,,1323872363,7/15/2014 22:22:38,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,183,157,,,201,161,MICROCALCIFICATION,DCIS,MICROCALCIFICATION,183,157,DCIS,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:27:37,,1323874578,7/15/2014 22:25:10,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,183,157,,,201,161,MICROCALCIFICATION,DCIS,MICROCALCIFICATION,183,157,DCIS,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:29:55,,1323875800,7/15/2014 22:29:48,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,183,157,,,201,161,MICROCALCIFICATION,DCIS,(P=0.03) and between MICROCALCIFICATION on previous films,162-171-175-183-202-205-214,135-146-154-157-171-175,subsequent finding of DCIS and between,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350522,7/15/2014 22:30:06,,1323875855,7/15/2014 22:29:47,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,183,157,,,201,161,MICROCALCIFICATION,DCIS,MICROCALCIFICATION,183,157,DCIS,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015.",183,157,183,157,201,161,1,RO-disease_may_have_finding,902662,"If only these 139 'true negative' screens are analysed, similar associations are seen between microcalcification on previous films and subsequent finding of DCIS (P=0.03) and between microcalcification on previous films and high grade invasive ductal carcinomas (P=0.015",microcalcification,DCIS
503350523,7/15/2014 22:07:02,,1323865227,7/15/2014 22:06:52,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS (GISTs),0-17-25-32,0-17-25-32,Gastrointestinal stromal tumors (GISTS),Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:11:48,,1323867519,7/15/2014 22:11:30,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS,0-17-25,32,(GISTS),Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:13:37,,1323868125,7/15/2014 22:13:29,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS (GISTs),0-17-25-32,17-25-32-0,Gastrointestinal stromal tumors (GISTS),Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:24:41,,1323873198,7/15/2014 22:24:23,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS,0-17-25,32,(GISTS),Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:30:38,,1323876117,7/15/2014 22:29:56,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS are the,0-17-25-40-44,17-25-32-40-44-48,stromal tumors (GISTS) are the most,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:32:03,,1323876698,7/15/2014 22:31:52,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS,0-17-25,32,(GISTS),Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:33:55,,1323877824,7/15/2014 22:33:43,instagc,1.0,13763729,USA,"","",75.182.89.225,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS,0-17-25,0-17-25-32,Gastrointestinal stromal tumors (GISTS),Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:35:40,,1323878877,7/15/2014 22:35:25,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS,0-17-25,17-25-0,Gastrointestinal stromal tumors,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:35:51,,1323878929,7/15/2014 22:35:45,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS are the,0-17-25-40-44,17-25-32-40-44-48,stromal tumors (GISTS) are the most,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350523,7/15/2014 22:36:35,,1323879281,7/15/2014 22:36:19,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,0,33,,,31,38,GASTROINTESTINAL STROMAL TUMORS,GISTS,GASTROINTESTINAL STROMAL TUMORS (GISTs),0-17-25-32,0-17-25-32,Gastrointestinal stromal tumors (GISTS),Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.,0 17 25,,0,33,31,38,-1,RO-has_manifestation,906423,Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract,Gastrointestinal stromal tumors,GISTs
503350524,7/15/2014 21:57:25,,1323860773,7/15/2014 21:56:54,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"symptoms, such as HEMATURIA,",91-101-106-109,46-56-59-67,detection of BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 21:59:37,,1323861838,7/15/2014 21:59:17,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"HEMATURIA,",109,59-67,BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 22:04:59,,1323864260,7/15/2014 22:04:44,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"HEMATURIA,",109,59-67,BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 22:17:13,,1323869834,7/15/2014 22:16:44,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"HEMATURIA,",109,59-67,BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 22:37:43,,1323879855,7/15/2014 22:37:17,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"HEMATURIA,",109,59-67,BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 22:38:08,,1323880105,7/15/2014 22:37:50,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"HEMATURIA,",109,59-67,BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 22:38:44,,1323880413,7/15/2014 22:38:11,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"HEMATURIA, bladder cancer.",109-136-144,59-67,BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 22:40:16,,1323881178,7/15/2014 22:39:53,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"HEMATURIA,",109,59-67,BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 22:54:57,,1323888120,7/15/2014 22:54:46,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"cancer in patients symptoms, such as HEMATURIA, or a history",67-74-91-101-106-109-120-123-125-77,38-46-56-59-67-74-77-86-91-109-101,"routine detection of BLADDER CANCER in patients with symptoms, such hematuria,","Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350524,7/15/2014 23:06:41,,1323894640,7/15/2014 23:06:30,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,109,59,,,118,73,HEMATURIA,BLADDER CANCER,"HEMATURIA,",109,59-67,BLADDER CANCER,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer.",109,59 67,109,59,118,73,1,RO-disease_may_have_finding,902781,"Bladder cancer screening differs from routine detection of bladder cancer in patients with symptoms, such as hematuria, or a history of bladder cancer",hematuria,bladder cancer
503350525,7/15/2014 21:58:15,,1323861130,7/15/2014 21:58:08,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,212,194,,,219,202,SEIZURE,EPILEPSY,SEIZURE,212,194,EPILEPSY,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 21:58:28,,1323861219,7/15/2014 21:58:12,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,212,194,,,219,202,SEIZURE,EPILEPSY,epilepsy epilepsy SEIZURE,16-194-212,16-194-212,epilepsy EPILEPSY seizure,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 22:01:34,,1323862848,7/15/2014 22:01:22,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,212,194,,,219,202,SEIZURE,EPILEPSY,epilepsy from the SEIZURE onset to the,194-203-208-212-220-226-229,178-182-191-194-203-208-212,the duration of EPILEPSY from the seizure,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 22:03:17,,1323863569,7/15/2014 22:03:06,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,212,194,,,219,202,SEIZURE,EPILEPSY,SEIZURE onset,212-220,194,EPILEPSY,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 22:07:09,,1323865282,7/15/2014 22:06:45,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,212,194,,,219,202,SEIZURE,EPILEPSY,duration of epilepsy from the SEIZURE,182-194-203-208-212-191,182-191-194-203-208-212,duration of EPILEPSY from the seizure,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 22:07:23,,1323865353,7/15/2014 22:07:12,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,212,194,,,219,202,SEIZURE,EPILEPSY,SEIZURE,212,194,EPILEPSY,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 22:15:08,,1323868867,7/15/2014 22:14:48,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,212,194,,,219,202,SEIZURE,EPILEPSY,epilepsy SEIZURE,194-212,194-212,EPILEPSY seizure,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 22:33:53,,1323877799,7/15/2014 22:33:39,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,212,194,,,219,202,SEIZURE,EPILEPSY,duration of epilepsy from the SEIZURE onset to the,182-194-203-208-212-220-226-229-191,178-182-191-194-203-208-212-220,the duration of EPILEPSY from the seizure onset,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 22:35:13,,1323878615,7/15/2014 22:34:25,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,212,194,,,219,202,SEIZURE,EPILEPSY,epilepsy SEIZURE,194-212,194-212,EPILEPSY seizure,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350525,7/15/2014 22:36:23,,1323879195,7/15/2014 22:36:13,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,212,194,,,219,202,SEIZURE,EPILEPSY,epilepsy from the SEIZURE,194-203-208-212,178-182-191-194-203-208-212,the duration of EPILEPSY from the seizure,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure.",212,194,212,194,219,202,-1,RO-has_definitional_manifestation,904668,"The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure",seizure,epilepsy
503350526,7/15/2014 22:00:16,,1323862212,7/15/2014 21:59:55,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,13-18-25,Long acting RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:03:53,,1323863797,7/15/2014 22:03:41,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,13-18-25,Long acting RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:09:59,,1323866609,7/15/2014 22:09:13,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,25,RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:16:42,,1323869618,7/15/2014 22:16:19,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,25,RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:17:15,,1323869847,7/15/2014 22:16:56,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,13-18-25,Long acting RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:18:40,,1323870487,7/15/2014 22:18:26,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,13-18-25,Long acting RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:32:56,,1323877271,7/15/2014 22:32:46,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,13-18-25,Long acting RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:33:00,,1323877296,7/15/2014 22:32:53,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"in patients with SCHIZOPHRENIA, including those patients",79-82-91-96-111-121-127,0-13-18-25-37-40-50,CONCLUSIONS: Long acting RISPERIDONE is effective and,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:37:37,,1323879779,7/15/2014 22:37:10,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,25,RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350526,7/15/2014 22:37:45,,1323879848,7/15/2014 22:37:29,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,96,25,,,109,36,SCHIZOPHRENIA,RISPERIDONE,"SCHIZOPHRENIA,",96,18-25-13,Long acting RISPERIDONE,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms.",96,25,96,25,109,36,1,RO-may_treat,908025,"CONCLUSIONS: Long-acting risperidone is effective and generally well tolerated in patients with schizophrenia, including those patients with stable symptoms",schizophrenia,risperidone
503350527,7/15/2014 21:58:40,,1323861352,7/15/2014 21:58:29,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"PORTAL VEIN stenosis,",42-49-54,0-7,PORTAL HYPERTENSION,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 21:59:43,,1323861864,7/15/2014 21:59:31,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"induced by graded PORTAL VEIN stenosis, whereas controls",24-32-35-42-49-54-64-72,0-7-20-24-32,PORTAL HYPERTENSION was induced by,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 22:16:43,,1323869632,7/15/2014 22:16:31,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"graded PORTAL VEIN stenosis,",35-42-49-54,0-7,PORTAL HYPERTENSION,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 22:18:22,,1323870412,7/15/2014 22:18:07,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"graded PORTAL VEIN stenosis,",35-42-49-54,0-7,PORTAL HYPERTENSION,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 22:38:24,,1323880210,7/15/2014 22:38:14,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"PORTAL VEIN stenosis,",42-49-54,0-7,PORTAL HYPERTENSION,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 22:39:49,,1323880985,7/15/2014 22:39:37,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,PORTAL VEIN,42-49,0-7,PORTAL HYPERTENSION,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 22:56:46,,1323888957,7/15/2014 22:55:07,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"PORTAL VEIN stenosis,",42-49-54,0-7,PORTAL HYPERTENSION,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 23:15:37,,1323899624,7/15/2014 23:15:34,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"induced by graded PORTAL VEIN stenosis, whereas controls",24-32-35-42-49-54-64-72,0-7-20-24-32,PORTAL HYPERTENSION was induced by,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 23:22:29,,1323903410,7/15/2014 23:22:05,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"graded PORTAL VEIN stenosis,",35-42-49-54,0-7,PORTAL HYPERTENSION,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350527,7/15/2014 23:23:36,,1323904149,7/15/2014 23:23:08,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,42,0,,,53,19,PORTAL VEIN,PORTAL HYPERTENSION,"induced by graded PORTAL VEIN stenosis,",24-32-35-42-49-54,0-7-20-24-32-35-42-49-54,"PORTAL HYPERTENSION was induced by graded portal vein stenosis,","Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation.",42 49,0 7,42,0,53,19,1,RO-has_finding_site,905126,"Portal hypertension was induced by graded portal vein stenosis, whereas controls had a sham operation",portal vein,Portal hypertension
503350528,7/15/2014 21:57:45,,1323860903,7/15/2014 21:57:41,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,124,143,,,131,158,VIRUSES,VIRAL INFECTION,the cells or VIRUSES during the viral,111-115-121-124-132-139-143,124-132-139-143-149-159,viruses during the VIRAL INFECTION cycle.,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 21:59:54,,1323862007,7/15/2014 21:59:37,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES,124,143-149-159,VIRAL INFECTION cycle.,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 22:09:24,,1323866331,7/15/2014 22:08:58,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES,124,143-149,VIRAL INFECTION,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 22:10:14,,1323866743,7/15/2014 22:10:00,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES,124,143-149,VIRAL INFECTION,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 22:14:10,,1323868362,7/15/2014 22:13:52,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES,124,143-149-159,VIRAL INFECTION cycle.,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 22:15:43,,1323869150,7/15/2014 22:15:34,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES,124,143-149-159,VIRAL INFECTION cycle.,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 22:28:49,,1323875195,7/15/2014 22:28:32,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES,124,143-149,VIRAL INFECTION,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 22:30:55,,1323876251,7/15/2014 22:30:42,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES,124,143-149,VIRAL INFECTION,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 22:32:53,,1323877249,7/15/2014 22:32:17,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES,124,143-149,VIRAL INFECTION,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350528,7/15/2014 22:38:49,,1323880447,7/15/2014 22:38:41,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,124,143,,,131,158,VIRUSES,VIRAL INFECTION,VIRUSES during the viral,124-132-139-143,124-132-139-143-149-159,viruses during the VIRAL INFECTION cycle.,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle.",124,143 149,124,143,131,158,1,RO-has_causative_agent,903536,"In order to determine the mode of antiviral action, the fragrant sumac extract was added at different times to the cells or viruses during the viral infection cycle",viruses,viral infection
503350529,7/15/2014 22:02:26,,1323863181,7/15/2014 22:02:05,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"PATHOLOGIC FRACTURES, hypercalcemia]),",49-60-194,32-37-194,"BONE METASTASES, hypercalcemia]),","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 22:04:25,,1323864007,7/15/2014 22:04:07,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"PATHOLOGIC FRACTURES,",49-60,32-37,"BONE METASTASES,","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 22:28:10,,1323874926,7/15/2014 22:27:53,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"PATHOLOGIC FRACTURES,",49-60,27-32-37,"(new BONE METASTASES,","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 22:36:45,,1323879394,7/15/2014 22:36:40,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"(new bone metastases, PATHOLOGIC FRACTURES, spinal cord compression,",27-32-37-49-60-71-78-83,11-20-27-32-37-49-60-71,"Skeletal events (new BONE METASTASES, pathologic fractures, spinal","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 22:41:26,,1323881610,7/15/2014 22:40:59,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"(new bone metastases, PATHOLOGIC FRACTURES,",27-32-37-49-60,32-37-49-60,"BONE METASTASES, pathologic fractures,","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 23:11:44,,1323897604,7/15/2014 23:11:24,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"PATHOLOGIC FRACTURES,",49-60,32-37,"BONE METASTASES,","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 23:12:24,,1323897929,7/15/2014 23:12:04,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"PATHOLOGIC FRACTURES,",49-60,32-37,"BONE METASTASES,","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 23:17:10,,1323900464,7/15/2014 23:17:07,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"(new bone metastases, PATHOLOGIC FRACTURES, spinal cord compression,",27-32-37-49-60-71-78-83,11-20-27-32-37-49-60-71,"Skeletal events (new BONE METASTASES, pathologic fractures, spinal","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 23:18:14,,1323901067,7/15/2014 23:17:53,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"(new bone metastases, PATHOLOGIC FRACTURES, spinal cord compression,",27-32-37-49-60-71-78-83,11-20-32-37-49-60-71,"Skeletal events BONE METASTASES, pathologic fractures, spinal","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350529,7/15/2014 23:21:43,,1323903074,7/15/2014 23:21:08,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,49,32,,,69,47,PATHOLOGIC FRACTURES,BONE METASTASES,"PATHOLOGIC FRACTURES,",49-60,32-37,"BONE METASTASES,","Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",49 60,32 37,49,32,69,47,-1,RO-disease_may_have_finding,902836,"Outcomes:  Skeletal events (new bone metastases, pathologic fractures, spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival",pathologic fractures,bone metastases
503350530,7/15/2014 21:58:48,,1323861449,7/15/2014 21:58:42,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,109,145,,,113,161,APML,ARSENIC TRIOXIDE,promyelocytic leukemia (APML) were treated with,85-99-108-115-120-128,120-128-133-145-153-174-182,treated with intravenous ARSENIC TRIOXIDE between December,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 21:59:28,,1323861756,7/15/2014 21:59:19,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,109,145,,,113,161,APML,ARSENIC TRIOXIDE,promyelocytic leukemia,85-99,145-153,ARSENIC TRIOXIDE,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 22:02:50,,1323863423,7/15/2014 22:02:24,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,109,145,,,113,161,APML,ARSENIC TRIOXIDE,acute promyelocytic leukemia (APML),79-85-99-108,133-145-153,intravenous ARSENIC TRIOXIDE,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 22:08:56,,1323866131,7/15/2014 22:08:46,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,109,145,,,113,161,APML,ARSENIC TRIOXIDE,acute promyelocytic leukemia (APML),85-99-108-79,145-153,ARSENIC TRIOXIDE,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 22:13:53,,1323868252,7/15/2014 22:13:33,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,109,145,,,113,161,APML,ARSENIC TRIOXIDE,promyelocytic leukemia (APML),85-99-108,145-153-133,intravenous ARSENIC TRIOXIDE,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 22:18:11,,1323870298,7/15/2014 22:17:56,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,109,145,,,113,161,APML,ARSENIC TRIOXIDE,acute promyelocytic leukemia (APML),85-99-108-79,133-145-153,intravenous ARSENIC TRIOXIDE,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 22:24:57,,1323873312,7/15/2014 22:24:44,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,109,145,,,113,161,APML,ARSENIC TRIOXIDE,promyelocytic leukemia (APML) were treated with,85-99-108-115-120-128,120-128-133-145-153-162,treated with intravenous ARSENIC TRIOXIDE (As(2)O(3)),A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 22:26:32,,1323874059,7/15/2014 22:26:15,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,109,145,,,113,161,APML,ARSENIC TRIOXIDE,(APML),108,145-153,ARSENIC TRIOXIDE,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 22:29:55,,1323875801,7/15/2014 22:29:37,instagc,1.0,13763729,USA,"","",75.182.89.225,109,145,,,113,161,APML,ARSENIC TRIOXIDE,promyelocytic leukemia (APML),85-99-108,145-153,ARSENIC TRIOXIDE,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350530,7/15/2014 22:33:30,,1323877559,7/15/2014 22:33:16,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,109,145,,,113,161,APML,ARSENIC TRIOXIDE,acute promyelocytic leukemia,79-85-99,145-153,ARSENIC TRIOXIDE,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003.,,145 153,109,145,113,161,1,RO-may_treat,908298,A total of 11 children (five males and six females) with hypergranular type of acute promyelocytic leukemia (APML) were treated with intravenous arsenic trioxide (As(2)O(3)) between December 1998 and October 2003,APML,arsenic trioxide
503350531,7/15/2014 21:58:35,,1323861265,7/15/2014 21:58:30,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI is a gram,0-13-26-29-31,66-76-82-85,causative agent of MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 21:58:49,,1323861467,7/15/2014 21:58:39,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,0-13,85,MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 22:09:56,,1323866602,7/15/2014 22:09:44,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,0-13,85,MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 22:10:10,,1323866698,7/15/2014 22:09:55,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,0-13,85,MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 22:12:50,,1323867901,7/15/2014 22:12:39,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,0-13,85,MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 22:16:05,,1323869310,7/15/2014 22:14:36,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,0-13,85,MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 22:32:03,,1323876692,7/15/2014 22:31:53,instagc,1.0,13763729,USA,"","",75.182.89.225,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,0-13,85,MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 22:32:54,,1323877255,7/15/2014 22:32:27,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI,0-13,85,MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 22:37:14,,1323879634,7/15/2014 22:37:08,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI is a gram,0-13-26-29-31,66-76-82-85,causative agent of MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350531,7/15/2014 22:39:02,,1323880536,7/15/2014 22:38:59,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,0,85,,,25,96,BURKHOLDERIA PSEUDOMALLEI,MELIOIDOSIS,BURKHOLDERIA PSEUDOMALLEI is a gram,0-13-26-29-31,66-76-82-85,causative agent of MELIOIDOSIS.,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis.,0 13,85,0,85,25,96,1,RO-has_causative_agent,903552,Burkholderia pseudomallei is a gram-negative bacillus that is the causative agent of melioidosis,Burkholderia pseudomallei,melioidosis
503350532,7/15/2014 21:57:55,,1323860999,7/15/2014 21:57:34,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"allergic rhinitis, asthma ATOPIC ECZEMA,",68-77-87-98-105,43-68-77-87-98-105,"ATOPIC allergic rhinitis, asthma atopic eczema,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 22:10:00,,1323866621,7/15/2014 22:09:47,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"ATOPIC ECZEMA,",98-105,43-50,"ATOPIC diseases,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 22:15:34,,1323869052,7/15/2014 22:15:12,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"ATOPIC ECZEMA,",98-105,43-50,"ATOPIC diseases,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 22:24:31,,1323873139,7/15/2014 22:23:59,clixsense,1.0,15235785,USA,MA,Lowell,71.233.2.198,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"rhinitis, asthma ATOPIC ECZEMA,",77-87-98-105,43-68-77-87-105,"ATOPIC allergic rhinitis, asthma eczema,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 22:34:32,,1323878193,7/15/2014 22:34:13,instagc,1.0,13763729,USA,"","",75.182.89.225,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"ATOPIC ECZEMA,",98-105,43-50,"ATOPIC diseases,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 22:35:40,,1323878870,7/15/2014 22:35:27,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"ATOPIC ECZEMA,",98-105,43-50,"ATOPIC diseases,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 22:37:09,,1323879564,7/15/2014 22:36:52,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"ATOPIC ECZEMA,",98-105,43-50,"ATOPIC diseases,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 22:57:45,,1323889427,7/15/2014 22:55:46,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"ATOPIC ECZEMA,",98-105,43-50,"ATOPIC diseases,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 22:58:27,,1323889723,7/15/2014 22:58:08,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"ATOPIC ECZEMA,",98-105,43-50,"ATOPIC diseases,","One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350532,7/15/2014 23:00:11,,1323890497,7/15/2014 22:59:46,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,98,43,,,111,49,ATOPIC ECZEMA,ATOPIC,"ATOPIC ECZEMA,",98-105,43,ATOPIC,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions.",98 105,43,98,43,111,49,-1,RO-cause_of,900166,"One suggestion for why some people develop atopic diseases, such as allergic rhinitis, asthma and atopic eczema, is that there are alterations in their intestinal microflora not seen in those without such conditions",atopic eczema,atopic
503350533,7/15/2014 22:00:54,,1323862523,7/15/2014 22:00:35,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,189,150,,,196,164,BLADDER,BLADDER INJURY,BLADDER,189,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:01:19,,1323862687,7/15/2014 22:01:05,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,189,150,,,196,164,BLADDER,BLADDER INJURY,BLADDER,189,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:04:10,,1323863883,7/15/2014 22:03:53,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,189,150,,,196,164,BLADDER,BLADDER INJURY,BLADDER,189,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:13:51,,1323868246,7/15/2014 22:13:37,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,189,150,,,196,164,BLADDER,BLADDER INJURY,BLADDER,189,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:19:24,,1323870790,7/15/2014 22:19:08,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,189,150,,,196,164,BLADDER,BLADDER INJURY,BLADDER,189,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:21:49,,1323871865,7/15/2014 22:21:27,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,189,150,,,196,164,BLADDER,BLADDER INJURY,Intraperitoneal rupture BLADDER,0-16-189,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:34:34,,1323878226,7/15/2014 22:34:21,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,189,150,,,196,164,BLADDER,BLADDER INJURY,BLADDER,189,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:40:29,,1323881253,7/15/2014 22:40:28,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,189,150,,,196,164,BLADDER,BLADDER INJURY,children because the BLADDER lies in the,168-177-185-189-197-202-205,134-138-143-150-158-165-168-177,the most common BLADDER INJURY in children because,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:54:52,,1323888098,7/15/2014 22:54:23,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,189,150,,,196,164,BLADDER,BLADDER INJURY,BLADDER,189,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350533,7/15/2014 22:56:03,,1323888607,7/15/2014 22:55:45,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,189,150,,,196,164,BLADDER,BLADDER INJURY,BLADDER lies in the abdomen.,189-197-202-205-209,150-158,BLADDER INJURY,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen.,189,150 158,189,150,196,164,1,RO-has_finding_site,905349,Intraperitoneal rupture usually involves the bladder dome; it often occurs when the bladder is distended at the time of trauma and is the most common bladder injury in children because the bladder lies in the abdomen,bladder,bladder injury
503350534,7/15/2014 22:01:28,,1323862798,7/15/2014 22:01:19,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,219,293,,,232,298,HAEMOPHILIA A,FVIII,"HAEMOPHILIA A,",219-231,293-299,FVIII inhibitor.,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 22:14:02,,1323868312,7/15/2014 22:13:53,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,219,293,,,232,298,HAEMOPHILIA A,FVIII,"HAEMOPHILIA A,",219-231,284-293-299,acquired FVIII inhibitor.,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 22:15:17,,1323868923,7/15/2014 22:14:58,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,219,293,,,232,298,HAEMOPHILIA A,FVIII,"HAEMOPHILIA A,",219-231,293,FVIII,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 22:33:49,,1323877745,7/15/2014 22:33:33,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,219,293,,,232,298,HAEMOPHILIA A,FVIII,"HAEMOPHILIA A,",219-231,284-293,acquired FVIII,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 22:39:31,,1323880789,7/15/2014 22:39:28,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,219,293,,,232,298,HAEMOPHILIA A,FVIII,"from patients with HAEMOPHILIA A, and seven serial",200-205-214-219-231-234-238-244,276-281-284-293-299,with an acquired FVIII inhibitor.,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 22:40:38,,1323881310,7/15/2014 22:40:27,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,219,293,,,232,298,HAEMOPHILIA A,FVIII,"patients with HAEMOPHILIA A, and seven serial",205-214-219-231-234-238-244,276-281-284-293-299,with an acquired FVIII inhibitor.,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 22:54:52,,1323888105,7/15/2014 22:53:59,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,219,293,,,232,298,HAEMOPHILIA A,FVIII,"HAEMOPHILIA A,",219-231,293-299,FVIII inhibitor.,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 23:07:54,,1323895333,7/15/2014 23:07:33,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,219,293,,,232,298,HAEMOPHILIA A,FVIII,"HAEMOPHILIA A,",219-231,293-299,FVIII inhibitor.,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 23:12:03,,1323897786,7/15/2014 23:11:37,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,219,293,,,232,298,HAEMOPHILIA A,FVIII,"HAEMOPHILIA A,",219-231,284-293-299,acquired FVIII inhibitor.,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350534,7/15/2014 23:24:15,,1323904521,7/15/2014 23:24:00,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,219,293,,,232,298,HAEMOPHILIA A,FVIII,"HAEMOPHILIA A, and seven serial samples",219-231-234-238-244-251,276-281-284-293-299,with an acquired FVIII inhibitor.,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor.",219 231,293,219,293,232,298,-1,RO-has_manifestation,906428,"In this study, a previously unpublished ELISA test for FVIII inhibitor screening (Genetic Testing Institute [GTI] FVIII inhibitor, Brookfield, WI, USA) was evaluated in 131 blood samples (124 samples from patients with haemophilia A, and seven serial samples from one patient with an acquired FVIII inhibitor",haemophilia A,FVIII
503350535,7/15/2014 21:58:24,,1323861174,7/15/2014 21:58:20,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,mellitus begin as DIABETIC KETOACIDOSIS.,59-68-74-77-86,37-41-47-50-59-68-74-77,new cases of DIABETES MELLITUS begin as diabetic,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 22:00:15,,1323862209,7/15/2014 22:00:03,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,DIABETIC KETOACIDOSIS.,77-86,50-59,DIABETES MELLITUS,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 22:12:59,,1323867937,7/15/2014 22:12:42,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,DIABETIC KETOACIDOSIS.,77-86,50-59,DIABETES MELLITUS,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 22:28:21,,1323875020,7/15/2014 22:28:10,instagc,1.0,13763729,USA,"","",75.182.89.225,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,DIABETIC KETOACIDOSIS.,77-86,50-59,DIABETES MELLITUS,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 22:36:59,,1323879494,7/15/2014 22:36:35,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,DIABETIC KETOACIDOSIS.,77-86,50-59,DIABETES MELLITUS,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 23:04:08,,1323893105,7/15/2014 23:03:52,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,DIABETIC KETOACIDOSIS.,77-86,50-59,DIABETES MELLITUS,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 23:15:32,,1323899580,7/15/2014 23:15:30,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,mellitus begin as DIABETIC KETOACIDOSIS.,59-68-74-77-86,37-41-47-50-59-68-74-77,new cases of DIABETES MELLITUS begin as diabetic,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 23:20:26,,1323902435,7/15/2014 23:20:08,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,DIABETIC KETOACIDOSIS.,77-86,50-59,DIABETES MELLITUS,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 23:26:00,,1323905530,7/15/2014 23:25:39,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,DIABETIC KETOACIDOSIS.,77-86,50-59,DIABETES MELLITUS,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350535,7/15/2014 23:26:09,,1323905606,7/15/2014 23:25:56,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,77,50,,,98,67,DIABETIC KETOACIDOSIS,DIABETES MELLITUS,DIABETIC KETOACIDOSIS.,77-86,50-59,DIABETES MELLITUS,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis.,77 86,50 59,77,50,98,67,1,RO-cause_of,900074,Rationale: ? A significant number of new cases of diabetes mellitus begin as diabetic ketoacidosis,diabetic ketoacidosis,diabetes mellitus
503350536,7/15/2014 21:57:51,,1323860983,7/15/2014 21:57:36,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,190,154,,,198,162,HEADACHE,MIGRAINE,"episodic tension type HEADACHE,",168-177-185-190,154,"MIGRAINE,","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 22:07:23,,1323865369,7/15/2014 22:07:00,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,190,154,,,198,162,HEADACHE,MIGRAINE,"migraine, HEADACHE,",154-190,154,"MIGRAINE,","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 22:11:01,,1323867137,7/15/2014 22:10:38,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,190,154,,,198,162,HEADACHE,MIGRAINE,"episodic tension type HEADACHE,",168-177-185-190,154,"MIGRAINE,","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 22:31:19,,1323876375,7/15/2014 22:31:12,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,190,154,,,198,162,HEADACHE,MIGRAINE,"episodic tension type HEADACHE, chronic tension",168-177-185-190-204-212,140-142-150-154-168-177,"5 groups: (1) MIGRAINE, episodic tension","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 22:35:36,,1323878844,7/15/2014 22:35:17,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,190,154,,,198,162,HEADACHE,MIGRAINE,"episodic tension type HEADACHE,",168-177-185-190,154,"MIGRAINE,","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 22:43:52,,1323882782,7/15/2014 22:43:32,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,190,154,,,198,162,HEADACHE,MIGRAINE,"tension type HEADACHE,",177-185-190,154,"MIGRAINE,","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 22:46:05,,1323883686,7/15/2014 22:45:38,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,190,154,,,198,162,HEADACHE,MIGRAINE,"episodic tension type HEADACHE, chronic tension",168-177-185-190-204-212,154-168-177,"MIGRAINE, episodic tension","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 22:56:14,,1323888678,7/15/2014 22:55:48,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,190,154,,,198,162,HEADACHE,MIGRAINE,"episodic tension type HEADACHE,",168-177-185-190,154,"MIGRAINE,","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 22:57:32,,1323889310,7/15/2014 22:57:17,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,190,154,,,198,162,HEADACHE,MIGRAINE,"episodic tension type HEADACHE,",168-177-185-190,154,"MIGRAINE,","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350536,7/15/2014 23:10:14,,1323896815,7/15/2014 23:09:50,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,190,154,,,198,162,HEADACHE,MIGRAINE,"episodic tension type HEADACHE,",168-177-185-190,154,"MIGRAINE,","Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache.",190,154,190,154,198,162,-1,RO-has_definitional_manifestation,904983,"Two hundred and one headache patients attending the Headache Center of the University of Turin were selected for the study and divided into 5 groups: (1) migraine, (2) episodic tension-type headache, (3) chronic tension-type headache, (4) migraine associated with episodic tension-type headache and (5) migraine associated with chronic tension-type headache",headache,migraine
503350537,7/15/2014 22:10:10,,1323866699,7/15/2014 22:09:26,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,247,311,,,256,316,ARTHRITIS,LUPUS,ARTHRITIS,247,311,LUPUS,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 22:16:30,,1323869501,7/15/2014 22:16:12,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,247,311,,,256,316,ARTHRITIS,LUPUS,Juvenile rheumatoid ARTHRITIS,227-236-247,302-311-317,Systemic LUPUS erythematosus,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 22:25:21,,1323873525,7/15/2014 22:25:02,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,247,311,,,256,316,ARTHRITIS,LUPUS,Juvenile rheumatoid ARTHRITIS,227-236-247,302-311-317,Systemic LUPUS erythematosus,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 22:34:06,,1323877929,7/15/2014 22:33:53,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,247,311,,,256,316,ARTHRITIS,LUPUS,Juvenile rheumatoid ARTHRITIS,227-236-247,300-311-317,? LUPUS erythematosus,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 22:36:36,,1323879290,7/15/2014 22:36:16,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,247,311,,,256,316,ARTHRITIS,LUPUS,Juvenile rheumatoid ARTHRITIS,227-236-247,302-311-317,Systemic LUPUS erythematosus,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 23:14:59,,1323899337,7/15/2014 23:14:29,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,247,311,,,256,316,ARTHRITIS,LUPUS,Juvenile rheumatoid ARTHRITIS,227-236-247,302-311-317,Systemic LUPUS erythematosus,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 23:17:44,,1323900781,7/15/2014 23:17:41,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,247,311,,,256,316,ARTHRITIS,LUPUS,? Juvenile rheumatoid ARTHRITIS Inflammatory bowel disease,225-227-236-247-259-272-278,288-300-302-311-317-333-342,Sarcoidosis ? Systemic LUPUS erythematosus Behcet's disease,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 23:18:07,,1323901006,7/15/2014 23:17:42,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,247,311,,,256,316,ARTHRITIS,LUPUS,Juvenile rheumatoid ARTHRITIS,227-236-247,300-302-311-317,? Systemic LUPUS erythematosus,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 23:22:41,,1323903508,7/15/2014 23:21:49,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,247,311,,,256,316,ARTHRITIS,LUPUS,diagnosis ARTHRITIS,247-62,77-311-87,indicates susceptibility LUPUS,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350537,7/15/2014 23:25:13,,1323905111,7/15/2014 23:24:53,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,247,311,,,256,316,ARTHRITIS,LUPUS,Juvenile rheumatoid ARTHRITIS,236-247-227,311-317,LUPUS erythematosus,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection.,247,311,247,311,256,316,-1,RO-has_manifestation,906154,BC]  Specific recommendation: ? Note if the patient carries a diagnosis that indicates susceptibility to uveitis or any signs or symptoms of these diseases: ? Ankylosing spondylitis ? Reactive arthritis ? Psoriatic arthritis ? Juvenile rheumatoid arthritis ? Inflammatory bowel disease ? Sarcoidosis ? Systemic lupus erythematosus ? Behcet's disease ? Wegener granulomatosis ? Relapsing polychondritis ? Systemic or cerebral vasculitis ? Multiple sclerosis ? Tubular interstitial nephritis ? Juvenile xanthogranuloma ? Toxoplasmosis ? Syphilis ? Herpes zoster ophthalmicus ? Lyme disease ? Tuberculosis ? West Nile virus ? Whipple disease ? HTLV-1 infection,arthritis,lupus
503350538,7/15/2014 22:02:36,,1323863261,7/15/2014 22:02:15,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,28-43,ANTIARRHYTHMIC effect,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:13:52,,1323868254,7/15/2014 22:13:39,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,28-43,ANTIARRHYTHMIC effect,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:14:07,,1323868332,7/15/2014 22:13:47,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,28-43,ANTIARRHYTHMIC effect,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:16:26,,1323869494,7/15/2014 22:16:09,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,28,ANTIARRHYTHMIC,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:22:19,,1323872092,7/15/2014 22:22:07,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,28,ANTIARRHYTHMIC,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:32:31,,1323877025,7/15/2014 22:32:18,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,propranolol only corrected CARDIAC ARRHYTHMIAS suggests that the,90-102-107-117-125-137-146-151,5-14-19-28-43-50-54,naloxone both produced ANTIARRHYTHMIC effect and prolonged,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:37:21,,1323879671,7/15/2014 22:37:07,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,28,ANTIARRHYTHMIC,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:40:12,,1323881161,7/15/2014 22:39:41,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,5-14-19-28-43-50-54,naloxone both produced ANTIARRHYTHMIC effect and prolonged,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:40:40,,1323881318,7/15/2014 22:40:11,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,28-43,ANTIARRHYTHMIC effect,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350538,7/15/2014 22:42:34,,1323882153,7/15/2014 22:42:14,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,117,28,,,136,42,CARDIAC ARRHYTHMIAS,ANTIARRHYTHMIC,CARDIAC ARRHYTHMIAS,117-125,28-43,ANTIARRHYTHMIC effect,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect.,117 125,28,117,28,136,42,1,RO-may_prevent,907040,That naloxone both produced antiarrhythmic effect and prolonged the survival time whereas propranolol only corrected cardiac arrhythmias suggests that the antiarrhythmic effect of naloxone may not result in prolongation of survival time and that different mechanisms may be involved in the antiarrhythmic effect,cardiac arrhythmias,antiarrhythmic
503350539,7/15/2014 21:56:23,,1323860378,7/15/2014 21:55:43,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES persist,90-99,48-56-59-71,"chronic or INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 21:59:44,,1323861917,7/15/2014 21:59:37,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES,90,59-71,"INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 22:17:31,,1323869977,7/15/2014 22:17:20,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES,90,59-71,"INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 22:22:14,,1323872055,7/15/2014 22:21:50,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES,90,59-71,"INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 22:25:23,,1323873559,7/15/2014 22:24:50,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,"epilepsy, SEIZURES",71-90,59-71,"INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 22:31:13,,1323876350,7/15/2014 22:29:57,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES,90,59-71,"INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 22:34:59,,1323878449,7/15/2014 22:34:42,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES,90,48-56-59-71,"chronic or INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 22:37:52,,1323879953,7/15/2014 22:36:58,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES,90,59-71,"INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 22:45:24,,1323883421,7/15/2014 22:45:07,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES,90,59-71,"INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350539,7/15/2014 22:59:31,,1323890152,7/15/2014 22:59:15,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,90,59,,,98,79,SEIZURES,INTRACTABLE EPILEPSY,SEIZURES,90,59-71,"INTRACTABLE EPILEPSY,","Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.",90,59 71,90,59,98,79,-1,RO-has_definitional_manifestation,904631,"Twenty to 30% of patients with epilepsy develop chronic or intractable epilepsy, i.e. the seizures persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs",seizures,intractable epilepsy
503350540,7/15/2014 22:14:20,,1323868436,7/15/2014 22:13:50,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,GASTRO OESOPHAGEAL REFLUX,46-53-65,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 22:24:16,,1323873030,7/15/2014 22:24:01,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,GASTRO OESOPHAGEAL REFLUX,46-53-65,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 22:29:21,,1323875531,7/15/2014 22:29:05,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,food stimulated GASTRO OESOPHAGEAL REFLUX,30-35-46-53-65,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 22:30:48,,1323876215,7/15/2014 22:30:10,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,GASTRO OESOPHAGEAL REFLUX,46-53-65,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 22:33:38,,1323877639,7/15/2014 22:33:18,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,GASTRO OESOPHAGEAL REFLUX,46-53-65,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 22:35:57,,1323878973,7/15/2014 22:35:41,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,GASTRO OESOPHAGEAL REFLUX,46-53-65,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 22:47:22,,1323884208,7/15/2014 22:46:50,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,food stimulated GASTRO OESOPHAGEAL REFLUX mechanisms,30-46-53-65-72-35,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 23:01:42,,1323891333,7/15/2014 23:00:50,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,food stimulated GASTRO OESOPHAGEAL REFLUX mechanisms,30-35-46-53-65-72,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 23:03:34,,1323892606,7/15/2014 23:03:10,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,food stimulated GASTRO OESOPHAGEAL REFLUX mechanisms,30-35-46-53-65-72,4-14-17,influence of CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350540,7/15/2014 23:04:31,,1323893311,7/15/2014 23:04:12,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,46,17,,,71,26,GASTRO-OESOPHAGEAL REFLUX,CISAPRIDE,GASTRO OESOPHAGEAL REFLUX,46-53-65,17,CISAPRIDE,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis.",46 53 65,17,46,17,71,26,1,RO-may_treat,908361,"The influence of Cisapride on food-stimulated gastro-oesophageal reflux mechanisms was studied in a double-blind cross-over investigation in 24 consecutive patients selected by endoscopy, 12 with microscopical evidence of gastro-oesophageal reflux and 12 with additional macroscopic oesophagitis",gastro-oesophageal reflux,Cisapride
503350541,7/15/2014 22:00:06,,1323862120,7/15/2014 21:59:57,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,thyroid tissue: (1) COLD NODULES; autonomous nodules;,155-163-171-175-180-193-204,217-227-238-242-252-267-278,papillary carcinoma; (4) MEDULLARY CARCINOMA; metastasis of,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 22:01:55,,1323862963,7/15/2014 22:01:45,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,COLD NODULES;,175-180,242-252,MEDULLARY CARCINOMA;,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 22:07:39,,1323865501,7/15/2014 22:07:23,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,COLD NODULES;,175-180,242-252,MEDULLARY CARCINOMA;,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 22:32:29,,1323877013,7/15/2014 22:32:15,instagc,1,13763729,USA,"","",75.182.89.225,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,COLD NODULES;,175-180,242-252,MEDULLARY CARCINOMA;,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 22:33:25,,1323877523,7/15/2014 22:33:16,bitcoinget,1,28377798,GBR,"","",195.166.117.126,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,thyroid tissue: (1) COLD NODULES; autonomous nodules;,155-163-171-175-180-193-204,217-227-238-242-252-267-278,papillary carcinoma; (4) MEDULLARY CARCINOMA; metastasis of,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 22:48:24,,1323884697,7/15/2014 22:47:57,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,"thyroid tissue: (1) COLD NODULES; autonomous nodules; papillary carcinoma; medullary carcinoma; metastasis of papillary carcinoma lymph node; anaplastic carcinoma, Graves' thyroid.",155-163-171-175-180-193-204-217-227-242-252-267-278-281-291-304-310-320-350-358-331,175-180-193-217-227-238-242-252-267-278-281-291-301-304-310-320-331-350-358-204,"cold nodules; autonomous nodules; papillary carcinoma; (4) MEDULLARY CARCINOMA; metastasis of papillary carcinoma to lymph node; anaplastic carcinoma, Graves' thyroid.","Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 22:57:12,,1323889184,7/15/2014 22:56:52,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,COLD NODULES;,175-180,242-252,MEDULLARY CARCINOMA;,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 22:57:24,,1323889249,7/15/2014 22:56:46,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,COLD NODULES;,175-180,242-252,MEDULLARY CARCINOMA;,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 23:17:27,,1323900611,7/15/2014 23:17:24,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,thyroid tissue: (1) COLD NODULES; autonomous nodules;,155-163-171-175-180-193-204,217-227-238-242-252-267-278,papillary carcinoma; (4) MEDULLARY CARCINOMA; metastasis of,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350541,7/15/2014 23:17:52,,1323900828,7/15/2014 23:17:39,clixsense,1,26770238,CAN,ON,London,209.183.157.27,175,242,,,187,261,COLD NODULES,MEDULLARY CARCINOMA,thyroid tissue: (1) COLD NODULES; autonomous nodules;,155-163-171-175-180-193-204,217-227-238-242-252-267,papillary carcinoma; (4) MEDULLARY CARCINOMA; metastasis,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",175 180,242 252,175,242,187,261,-1,RO-disease_may_have_finding,902601,"Affinity labelling with a 125I-labelled photoactive derivative of TSH (HSAB-TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) cold nodules; (2) autonomous nodules; (3) papillary carcinoma; (4) medullary carcinoma; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid",cold nodules,medullary carcinoma
503350542,7/15/2014 21:57:57,,1323860998,7/15/2014 21:57:45,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,BRONCHIECTASIS,106,125-132,CYSTIC FIBROSIS,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 22:00:16,,1323862211,7/15/2014 21:59:43,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,BRONCHIECTASIS and cystic fibrosis,106-121-125-132,106-121-125-132,bronchiectasis and CYSTIC FIBROSIS,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 22:32:27,,1323876997,7/15/2014 22:32:10,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,BRONCHIECTASIS,106,125-132,CYSTIC FIBROSIS,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 22:36:32,,1323879267,7/15/2014 22:36:27,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,"patients with bronchitis, BRONCHIECTASIS and cystic fibrosis",80-89-94-106-121-125-132,94-106-121-125-132-141-145-154,"bronchitis, bronchiectasis and CYSTIC FIBROSIS and occurred in","Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 22:37:21,,1323879676,7/15/2014 22:37:08,clixsense,1,7265596,USA,IA,Neola,199.120.116.136,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,"bronchitis, BRONCHIECTASIS and cystic fibrosis",94-106-121-125-132,94-106-121-125-132,"bronchitis, bronchiectasis and CYSTIC FIBROSIS","Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 22:37:54,,1323879963,7/15/2014 22:37:08,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,"patients with bronchitis, BRONCHIECTASIS and cystic fibrosis",80-89-94-106-121-125-132,80-94-106-121-125-132-141-145-89,"patients with bronchitis, bronchiectasis and CYSTIC FIBROSIS and occurred","Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 22:39:32,,1323880799,7/15/2014 22:39:21,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,BRONCHIECTASIS,106,125-132,CYSTIC FIBROSIS,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 22:41:03,,1323881498,7/15/2014 22:40:37,neodev,1,13525941,AUS,02,Sydney,14.200.47.168,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,BRONCHIECTASIS,106,125-132,CYSTIC FIBROSIS,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 23:00:03,,1323890439,7/15/2014 22:59:48,instagc,1,23149109,USA,NC,Durham,75.189.206.205,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,BRONCHIECTASIS and cystic fibrosis,106-121-125-132,106-121-125-132,bronchiectasis and CYSTIC FIBROSIS,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350542,7/15/2014 23:01:44,,1323891368,7/15/2014 23:01:24,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,106,125,,,120,140,BRONCHIECTASIS,CYSTIC FIBROSIS,BRONCHIECTASIS,106,125-132,CYSTIC FIBROSIS,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess.",106,125 132,106,125,120,140,-1,RO-has_manifestation,906314,"Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess",bronchiectasis,cystic fibrosis
503350543,7/15/2014 22:00:46,,1323862455,7/15/2014 22:00:32,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,of radiation induced XEROSTOMIA.,336-339-349-357,289-298-301-306-318-322-326,efficacy of oral PILOCARPINE for the treatment,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:00:46,,1323862464,7/15/2014 22:00:31,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,radiation induced XEROSTOMIA.,339-349-357,306-339-349-357,PILOCARPINE radiation induced xerostomia.,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:04:44,,1323864190,7/15/2014 22:04:23,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,XEROSTOMIA.,357,306,PILOCARPINE,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:15:33,,1323869048,7/15/2014 22:15:23,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,radiation induced XEROSTOMIA.,339-349-357,301-306,oral PILOCARPINE,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:15:52,,1323869219,7/15/2014 22:15:36,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,XEROSTOMIA.,357,306,PILOCARPINE,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:18:58,,1323870604,7/15/2014 22:17:55,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,oral pilocarpine of radiation induced XEROSTOMIA.,301-336-339-349-357-306,289-298-301-306-318-322-326-339-349-357,efficacy of oral PILOCARPINE for the treatment radiation induced xerostomia.,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:26:12,,1323873957,7/15/2014 22:25:56,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,XEROSTOMIA.,357,306,PILOCARPINE,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:30:42,,1323876147,7/15/2014 22:30:27,instagc,1.0,13763729,USA,"","",75.182.89.225,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,radiation induced XEROSTOMIA.,349-357-339,301-306,oral PILOCARPINE,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:30:59,,1323876273,7/15/2014 22:30:40,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,of radiation induced XEROSTOMIA.,336-339-349-357,289-298-301-306-318-322-326,efficacy of oral PILOCARPINE for the treatment,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350543,7/15/2014 22:35:09,,1323878555,7/15/2014 22:34:54,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,357,306,,,367,317,XEROSTOMIA,PILOCARPINE,- XEROSTOMIA.,348-357,301-306,oral PILOCARPINE,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia.",357,306,357,306,367,317,1,RO-may_treat,908334,"Two hundred sixty-five patients with head and neck cancer who had previously participated in either a fixed-dose, dose-titration, or dose-ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36-month multicenter maintenance study to evaluate the long-term safety and efficacy of oral pilocarpine for the treatment of radiation-induced xerostomia",xerostomia,pilocarpine
503350544,7/15/2014 21:59:10,,1323861613,7/15/2014 21:59:02,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,58,0,,,64,15,CRAMPS,QUININE SULFATE,nocturnal CRAMPS.,48-58,0-8,QUININE SULFATE,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:12:45,,1323867858,7/15/2014 22:12:27,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,58,0,,,64,15,CRAMPS,QUININE SULFATE,nocturnal CRAMPS.,48-58,0-8,QUININE SULFATE,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:13:10,,1323867969,7/15/2014 22:13:00,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,58,0,,,64,15,CRAMPS,QUININE SULFATE,CRAMPS.,58,0-8,QUININE SULFATE,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:17:12,,1323869836,7/15/2014 22:17:01,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,58,0,,,64,15,CRAMPS,QUININE SULFATE,nocturnal CRAMPS.,48-58,0-8,QUININE SULFATE,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:24:40,,1323873179,7/15/2014 22:24:21,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,58,0,,,64,15,CRAMPS,QUININE SULFATE,nocturnal CRAMPS.,48-58,0-8,QUININE SULFATE,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:28:06,,1323874859,7/15/2014 22:27:54,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,58,0,,,64,15,CRAMPS,QUININE SULFATE,CRAMPS.,58,0-8,QUININE SULFATE,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:29:11,,1323875420,7/15/2014 22:29:05,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,58,0,,,64,15,CRAMPS,QUININE SULFATE,drug for nocturnal CRAMPS.,39-44-48-58,0-8-16-19-21,QUININE SULFATE is a widely,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:39:20,,1323880703,7/15/2014 22:39:12,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,58,0,,,64,15,CRAMPS,QUININE SULFATE,nocturnal CRAMPS.,48-58,0-8,QUININE SULFATE,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:40:10,,1323881155,7/15/2014 22:40:03,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,58,0,,,64,15,CRAMPS,QUININE SULFATE,drug for nocturnal CRAMPS.,39-44-48-58,0-8-16-19-21,QUININE SULFATE is a widely,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350544,7/15/2014 22:45:06,,1323883319,7/15/2014 22:44:56,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.170,58,0,,,64,15,CRAMPS,QUININE SULFATE,nocturnal CRAMPS.,48-58,0-8,QUININE SULFATE,Quinine sulfate is a widely prescribed drug for nocturnal cramps.,58,0 8,58,0,64,15,1,RO-may_prevent,907323,Quinine sulfate is a widely prescribed drug for nocturnal cramps,cramps,Quinine sulfate
503350545,7/15/2014 21:57:39,,1323860872,7/15/2014 21:57:36,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"slight, moderate or SEVERE DYSPLASIA, carcinoma in situ,",82-90-99-102-109-120-130-133,99-102-109-120-130-133-139-152-161,"or severe dysplasia, CARCINOMA IN SITU, questionable invasive carcinoma","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 22:00:51,,1323862514,7/15/2014 22:00:32,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"SEVERE DYSPLASIA, carcinoma in situ,",102-109-120-130-133,102-109-120-130-133,"severe dysplasia, CARCINOMA IN SITU,","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 22:18:40,,1323870493,7/15/2014 22:18:21,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"SEVERE DYSPLASIA,",102-109,120-130-133,"CARCINOMA IN SITU,","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 22:31:51,,1323876621,7/15/2014 22:31:27,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"SEVERE DYSPLASIA,",102-109,120-130-133,"CARCINOMA IN SITU,","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 22:55:33,,1323888388,7/15/2014 22:54:52,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"SEVERE DYSPLASIA, carcinoma",102-109-120,102-109-120-130-133,"severe dysplasia, CARCINOMA IN SITU,","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 23:00:22,,1323890560,7/15/2014 22:59:55,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"SEVERE DYSPLASIA,",102-109,120-130-133,"CARCINOMA IN SITU,","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 23:17:06,,1323900422,7/15/2014 23:17:03,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"slight, moderate or SEVERE DYSPLASIA, carcinoma in situ,",82-90-99-102-109-120-130-133,99-102-109-120-130-133-139-152-161,"or severe dysplasia, CARCINOMA IN SITU, questionable invasive carcinoma","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 23:19:21,,1323901828,7/15/2014 23:18:57,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"SEVERE DYSPLASIA,",102-109,120-130-133,"CARCINOMA IN SITU,","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 23:21:49,,1323903152,7/15/2014 23:21:30,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"slight, moderate or SEVERE DYSPLASIA,",82-90-99-102-109,120-130-133,"CARCINOMA IN SITU,","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350545,7/15/2014 23:25:47,,1323905424,7/15/2014 23:24:45,clixsense,1.0,23272697,GBR,F6,Romford,94.11.43.229,102,120,,,118,137,SEVERE DYSPLASIA,CARCINOMA IN SITU,"SEVERE DYSPLASIA, invasive carcinoma.",102-109-175-184,120-130-133-139-152-161,"CARCINOMA IN SITU, questionable invasive carcinoma","Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma.",102 109,120 130 133,102,120,118,137,-1,RO-disease_has_finding,901517,"Both in mice and in human material, the histological changes were classified into slight, moderate or severe dysplasia, carcinoma in situ, questionable invasive carcinoma and invasive carcinoma",severe dysplasia,carcinoma in situ
503350546,7/15/2014 21:59:05,,1323861569,7/15/2014 21:58:46,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS of the head,0-10-13-17,51-55-65-75-79-87,all MALIGNANT MELANOMAS and mucosal melanomas,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 22:05:48,,1323864636,7/15/2014 22:05:36,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS of the head and neck,0-10-13-17-22-26,55-65-75-79-87,MALIGNANT MELANOMAS and mucosal melanomas,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 22:12:15,,1323867677,7/15/2014 22:11:49,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS,0,55-65,MALIGNANT MELANOMAS,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 22:28:29,,1323875081,7/15/2014 22:28:11,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS,0,55-65,MALIGNANT MELANOMAS,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 22:36:07,,1323879054,7/15/2014 22:35:58,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS,0,55-65,MALIGNANT MELANOMAS,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 22:37:42,,1323879839,7/15/2014 22:37:37,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS of the head,0-10-13-17,44-48-51-55-65-75-79-87,20% of all MALIGNANT MELANOMAS and mucosal melanomas,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 22:39:04,,1323880562,7/15/2014 22:38:53,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS,0,55-65,MALIGNANT MELANOMAS,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 22:39:39,,1323880909,7/15/2014 22:39:20,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS of the head mucosal melanomas,0-10-13-17-79-87,44-48-51-55-65-75-79-87,20% of all MALIGNANT MELANOMAS and mucosal melanomas,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 22:59:54,,1323890367,7/15/2014 22:59:43,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS,0,55-65,MALIGNANT MELANOMAS,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350546,7/15/2014 23:09:03,,1323896059,7/15/2014 23:08:45,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,0,55,,,9,74,MELANOMAS,MALIGNANT MELANOMAS,MELANOMAS,0,55-65,MALIGNANT MELANOMAS,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%.,0,55 65,0,55,9,74,-1,RO-has_manifestation,906217,Melanomas of the head and neck represent 15-20% of all malignant melanomas and mucosal melanomas 1-2%,Melanomas,malignant melanomas
503350547,7/15/2014 22:03:09,,1323863535,7/15/2014 22:02:46,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR or nephroblastoma is a malignant tumor,0-7-13-16-31-34-36-46,0-7-13-16-31-34-36,Wilms' tumor or NEPHROBLASTOMA is a malignant,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 22:06:40,,1323865077,7/15/2014 22:06:28,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR,0-7,16,NEPHROBLASTOMA,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 22:06:58,,1323865219,7/15/2014 22:06:46,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR,0-7,0-7-16,Wilms' tumor NEPHROBLASTOMA,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 22:28:49,,1323875201,7/15/2014 22:28:28,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR or nephroblastoma is,0-7-13-16-31,0-7-13-16-31-34-36,Wilms' tumor or NEPHROBLASTOMA is a malignant,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 22:38:52,,1323880492,7/15/2014 22:38:40,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR,0-7,16,NEPHROBLASTOMA,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 22:41:31,,1323881657,7/15/2014 22:41:14,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR,0-7,16,NEPHROBLASTOMA,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 22:59:44,,1323890277,7/15/2014 22:58:52,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR,0-7,16,NEPHROBLASTOMA,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 23:02:17,,1323891712,7/15/2014 23:02:02,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR,0-7,16,NEPHROBLASTOMA,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 23:13:01,,1323898243,7/15/2014 23:12:49,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR,0-7,16,NEPHROBLASTOMA,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350547,7/15/2014 23:18:16,,1323901080,7/15/2014 23:18:13,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,0,16,,,12,30,WILMS' TUMOR,NEPHROBLASTOMA,WILMS' TUMOR or nephroblastoma is,0-7-13-16-31,0-7-13-16-31-34-36,Wilms' tumor or NEPHROBLASTOMA is a malignant,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature.,0 7,16,0,16,12,30,-1,RO-has_manifestation,906101,Wilms' tumor or nephroblastoma is a malignant tumor of childhood and there are less than 200 cases in adults reported in the literature,Wilms' tumor,nephroblastoma
503350548,7/15/2014 22:10:35,,1323866877,7/15/2014 22:10:12,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,99,154,,,108,159,HAY FEVER,ATOPY,HAY FEVER,99-103,154,ATOPY,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 22:35:55,,1323878968,7/15/2014 22:35:37,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,99,154,,,108,159,HAY FEVER,ATOPY,HAY FEVER,99-103,154,ATOPY,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 22:38:15,,1323880161,7/15/2014 22:37:53,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,99,154,,,108,159,HAY FEVER,ATOPY,HAY FEVER,99-103,154,ATOPY,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 22:40:32,,1323881259,7/15/2014 22:40:30,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,99,154,,,108,159,HAY FEVER,ATOPY,patients suffering from HAY FEVER with the most,75-84-94-99-103-109-114-118,130-141-151-154-160-165-168,hereditary liability of ATOPY than in the,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 22:55:03,,1323888157,7/15/2014 22:54:47,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,99,154,,,108,159,HAY FEVER,ATOPY,HAY FEVER,99-103,130-141-151-154,hereditary liability of ATOPY,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 23:04:23,,1323893228,7/15/2014 23:04:09,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,99,154,,,108,159,HAY FEVER,ATOPY,HAY FEVER,99-103,154,ATOPY,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 23:09:49,,1323896554,7/15/2014 23:09:31,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,99,154,,,108,159,HAY FEVER,ATOPY,HAY FEVER,99-103,154,ATOPY,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 23:16:35,,1323900078,7/15/2014 23:16:33,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,99,154,,,108,159,HAY FEVER,ATOPY,patients suffering from HAY FEVER with the most,75-84-94-99-103-109-114-118,130-141-151-154-160-165-168,hereditary liability of ATOPY than in the,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 23:22:58,,1323903717,7/15/2014 23:22:34,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,99,154,,,108,159,HAY FEVER,ATOPY,HAY FEVER,99-103,154,ATOPY,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350548,7/15/2014 23:25:10,,1323905066,7/15/2014 23:24:55,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,99,154,,,108,159,HAY FEVER,ATOPY,patients suffering from HAY FEVER,75-84-94-99-103,130-141-151-154,hereditary liability of ATOPY,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups.,99 103,154,99,154,108,159,-1,RO-cause_of,900242,Malignancies were observed less frequently in the closest relatives of the patients suffering from hay fever with the most proved hereditary liability of atopy than in the relatives of control groups,hay fever,atopy
503350549,7/15/2014 22:01:16,,1323862673,7/15/2014 22:00:52,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,84,44,,,86,51,MI,ASPIRIN,incidence of MI,71-81-84,17-29-32-40-44,combination of heparin and ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:03:31,,1323863621,7/15/2014 22:01:40,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,84,44,,,86,51,MI,ASPIRIN,MI,84,44,ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:14:23,,1323868478,7/15/2014 22:13:54,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,84,44,,,86,51,MI,ASPIRIN,MI -,84-100,44,ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:14:56,,1323868765,7/15/2014 22:14:40,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,84,44,,,86,51,MI,ASPIRIN,MI,84,44,ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:30:48,,1323876218,7/15/2014 22:30:27,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,84,44,,,86,51,MI,ASPIRIN,MI,84,44,ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:33:05,,1323877323,7/15/2014 22:32:46,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,84,44,,,86,51,MI,ASPIRIN,MI,84,44,ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:35:07,,1323878534,7/15/2014 22:34:51,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,84,44,,,86,51,MI,ASPIRIN,MI,84,44,ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:36:24,,1323879200,7/15/2014 22:36:12,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.170,84,44,,,86,51,MI,ASPIRIN,MI,84,44,ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:37:35,,1323879766,7/15/2014 22:37:30,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,84,44,,,86,51,MI,ASPIRIN,the incidence of MI during the in,67-71-81-84-87-94-98,29-32-40-44-52-55-59,of heparin and ASPIRIN in ACS reduces,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350549,7/15/2014 22:38:38,,1323880368,7/15/2014 22:38:26,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,84,44,,,86,51,MI,ASPIRIN,MI,84,44,ASPIRIN,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",84,44,84,44,86,51,1,RO-may_prevent,907404,"Rationale: ? The combination of heparin and aspirin in ACS reduces the incidence of MI during the in-hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures",MI,aspirin
503350550,7/15/2014 22:10:16,,1323866758,7/15/2014 22:10:01,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,NUMBER of systemic allergic reactions,97-104-107-116-125,22-31-40-17,late systemic ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 22:16:17,,1323869383,7/15/2014 22:15:44,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,NUMBER of systemic allergic reactions to inhalant allergen immunotherapy.,97-104-107-116-125-135-138-147-156,17-22-31-40,late systemic ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 22:22:06,,1323871971,7/15/2014 22:21:40,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,NUMBER,97,17-22-31-40,late systemic ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 22:23:10,,1323872558,7/15/2014 22:22:55,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,NUMBER of systemic allergic reactions,97-104-107-116-125,31-40,ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 22:31:52,,1323876632,7/15/2014 22:31:31,instagc,1.0,13763729,USA,"","",75.182.89.225,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,NUMBER of systemic allergic reactions,97-104-107-116-125,22-31-40,systemic ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 22:35:06,,1323878553,7/15/2014 22:34:43,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,NUMBER of systemic allergic reactions,97-104-107-116-125,22-30-31-40,systemic - ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 22:35:16,,1323878653,7/15/2014 22:35:04,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,of the total NUMBER of systemic allergic,84-87-91-97-104-107-116,12-17-22-31-40-50-58-62,that late systemic ALLERGIC REACTIONS account for a,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 22:59:48,,1323890301,7/15/2014 22:59:13,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,NUMBER of systemic allergic reactions,97-104-107-116-125,22-31-40,systemic ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 23:05:20,,1323893901,7/15/2014 23:04:52,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,total NUMBER of systemic allergic reactions,91-97-104-107-116-125,17-22-31-40,late systemic ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350550,7/15/2014 23:06:14,,1323894387,7/15/2014 23:05:41,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,97,31,,,103,49,NUMBER,ALLERGIC REACTIONS,NUMBER,97,31-40-22,systemic ALLERGIC REACTIONS,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy.,97,31 40,97,31,103,49,-1,RO-cause_of,900330,We conclude that late systemic-allergic reactions account for a significant percent of the total number of systemic-allergic reactions to inhalant allergen immunotherapy,number,allergic reactions
503350551,7/15/2014 21:58:51,,1323861510,7/15/2014 21:58:06,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS,",0-7,57-64,"ATOPIC DIATHESIS,","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:07:26,,1323865408,7/15/2014 22:07:07,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS,",0-7,57-64,"ATOPIC DIATHESIS,","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:25:02,,1323873385,7/15/2014 22:24:32,clixsense,1.0,15235785,USA,MA,Lowell,71.233.2.198,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS, atopic diathesis,",0-7-57-64,0-7-57-64,"Atopic dermatitis, ATOPIC DIATHESIS,","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:28:27,,1323875077,7/15/2014 22:27:17,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS, the dermatologic manifestation",0-7-19-23-36,36-50-53-57-64-75-79-81,"manifestation of the ATOPIC DIATHESIS, has a variety","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:34:10,,1323877973,7/15/2014 22:33:59,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS,",0-7,57-64,"ATOPIC DIATHESIS,","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:34:53,,1323878387,7/15/2014 22:34:37,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS,",0-7,57-64,"ATOPIC DIATHESIS,","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:35:05,,1323878517,7/15/2014 22:34:53,instagc,1.0,13763729,USA,"","",75.182.89.225,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS,",0-7,57-64,"ATOPIC DIATHESIS,","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:35:53,,1323878953,7/15/2014 22:35:19,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS,",0-7,57-64,"ATOPIC DIATHESIS,","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:36:52,,1323879437,7/15/2014 22:36:37,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS,",0-7,57-64,"ATOPIC DIATHESIS,","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350551,7/15/2014 22:40:41,,1323881321,7/15/2014 22:40:39,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,0,57,,,17,73,ATOPIC DERMATITIS,ATOPIC DIATHESIS,"ATOPIC DERMATITIS, the dermatologic manifestation",0-7-19-23-36,36-50-53-57-64-75-79-81,"manifestation of the ATOPIC DIATHESIS, has a variety","Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations.",0 7,57 64,0,57,17,73,-1,RO-cause_of,900179,"Atopic dermatitis, the dermatologic manifestation of the atopic diathesis, has a variety of clinical presentations",Atopic dermatitis,atopic diathesis
503350552,7/15/2014 22:03:26,,1323863592,7/15/2014 22:03:19,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,BACTERIAL VAGINOSIS.,53-63,0,CLINDAMYCIN,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 22:40:36,,1323881296,7/15/2014 22:40:17,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,BACTERIAL VAGINOSIS.,53-63,0,CLINDAMYCIN,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 22:57:42,,1323889399,7/15/2014 22:57:31,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,BACTERIAL VAGINOSIS.,53-63,0,CLINDAMYCIN,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 23:02:18,,1323891715,7/15/2014 23:02:10,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,treatment of BACTERIAL VAGINOSIS.,40-50-53-63,0-12-19,CLINDAMYCIN versus metronidazole,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 23:04:10,,1323893093,7/15/2014 23:03:55,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,BACTERIAL VAGINOSIS.,53-63,0-12-19,CLINDAMYCIN versus metronidazole,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 23:11:11,,1323897314,7/15/2014 23:10:57,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,BACTERIAL VAGINOSIS.,53-63,0,CLINDAMYCIN,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 23:17:40,,1323900737,7/15/2014 23:17:38,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,the treatment of BACTERIAL VAGINOSIS.,36-40-50-53-63,0-12-19-33,CLINDAMYCIN versus metronidazole in,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 23:20:55,,1323902702,7/15/2014 23:20:44,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,treatment BACTERIAL VAGINOSIS.,40-53-63,0-12-19,CLINDAMYCIN versus metronidazole,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 23:24:25,,1323904655,7/15/2014 23:24:11,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,BACTERIAL VAGINOSIS.,53-63,0,CLINDAMYCIN,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350552,7/15/2014 23:26:21,,1323905712,7/15/2014 23:26:10,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,53,0,,,72,11,BACTERIAL VAGINOSIS,CLINDAMYCIN,BACTERIAL VAGINOSIS.,53-63,0,CLINDAMYCIN,Clindamycin versus metronidazole in the treatment of bacterial vaginosis.,53 63,0,53,0,72,11,1,RO-may_treat,907536,Clindamycin versus metronidazole in the treatment of bacterial vaginosis,bacterial vaginosis,Clindamycin
503350553,7/15/2014 21:57:52,,1323860969,7/15/2014 21:57:46,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,16,59,,,20,69,SKIN,DERMATOSES,The spectrum of SKIN diseases in such,0-4-13-16-21-30-33,33-38-47-59-70-73-81,such patients encompasses DERMATOSES of diverse etiologies;,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:02:45,,1323863357,7/15/2014 22:02:28,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,16,59,,,20,69,SKIN,DERMATOSES,SKIN HIV,16-129,59-129,DERMATOSES HIV,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:03:09,,1323863540,7/15/2014 22:02:53,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,16,59,,,20,69,SKIN,DERMATOSES,spectrum of SKIN diseases,4-13-16-21,47-59-70-73-81,encompasses DERMATOSES of diverse etiologies;,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:04:45,,1323864192,7/15/2014 22:04:33,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,16,59,,,20,69,SKIN,DERMATOSES,SKIN diseases,16-21,59-70-73-81,DERMATOSES of diverse etiologies;,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:13:10,,1323867967,7/15/2014 22:12:51,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,16,59,,,20,69,SKIN,DERMATOSES,SKIN diseases,16-21,59,DERMATOSES,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:20:35,,1323871334,7/15/2014 22:20:10,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,16,59,,,20,69,SKIN,DERMATOSES,SKIN diseases,16-21,59-70-73-81,DERMATOSES of diverse etiologies;,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:34:14,,1323878020,7/15/2014 22:33:47,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,16,59,,,20,69,SKIN,DERMATOSES,SKIN diseases,16-21,59,DERMATOSES,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:35:57,,1323878972,7/15/2014 22:35:40,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,16,59,,,20,69,SKIN,DERMATOSES,SKIN,16,59,DERMATOSES,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:36:52,,1323879439,7/15/2014 22:35:31,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,16,59,,,20,69,SKIN,DERMATOSES,The spectrum of SKIN diseases in such patients encompasses dermatoses of diverse etiologies;,0-4-13-16-21-30-33-38-47-59-70-73-81,0-4-13-16-21-33-38-47-59-70-73-81-30,The spectrum of skin diseases in such patients encompasses DERMATOSES of diverse etiologies;,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350553,7/15/2014 22:36:57,,1323879481,7/15/2014 22:36:36,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,16,59,,,20,69,SKIN,DERMATOSES,SKIN diseases,16-21,59,DERMATOSES,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not.,16,59,16,59,20,69,1,RO-has_finding_site,905095,The spectrum of skin diseases in such patients encompasses dermatoses of diverse etiologies; a few are peculiar to patients with HIV while others are not,skin,dermatoses
503350554,7/15/2014 22:00:31,,1323862311,7/15/2014 22:00:08,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA unresectable hepatocellular carcinoma.,85-128-141-156,128-141-156,unresectable HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:04:33,,1323864067,7/15/2014 22:04:10,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,TNF plus HYPERTHERMIA,76-80-85,128-141-156,unresectable HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:22:25,,1323872145,7/15/2014 22:22:08,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA hepatocellular carcinoma.,85-141-156,141-156,HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:23:09,,1323872551,7/15/2014 22:22:48,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,85,141-156,HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:33:30,,1323877562,7/15/2014 22:33:17,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,85,141-156,HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:34:10,,1323877989,7/15/2014 22:33:53,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,TNF plus HYPERTHERMIA,76-80-85,141-156,HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:35:57,,1323878975,7/15/2014 22:35:52,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,that TNF plus HYPERTHERMIA may be effective,71-76-80-85-98-102-105,115-119-128-141-156,for treating unresectable HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:36:41,,1323879345,7/15/2014 22:36:15,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,85,141-156,HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:56:17,,1323888681,7/15/2014 22:55:56,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,85,141-156,HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350554,7/15/2014 22:56:51,,1323888990,7/15/2014 22:56:34,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,85,141,,,97,165,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,85,128-141-156,unresectable HEPATOCELLULAR CARCINOMA.,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma.,85,141 156,85,141,97,165,-1,RO-disease_may_have_finding,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus hyperthermia may be effective for treating unresectable hepatocellular carcinoma,hyperthermia,hepatocellular carcinoma
503350555,7/15/2014 22:03:57,,1323863813,7/15/2014 22:03:32,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI) staphylococcal infections,115-203-218,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:16:11,,1323869351,7/15/2014 22:15:53,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,(oxacillin resistant [methicillin resistant] STAPHYLOCOCCI),70-81-91-104-115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:16:18,,1323869384,7/15/2014 22:15:45,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI),115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:20:59,,1323871523,7/15/2014 22:20:33,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI),115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:28:30,,1323875091,7/15/2014 22:28:08,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI),115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:33:14,,1323877410,7/15/2014 22:32:02,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI),115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:34:04,,1323877921,7/15/2014 22:33:43,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,(oxacillin resistant STAPHYLOCOCCI),70-81-115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:34:36,,1323878242,7/15/2014 22:34:11,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,(oxacillin resistant [methicillin resistant] STAPHYLOCOCCI),70-81-91-104-115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:36:35,,1323879289,7/15/2014 22:36:08,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,STAPHYLOCOCCI),115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350555,7/15/2014 22:39:28,,1323880752,7/15/2014 22:39:00,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,115,203,,,128,228,STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,(oxacillin resistant [methicillin resistant] STAPHYLOCOCCI),70-81-91-104-115,203-218,STAPHYLOCOCCAL INFECTIONS,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin.",115,203 218,115,203,128,228,1,RO-has_causative_agent,903638,"1   If staphylococci resistant to penicillinase-resistant penicillins (oxacillin-resistant [methicillin-resistant] staphylococci) are prevalent in the hospital or community, empiric therapy of suspected staphylococcal infections should include another appropriate anti-infective (e.g., vancomycin",staphylococci,staphylococcal infections
503350556,7/15/2014 21:59:17,,1323861690,7/15/2014 21:59:10,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,three patients thrombosed VEINS were documented by,3-9-18-29-35-40-51,88-92-101-104-111-122-126-140,the presence of VENOUS THROMBOSIS was substantiated by,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:06:05,,1323864768,7/15/2014 22:05:44,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS,18-29,104-111,VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:08:45,,1323866064,7/15/2014 22:08:32,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS,18-29,104-111,VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:17:29,,1323869968,7/15/2014 22:17:11,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS,18-29,104-111,VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:21:17,,1323871602,7/15/2014 22:20:58,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS,18-29,104-111,VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:21:50,,1323871862,7/15/2014 22:21:36,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS,18-29,88-104-111,the VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:23:59,,1323872920,7/15/2014 22:23:29,clixsense,1.0,15235785,USA,MA,Lowell,71.233.2.198,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS venous,18-29-104,104-111-54,venography VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:25:29,,1323873587,7/15/2014 22:25:07,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS,18-29,104-111,VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:35:26,,1323878779,7/15/2014 22:35:10,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS,18-29,104-111,VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350556,7/15/2014 22:37:52,,1323879956,7/15/2014 22:37:33,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,29,104,,,34,121,VEINS,VENOUS THROMBOSIS,thrombosed VEINS,29-18,104-111,VENOUS THROMBOSIS,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings.",29,104 111,29,104,34,121,1,RO-has_finding_site,905367,"In three patients thrombosed veins were documented by venography and in all five cases, the presence of venous thrombosis was substantiated by the clinical findings",veins,venous thrombosis
503350557,7/15/2014 21:59:36,,1323861842,7/15/2014 21:59:29,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91,SMZL,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 22:01:10,,1323862646,7/15/2014 22:00:56,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91,SMZL,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 22:17:07,,1323869757,7/15/2014 22:16:55,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91,SMZL,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 22:22:32,,1323872236,7/15/2014 22:22:07,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91-96-101-111-117,SMZL with bilateral renal invasion.,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 22:23:04,,1323872510,7/15/2014 22:22:52,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91,SMZL,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 22:27:06,,1323874410,7/15/2014 22:26:42,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91,SMZL,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 22:45:37,,1323883494,7/15/2014 22:45:04,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE, SMZL bilateral renal invasion.",28-37-46-101-111-117-91,91-101-111-117,SMZL bilateral renal invasion.,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 22:58:53,,1323889897,7/15/2014 22:58:37,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91-96-101-111-117,SMZL with bilateral renal invasion.,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 23:05:28,,1323893979,7/15/2014 23:05:06,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91,SMZL,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350557,7/15/2014 23:13:15,,1323898349,7/15/2014 23:12:46,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,28,91,,,52,95,INDOLENT CLINICAL COURSE,SMZL,"INDOLENT CLINICAL COURSE,",28-37-46,91,SMZL,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion.",28 37 46,91,28,91,52,95,1,RO-disease_may_have_finding,902982,"SMZL is characterized by an indolent clinical course, and no previous report has described SMZL with bilateral renal invasion",indolent clinical course,SMZL
503350558,7/15/2014 21:58:19,,1323861160,7/15/2014 21:58:08,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,99,160,,,106,168,ASCITES,HEPATOMA,"(thymus, spleen, Zajdela ASCITES hepatoma) and is",74-83-91-99-107-117-121,140-144-149-160-169-174-178,TAT gene expressing HEPATOMA 7777 and normal,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:00:19,,1323862224,7/15/2014 22:00:11,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,99,160,,,106,168,ASCITES,HEPATOMA,Zajdela ASCITES hepatoma),91-99-107,160-169,HEPATOMA 7777,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:13:36,,1323868137,7/15/2014 22:13:11,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,99,160,,,106,168,ASCITES,HEPATOMA,ASCITES,99,160,HEPATOMA,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:15:13,,1323868889,7/15/2014 22:14:45,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,99,160,,,106,168,ASCITES,HEPATOMA,ASCITES,99,160,HEPATOMA,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:16:55,,1323869692,7/15/2014 22:16:07,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,99,160,,,106,168,ASCITES,HEPATOMA,Zajdela ASCITES hepatoma),91-99-107,160-169,HEPATOMA 7777,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:30:25,,1323875978,7/15/2014 22:30:08,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,99,160,,,106,168,ASCITES,HEPATOMA,ASCITES,99,160,HEPATOMA,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:35:56,,1323878971,7/15/2014 22:35:27,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,99,160,,,106,168,ASCITES,HEPATOMA,Zajdela ASCITES hepatoma),91-99-107,144-149-160-140,TAT gene expressing HEPATOMA,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:36:25,,1323879212,7/15/2014 22:35:56,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,99,160,,,106,168,ASCITES,HEPATOMA,Zajdela ASCITES hepatoma),91-99-107,160-169,HEPATOMA 7777,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:42:01,,1323881862,7/15/2014 22:41:56,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,99,160,,,106,168,ASCITES,HEPATOMA,"(thymus, spleen, Zajdela ASCITES hepatoma) and is",74-83-91-99-107-117-121,140-144-149-160-169-174-178,TAT gene expressing HEPATOMA 7777 and normal,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350558,7/15/2014 22:56:20,,1323888714,7/15/2014 22:56:04,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,99,160,,,106,168,ASCITES,HEPATOMA,"(thymus, spleen, Zajdela ASCITES hepatoma)",74-83-91-99-107,140-144-149-160-169,TAT gene expressing HEPATOMA 7777,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes.",99,160,99,160,106,168,-1,RO-disease_may_have_finding,903000,"of TAT gene is methylated in those cells where TAT gene does not function (thymus, spleen, Zajdela ascites hepatoma) and is demethylated in TAT gene expressing hepatoma 7777 and normal rat hepatocytes",ascites,hepatoma
503350559,7/15/2014 21:59:23,,1323861722,7/15/2014 21:59:12,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,123,172,,,132,177,NEPHRITIS,LUPUS,lupus NEPHRITIS,117-123,172-178-192,LUPUS erythematosus visceralis,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 21:59:31,,1323861807,7/15/2014 21:59:19,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,123,172,,,132,177,NEPHRITIS,LUPUS,"visceralis and lupus NEPHRITIS during pregnancy, the",102-113-117-123-133-140-151,155-165-168-172-178-192-203,influence of the LUPUS erythematosus visceralis on,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 22:04:04,,1323863849,7/15/2014 22:03:42,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,123,172,,,132,177,NEPHRITIS,LUPUS,lupus NEPHRITIS,117-123,172-178-192,LUPUS erythematosus visceralis,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 22:07:53,,1323865631,7/15/2014 22:07:40,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,123,172,,,132,177,NEPHRITIS,LUPUS,visceralis and lupus NEPHRITIS,102-113-117-123,172-178-192,LUPUS erythematosus visceralis,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 22:13:48,,1323868221,7/15/2014 22:12:16,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,123,172,,,132,177,NEPHRITIS,LUPUS,NEPHRITIS,123,172,LUPUS,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 22:32:44,,1323877163,7/15/2014 22:32:29,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,123,172,,,132,177,NEPHRITIS,LUPUS,NEPHRITIS,123,172-178-192,LUPUS erythematosus visceralis,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 22:33:43,,1323877673,7/15/2014 22:33:00,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,123,172,,,132,177,NEPHRITIS,LUPUS,lupus NEPHRITIS,123-117,172-178-192,LUPUS erythematosus visceralis,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 22:39:15,,1323880666,7/15/2014 22:38:48,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,123,172,,,132,177,NEPHRITIS,LUPUS,visceralis and lupus NEPHRITIS,102-113-117-123,172-178-192,LUPUS erythematosus visceralis,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 22:40:26,,1323881233,7/15/2014 22:39:28,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,123,172,,,132,177,NEPHRITIS,LUPUS,"visceralis and lupus NEPHRITIS during pregnancy, the influence of the lupus erythematosus visceralis",102-113-117-123-133-140-151-155-165-168-172-178-192,155-165-168-172-178-192-203-206,influence of the LUPUS erythematosus visceralis on pregnancy,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350559,7/15/2014 22:44:54,,1323883215,7/15/2014 22:44:38,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,123,172,,,132,177,NEPHRITIS,LUPUS,lupus NEPHRITIS,117-123,172-178-192,LUPUS erythematosus visceralis,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed.",123,172,123,172,132,177,-1,RO-has_manifestation,906012,"With the help of the literature and on the basis of own experiences course of the lupus erythematosus visceralis and lupus nephritis during pregnancy, the influence of the lupus erythematosus visceralis on pregnancy and development of the child, peculiarities of the treatment of lupus erythematosus visceralis during pregnancy as well as questions of prevention and interruption of pregnancy are discussed",nephritis,lupus
503350560,7/15/2014 22:17:00,,1323869722,7/15/2014 22:16:44,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,ALLERGIC DISORDERS,289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 22:23:46,,1323872838,7/15/2014 22:23:22,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,ALLERGIC DISORDERS,289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 22:32:09,,1323876781,7/15/2014 22:31:51,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,ALLERGIC DISORDERS,289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 22:32:24,,1323876977,7/15/2014 22:31:40,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,ALLERGIC DISORDERS,289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 22:35:58,,1323878976,7/15/2014 22:35:47,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,ALLERGIC DISORDERS,289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 22:38:23,,1323880203,7/15/2014 22:38:10,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,phenomenon contributing to ALLERGIC DISORDERS,262-273-286-289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 22:56:33,,1323888854,7/15/2014 22:56:17,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,ALLERGIC DISORDERS,289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 23:24:33,,1323904734,7/15/2014 23:24:16,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,phenomenon contributing to ALLERGIC DISORDERS,262-273-286-289-298,315-318-325-328-337,be caused by ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 23:25:12,,1323905109,7/15/2014 23:24:50,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,ALLERGIC DISORDERS,289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350560,7/15/2014 23:25:38,,1323905330,7/15/2014 23:25:26,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,289,328,,,307,346,ALLERGIC DISORDERS,ALLERGIC REACTIONS,ALLERGIC DISORDERS,289-298,328-337,ALLERGIC REACTIONS.,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions.",289 298,328 337,289,328,307,346,-1,RO-cause_of,900233,"Cutaneous sensitivity to histamine, responses to prick tests with allergens, and serum IgE concentrations were measured and hay fever assessed by questionnaire in an unselected population to determine whether increased sensitivity to histamine is an independent phenomenon contributing to allergic disorders or may be caused by allergic reactions",allergic disorders,allergic reactions
503350561,7/15/2014 22:00:29,,1323862310,7/15/2014 22:00:20,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN tumors.,32-37,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:01:21,,1323862704,7/15/2014 22:01:11,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,32,0,,,36,15,SKIN,DERMATOFIBROMAS,are very common SKIN tumors.,16-20-25-32-37,0-16-20-25,DERMATOFIBROMAS are very common,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:06:16,,1323864845,7/15/2014 22:05:54,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN,32,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:11:38,,1323867450,7/15/2014 22:10:44,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN tumors.,32-37,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:17:27,,1323869923,7/15/2014 22:17:16,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN tumors.,32-37,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:18:45,,1323870510,7/15/2014 22:18:25,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN tumors.,32-37,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:25:55,,1323873794,7/15/2014 22:25:41,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN,32,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:33:41,,1323877664,7/15/2014 22:33:15,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN tumors.,32-37,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:34:42,,1323878285,7/15/2014 22:34:35,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN tumors.,32-37,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350561,7/15/2014 22:34:52,,1323878377,7/15/2014 22:34:39,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,32,0,,,36,15,SKIN,DERMATOFIBROMAS,SKIN tumors.,32-37,0,DERMATOFIBROMAS,Dermatofibromas are very common skin tumors.,32,0,32,0,36,15,1,RO-has_finding_site,905071,Dermatofibromas are very common skin tumors,skin,Dermatofibromas
503350562,7/15/2014 22:01:51,,1323862931,7/15/2014 22:01:40,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA,28,50-60-55,high dose METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:09:03,,1323866178,7/15/2014 22:08:48,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA,28,50-55-60,high dose METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:13:46,,1323868198,7/15/2014 22:13:36,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA,28,50-55-60,high dose METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:22:37,,1323872273,7/15/2014 22:22:21,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA,28,60,METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:24:43,,1323873208,7/15/2014 22:24:21,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,28,60,,,36,72,LEUKEMIA,METHOTREXATE,two patients with LEUKEMIA treated with high dose methotrexate.,10-14-23-28-37-45-50-55-60,10-14-23-28-45-50-55-60-37,two patients with leukemia treated with high dose METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:29:04,,1323875326,7/15/2014 22:28:51,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA,28,60,METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:33:42,,1323877678,7/15/2014 22:33:28,instagc,1.0,13763729,USA,"","",75.182.89.225,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA,28,60,METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:36:18,,1323879148,7/15/2014 22:36:09,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA,28,60,METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:39:18,,1323880691,7/15/2014 22:38:46,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA methotrexate.,28-60,60-28,leukemia METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350562,7/15/2014 22:39:19,,1323880694,7/15/2014 22:39:03,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.170,28,60,,,36,72,LEUKEMIA,METHOTREXATE,LEUKEMIA,28,60,METHOTREXATE.,We report two patients with leukemia treated with high dose methotrexate.,28,60,28,60,36,72,1,RO-may_treat,908155,We report two patients with leukemia treated with high dose methotrexate,leukemia,methotrexate
503350563,7/15/2014 21:58:10,,1323861111,7/15/2014 21:57:56,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas ANAPLASIA,0-11-100,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 21:59:10,,1323861634,7/15/2014 21:59:05,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,ANAPLASIA,100,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 22:00:31,,1323862313,7/15/2014 22:00:17,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,ANAPLASIA increased.,100-110,0-11-24-28,ANAPLASTIC ASTROCYTOMAS and glioblastomas,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 22:08:08,,1323865837,7/15/2014 22:07:54,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,ANAPLASIA,100,0-11-28-24,ANAPLASTIC ASTROCYTOMAS and glioblastomas,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 22:12:40,,1323867844,7/15/2014 22:11:08,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,ANAPLASIA,100,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 22:14:38,,1323868596,7/15/2014 22:14:30,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,ANAPLASIA,100,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 22:20:06,,1323871156,7/15/2014 22:19:54,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,ANAPLASIA,100,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 22:20:57,,1323871517,7/15/2014 22:20:36,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,ANAPLASIA,100,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 22:26:10,,1323873935,7/15/2014 22:25:59,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,ANAPLASIA,100,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350563,7/15/2014 22:32:03,,1323876689,7/15/2014 22:31:56,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,100,0,,,109,23,ANAPLASIA,ANAPLASTIC ASTROCYTOMAS,parenchymal positivity as ANAPLASIA increased.,74-86-97-100-110,0-11-24-28-42,ANAPLASTIC ASTROCYTOMAS and glioblastomas showed,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased.,100,0 11,100,0,109,23,1,RO-disease_has_finding,901910,Anaplastic astrocytomas and glioblastomas showed progressive reduction of parenchymal positivity as anaplasia increased,anaplasia,Anaplastic astrocytomas
503350564,7/15/2014 21:58:25,,1323861190,7/15/2014 21:58:09,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,128,145-158-173,unresectable HEPATOCELLULAR CARCINOMA,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 21:58:45,,1323861419,7/15/2014 21:58:00,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA for unresectable hepatocellular carcinoma,128-141-145-158-173,128-141-145-158-173,hyperthermia for unresectable HEPATOCELLULAR CARCINOMA,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 22:01:45,,1323862909,7/15/2014 22:01:36,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,128,158-173,HEPATOCELLULAR CARCINOMA,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 22:19:24,,1323870792,7/15/2014 22:19:06,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,128,158-173-145,unresectable HEPATOCELLULAR CARCINOMA,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 22:23:40,,1323872816,7/15/2014 22:23:29,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,of radiotherapy and HYPERTHERMIA for unresectable hepatocellular carcinoma,108-111-124-128-141-145-158-173,111-128-141-145-158-173-183-186-124,radiotherapy and hyperthermia for unresectable HEPATOCELLULAR CARCINOMA is warranted.,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 22:31:28,,1323876436,7/15/2014 22:31:20,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,of radiotherapy and HYPERTHERMIA for unresectable hepatocellular,108-111-124-128-141-145-158,128-141-145-158-173-183-186,hyperthermia for unresectable HEPATOCELLULAR CARCINOMA is warranted.,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 22:35:22,,1323878726,7/15/2014 22:35:10,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,128,158-173,HEPATOCELLULAR CARCINOMA,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 22:35:24,,1323878734,7/15/2014 22:35:05,instagc,1.0,13763729,USA,"","",75.182.89.225,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,128,158-173,HEPATOCELLULAR CARCINOMA,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 22:36:13,,1323879114,7/15/2014 22:35:46,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,of radiotherapy and HYPERTHERMIA for unresectable hepatocellular,108-111-124-128-141-145-158,158-173-186,HEPATOCELLULAR CARCINOMA warranted.,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350564,7/15/2014 22:37:05,,1323879518,7/15/2014 22:36:53,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,128,158,,,140,182,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,128,158-173,HEPATOCELLULAR CARCINOMA,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.",128,158 173,128,158,140,182,-1,RO-disease_may_have_finding,902504,"In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted",hyperthermia,hepatocellular carcinoma
503350565,7/15/2014 21:59:18,,1323861694,7/15/2014 21:59:12,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,upper AIRWAY,78-84,0-12-18,OBSTRUCTIVE SLEEP APNOEA,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 22:03:54,,1323863800,7/15/2014 22:03:33,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,AIRWAY,84,0-12-18,OBSTRUCTIVE SLEEP APNOEA,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 22:05:40,,1323864588,7/15/2014 22:05:21,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,upper AIRWAY,78-84,0-12-18-25,OBSTRUCTIVE SLEEP APNOEA (OSA),Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 22:14:15,,1323868406,7/15/2014 22:14:03,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,upper AIRWAY,78-84,0-12-18-25,OBSTRUCTIVE SLEEP APNOEA (OSA),Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 22:16:30,,1323869507,7/15/2014 22:16:13,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,upper AIRWAY,78-84,0-12-18-25,OBSTRUCTIVE SLEEP APNOEA (OSA),Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 22:30:08,,1323875859,7/15/2014 22:29:22,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,upper AIRWAY,84-78,0-12-18,OBSTRUCTIVE SLEEP APNOEA,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 22:32:15,,1323876875,7/15/2014 22:32:04,instagc,1.0,13763729,USA,"","",75.182.89.225,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,upper AIRWAY,78-84,0-12-18,OBSTRUCTIVE SLEEP APNOEA,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 22:39:53,,1323881018,7/15/2014 22:39:43,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,AIRWAY during sleep owing,84-91-98-104,0-12-18-31-34,OBSTRUCTIVE SLEEP APNOEA is characterised,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 23:05:10,,1323893847,7/15/2014 23:04:24,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,upper AIRWAY during sleep,78-84-91-98,0-12-18-25,OBSTRUCTIVE SLEEP APNOEA (OSA),Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350565,7/15/2014 23:22:39,,1323903503,7/15/2014 23:22:20,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,84,0,,,90,24,AIRWAY,OBSTRUCTIVE SLEEP APNOEA,repetitive collapse of the upper AIRWAY during sleep,51-62-71-74-78-84-91-98,0-12-18-25,OBSTRUCTIVE SLEEP APNOEA (OSA),Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,84,0 12 18,84,0,90,24,1,RO-has_finding_site,905340,Obstructive sleep apnoea (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep-related decrement in upper airway muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration,airway,Obstructive sleep apnoea
503350566,7/15/2014 22:04:40,,1323864136,7/15/2014 22:04:04,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,70,33,,,74,40,IDDM,INSULIN,"insulin dependent diabetes mellitus (IDDM),",33-51-60-69-41,33-41-51-60-69,"INSULIN dependent diabetes mellitus (IDDM),","Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 22:17:00,,1323869724,7/15/2014 22:16:43,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,70,33,,,74,40,IDDM,INSULIN,"diabetes mellitus (IDDM),",51-60-69,33-41-51-60-69,"INSULIN dependent diabetes mellitus (IDDM),","Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 22:20:10,,1323871180,7/15/2014 22:19:43,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,70,33,,,74,40,IDDM,INSULIN,"insulin dependent diabetes mellitus (IDDM),",33-41-51-60-69,33-41-51-60-69,"INSULIN dependent diabetes mellitus (IDDM),","Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 22:24:05,,1323872960,7/15/2014 22:23:41,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,70,33,,,74,40,IDDM,INSULIN,"insulin dependent diabetes mellitus (IDDM), and substantial insulin",33-51-60-69-77-81-93-41,7-15-26-33-41-51-60,insulin deficiency causes INSULIN dependent diabetes mellitus,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 22:30:27,,1323876004,7/15/2014 22:30:12,instagc,1.0,13763729,USA,"","",75.182.89.225,70,33,,,74,40,IDDM,INSULIN,"insulin dependent diabetes mellitus (IDDM),",33-41-51-60-69,33-41-51-60,INSULIN dependent diabetes mellitus,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 22:33:26,,1323877519,7/15/2014 22:33:06,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,70,33,,,74,40,IDDM,INSULIN,"insulin dependent diabetes mellitus (IDDM),",33-51-60-69-41,33-41-51-60-69,"INSULIN dependent diabetes mellitus (IDDM),","Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 22:58:43,,1323889799,7/15/2014 22:57:57,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,70,33,,,74,40,IDDM,INSULIN,"insulin dependent diabetes mellitus (IDDM),",33-41-51-60-69,33-41-51-60-69,"INSULIN dependent diabetes mellitus (IDDM),","Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 23:08:23,,1323895609,7/15/2014 23:07:55,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,70,33,,,74,40,IDDM,INSULIN,"insulin dependent diabetes mellitus (IDDM),",33-41-51-60-69,33,INSULIN,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 23:15:29,,1323899568,7/15/2014 23:15:18,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,70,33,,,74,40,IDDM,INSULIN,"diabetes mellitus (IDDM), and substantial insulin",51-60-69-77-81-93,7-15-26-33-41-51-60,insulin deficiency causes INSULIN dependent diabetes mellitus,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350566,7/15/2014 23:19:42,,1323901996,7/15/2014 23:19:22,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,70,33,,,74,40,IDDM,INSULIN,insulin dependent diabetes mellitus,33-51-60-41,33-41-51-60,INSULIN dependent diabetes mellitus,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia.",,33,70,33,74,40,1,RO-may_treat,908320,"Severe insulin deficiency causes insulin-dependent diabetes mellitus (IDDM), and substantial insulin excess causes hypoglycaemia",IDDM,insulin
503350567,7/15/2014 21:58:07,,1323861081,7/15/2014 21:58:03,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,331,249,,,333,266,AR,MUCOLIPIDOSIS III,Mucolipidosis IV (sialolipidosis) AR; locus: 19cen q12,297-311-314-331-335-342-348,232-235-240-249-263-275-282,(I cell disease) MUCOLIPIDOSIS III Hurler polydystrophy),"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 21:59:35,,1323861825,7/15/2014 21:59:05,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,331,249,,,333,266,AR,MUCOLIPIDOSIS III,(sialolipidosis) AR;,331-314,249-263-314,MUCOLIPIDOSIS III (sialolipidosis),"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 22:02:13,,1323863084,7/15/2014 22:01:27,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,331,249,,,333,266,AR,MUCOLIPIDOSIS III,Mucolipidosis IV (sialolipidosis) AR;,297-311-314-331,249-263-275-282-267,MUCOLIPIDOSIS III (Pseudo Hurler polydystrophy),"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 22:13:02,,1323867946,7/15/2014 22:12:25,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,331,249,,,333,266,AR,MUCOLIPIDOSIS III,Mucolipidosis IV (sialolipidosis) AR;,297-311-314-331,249-263,MUCOLIPIDOSIS III,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 22:20:25,,1323871256,7/15/2014 22:18:29,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,331,249,,,333,266,AR,MUCOLIPIDOSIS III,AR;,331,249-263,MUCOLIPIDOSIS III,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 22:22:36,,1323872268,7/15/2014 22:22:18,fusioncash,1.0,19963999,USA,IL,Springfield,108.243.49.56,331,249,,,333,266,AR,MUCOLIPIDOSIS III,Mucolipidosis IV (sialolipidosis) AR;,297-311-314-331,232-235-240-249-263-275-282,(I cell disease) MUCOLIPIDOSIS III Hurler polydystrophy),"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 22:29:24,,1323875567,7/15/2014 22:29:06,instagc,1.0,13763729,USA,"","",75.182.89.225,331,249,,,333,266,AR,MUCOLIPIDOSIS III,Mucolipidosis IV (sialolipidosis) AR;,297-311-314-331,249-263,MUCOLIPIDOSIS III,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 22:35:27,,1323878786,7/15/2014 22:35:07,tremorgames,1,26860817,NLD,06,Boxmeer,84.29.157.221,331,249,,,333,266,AR,MUCOLIPIDOSIS III,AR;,331,249-263,MUCOLIPIDOSIS III,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 22:54:16,,1323887836,7/15/2014 22:53:57,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,331,249,,,333,266,AR,MUCOLIPIDOSIS III,Mucolipidosis IV (sialolipidosis) AR;,297-311-314-331,249-263-275-282-267,MUCOLIPIDOSIS III (Pseudo Hurler polydystrophy),"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350567,7/15/2014 23:03:51,,1323892917,7/15/2014 23:02:51,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,331,249,,,333,266,AR,MUCOLIPIDOSIS III,Mucolipidosis IV (sialolipidosis) AR;,297-311-314-331,249-263-275-282,MUCOLIPIDOSIS III Hurler polydystrophy),"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23.",331,249 263,331,249,333,266,-1,RO-has_manifestation,906211,"Keratan sulfate Dermatan sulfate  Dermatan sulfate, heparan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate Glycoproteinoses Mannosidosis  Fucosidosis  Aspartylglucosaminuria  Sialidosis  Galactosialidosis    Mucolipidosis II (I-cell disease) Mucolipidosis III (Pseudo-Hurler polydystrophy) Mucolipidosis IV (sialolipidosis) AR; locus: 19cen-q12 Locus: 1p34  Locus: 4q32-q33  Locus: 6p21.3  Locus: 20q13    Locus: 4q21-q23",AR,Mucolipidosis III
503350568,7/15/2014 22:05:28,,1323864489,7/15/2014 22:05:10,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"Leigh's disease DYSTONIA,",10-18-127,10-18-36-48,Leigh's disease NECROTIZING ENCEPHALOMYELOPATHY),"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 22:09:12,,1323866237,7/15/2014 22:08:44,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"DYSTONIA,",127,26-36-48,(SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 22:14:44,,1323868649,7/15/2014 22:14:20,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"DYSTONIA,",127,10-18-26-36-48,Leigh's disease (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 22:40:03,,1323881081,7/15/2014 22:39:54,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"as early onset, DYSTONIA, paraparesis the presence",111-114-120-127-137-149-153,10-18-26-36-48-69-72-81,Leigh's disease (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 22:41:52,,1323881796,7/15/2014 22:41:50,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"as early onset, DYSTONIA, paraparesis the presence",111-114-120-127-137-149-153,10-18-26-36-48-69-72-81,Leigh's disease (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 22:43:12,,1323882494,7/15/2014 22:42:55,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"DYSTONIA,",127,26-36-48,(SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 22:53:27,,1323887369,7/15/2014 22:52:39,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"DYSTONIA, paraparesis",127-137,10-18-26-36-48,Leigh's disease (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 23:02:06,,1323891575,7/15/2014 23:00:37,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"DYSTONIA, paraparesis",127-137,26-36-48,(SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 23:16:27,,1323900006,7/15/2014 23:15:58,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"DYSTONIA,",127,10-18-26-36-48,Leigh's disease (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY),"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350568,7/15/2014 23:16:57,,1323900365,7/15/2014 23:16:54,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,127,27,,,135,67,DYSTONIA,SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY,"as early onset, DYSTONIA, paraparesis the presence",111-114-120-127-137-149-153,10-18-26-36-48-69-72-81,Leigh's disease (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY) is reported with,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy.",127,36 48,127,27,135,67,1,RO-has_manifestation,906024,"A case of Leigh's disease (subacute necrotizing encephalomyelopathy) is reported with such noteworthy features as early onset, dystonia, paraparesis the presence of low attenuation areas in both basal ganglias on computerized tomography of the brain and the presence of a high signal intensity in both basal ganglias in T2 weighted image by MR. The electron microscopic findings of muscle biopsy are suggestive of pleoconial mitochondrial myopathy",dystonia,subacute necrotizing encephalomyelopathy
503350569,7/15/2014 21:59:04,,1323861570,7/15/2014 21:58:51,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,PSAMMOMA BODIES duodenal somatostatinomas.,28-37-77-86,77-86,duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 21:59:56,,1323862026,7/15/2014 21:59:43,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,histological finding of PSAMMOMA BODIES is important in,4-17-25-28-37-44-47-57,64-74-77-86,diagnosis of duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 22:01:38,,1323862875,7/15/2014 22:01:23,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,PSAMMOMA BODIES,28-37,77-86,duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 22:23:29,,1323872715,7/15/2014 22:22:23,clixsense,1,15235785,USA,MA,Lowell,71.233.2.198,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,PSAMMOMA BODIES duodenal somatostatinomas.,28-37-86-77,77-86,duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 22:27:52,,1323874675,7/15/2014 22:27:31,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,PSAMMOMA BODIES,28-37,77-86,duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 22:51:07,,1323886098,7/15/2014 22:48:16,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,PSAMMOMA BODIES,28-37,86-77,duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 23:00:33,,1323890670,7/15/2014 23:00:23,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,PSAMMOMA BODIES,28-37,77-86,duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 23:03:54,,1323892909,7/15/2014 23:03:36,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,PSAMMOMA BODIES,28-37,77-86,duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 23:04:04,,1323893061,7/15/2014 23:03:54,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,PSAMMOMA BODIES,28-37,77-86,duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350569,7/15/2014 23:18:28,,1323901171,7/15/2014 23:18:16,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,28,86,,,43,102,PSAMMOMA BODIES,SOMATOSTATINOMAS,histological finding PSAMMOMA BODIES important,4-17-28-37-47,64-74-77-86,diagnosis of duodenal SOMATOSTATINOMAS.,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas.,28 37,86,28,86,43,102,1,RO-disease_has_finding,901958,The histological finding of psammoma bodies is important in the diagnosis of duodenal somatostatinomas,psammoma bodies,somatostatinomas
503350570,7/15/2014 22:14:49,,1323868735,7/15/2014 22:14:39,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,THROMBOCYTHAEMIA,21,94-104,ESSENTIAL THROMBOCYTHAEMIA,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:19:06,,1323870643,7/15/2014 22:18:46,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,"THROMBOCYTHAEMIA due to polycythaemia vera,",21-38-42-45-59,94-104,ESSENTIAL THROMBOCYTHAEMIA,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:25:21,,1323873534,7/15/2014 22:25:03,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,THROMBOCYTHAEMIA,21,94-104,ESSENTIAL THROMBOCYTHAEMIA,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:28:36,,1323875134,7/15/2014 22:28:22,instagc,1.0,13763729,USA,"","",75.182.89.225,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,THROMBOCYTHAEMIA,21,94-104,ESSENTIAL THROMBOCYTHAEMIA,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:34:34,,1323878217,7/15/2014 22:34:19,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,THROMBOCYTHAEMIA,21,94-104,ESSENTIAL THROMBOCYTHAEMIA,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:36:52,,1323879438,7/15/2014 22:36:47,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,Eleven patients with THROMBOCYTHAEMIA due to polycythaemia,0-7-16-21-38-42-45,73-81-91-94-104-121-126-134,myeloid leukaemia or ESSENTIAL THROMBOCYTHAEMIA were treated with,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:37:51,,1323879942,7/15/2014 22:37:15,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,THROMBOCYTHAEMIA,21,73-81-91-94-104,myeloid leukaemia or ESSENTIAL THROMBOCYTHAEMIA,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:38:09,,1323880115,7/15/2014 22:37:55,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,THROMBOCYTHAEMIA due to polycythaemia,21-38-42-45,73-81-91-94-104,myeloid leukaemia or ESSENTIAL THROMBOCYTHAEMIA,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:39:20,,1323880708,7/15/2014 22:39:18,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,Eleven patients with THROMBOCYTHAEMIA due to polycythaemia,0-7-16-21-38-42-45,73-81-91-94-104-121-126-134,myeloid leukaemia or ESSENTIAL THROMBOCYTHAEMIA were treated with,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350570,7/15/2014 22:41:21,,1323881584,7/15/2014 22:40:53,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,21,94,,,37,120,THROMBOCYTHAEMIA,ESSENTIAL THROMBOCYTHAEMIA,THROMBOCYTHAEMIA,21,94-104,ESSENTIAL THROMBOCYTHAEMIA,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients.",21,94 104,21,94,37,120,1,RO-disease_has_finding,901661,"Eleven patients with thrombocythaemia due to polycythaemia vera, chronic myeloid leukaemia or essential thrombocythaemia were treated with recombinant interferon-alpha 2C and complete remissions were achieved in 7 of the 8 evaluable patients",thrombocythaemia,essential thrombocythaemia
503350571,7/15/2014 22:08:31,,1323866000,7/15/2014 22:08:09,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,165,172,,,170,185,NAILS,TINEA UNGUIUM,"NAILS, tinea unguium;",165-172-178,172-178,TINEA UNGUIUM;,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 22:17:55,,1323870128,7/15/2014 22:17:32,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,165,172,,,170,185,NAILS,TINEA UNGUIUM,"of the NAILS, tinea unguium;",158-161-165-172-178,172-178,TINEA UNGUIUM;,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 22:18:07,,1323870246,7/15/2014 22:17:29,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,165,172,,,170,185,NAILS,TINEA UNGUIUM,"tinea barbae; of the NAILS,",144-150-158-161-165,172-178,TINEA UNGUIUM;,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 22:24:14,,1323873017,7/15/2014 22:24:00,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,165,172,,,170,185,NAILS,TINEA UNGUIUM,"NAILS,",165,172-178,TINEA UNGUIUM;,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 22:34:52,,1323878389,7/15/2014 22:34:32,instagc,1.0,13763729,USA,"","",75.182.89.225,165,172,,,170,185,NAILS,TINEA UNGUIUM,"NAILS,",165,172-178,TINEA UNGUIUM;,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 22:37:49,,1323879919,7/15/2014 22:37:26,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,165,172,,,170,185,NAILS,TINEA UNGUIUM,"NAILS,",165,172-178,TINEA UNGUIUM;,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 22:38:28,,1323880277,7/15/2014 22:38:22,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,165,172,,,170,185,NAILS,TINEA UNGUIUM,"barbae; of the NAILS, tinea unguium; and",150-158-161-165-172-178-187,158-161-165-172-178-187-191-194,"of the nails, TINEA UNGUIUM; and of the","Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 22:58:29,,1323889725,7/15/2014 22:57:53,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,165,172,,,170,185,NAILS,TINEA UNGUIUM,"NAILS, tinea unguium;",165-172-178,172-178,TINEA UNGUIUM;,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 22:59:14,,1323890056,7/15/2014 22:58:29,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,165,172,,,170,185,NAILS,TINEA UNGUIUM,"NAILS, tinea unguium;",165-172-178,172-178,TINEA UNGUIUM;,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350571,7/15/2014 23:01:24,,1323891136,7/15/2014 23:01:01,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,165,172,,,170,185,NAILS,TINEA UNGUIUM,"NAILS, tinea unguium;",165-172-178,165-172-178,"nails, TINEA UNGUIUM;","Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot.",165,172 178,165,172,170,185,1,RO-has_finding_site,905472,"Ringworm of the scalp is called tinea capitis; of the body, tinea corporis; of the groin, tinea cruris; of the hand, tinea manus; of the beard, tinea barbae; of the nails, tinea unguium; and of the feet, tinea pedis or athlete's foot",nails,tinea unguium
503350572,7/15/2014 21:59:05,,1323861571,7/15/2014 21:58:52,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"DIABETIC KETOACIDOSIS,",139-148,43-50-51-61,insulin - dependent DIABETES,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 21:59:09,,1323861618,7/15/2014 21:58:58,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"specific incidence of DIABETIC KETOACIDOSIS, the principal cause",117-126-136-139-148-162-166-176,38-43-51-61-70-73-80,with insulin dependent DIABETES in Moscow in,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 22:12:20,,1323867719,7/15/2014 22:11:58,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"DIABETIC KETOACIDOSIS,",139-148,43-61-51,insulin dependent DIABETES,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 22:13:28,,1323868081,7/15/2014 22:13:05,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"DIABETIC KETOACIDOSIS,",139-148,43-51-61,insulin dependent DIABETES,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 22:18:06,,1323870249,7/15/2014 22:17:40,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"DIABETIC KETOACIDOSIS,",139-148,61,DIABETES,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 22:28:50,,1323875209,7/15/2014 22:28:37,instagc,1.0,13763729,USA,"","",75.182.89.225,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"DIABETIC KETOACIDOSIS,",139-148,43-51-61,insulin dependent DIABETES,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 22:38:09,,1323880131,7/15/2014 22:37:38,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"DIABETIC KETOACIDOSIS,",139-148,43-51-61,insulin dependent DIABETES,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 23:17:31,,1323900665,7/15/2014 23:17:28,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"specific incidence of DIABETIC KETOACIDOSIS, the principal cause",117-126-136-139-148-162-166-176,38-43-51-61-70-73-80,with insulin dependent DIABETES in Moscow in,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 23:17:38,,1323900719,7/15/2014 23:16:39,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"specific incidence DIABETIC KETOACIDOSIS, principal cause",117-126-139-148-166-176,43-51-61-73,insulin dependent DIABETES Moscow,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350572,7/15/2014 23:18:30,,1323901228,7/15/2014 23:18:09,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,139,61,,,160,69,DIABETIC KETOACIDOSIS,DIABETES,"DIABETIC KETOACIDOSIS,",139-148,43-51-61,insulin dependent DIABETES,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.",139 148,61,139,61,160,69,1,RO-cause_of,900071,"Analysis of the mortality of children with insulin-dependent diabetes in Moscow in the eighties revealed a very high specific incidence of diabetic ketoacidosis, the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases",diabetic ketoacidosis,diabetes
503350573,7/15/2014 22:11:02,,1323867139,7/15/2014 22:10:36,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,98,160,,,112,166,RABIES VIRUSES,RABIES,RABIES VIRUSES,98-105,160-183,"RABIES Mokola,","This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 22:19:40,,1323870959,7/15/2014 22:19:20,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,98,160,,,112,166,RABIES VIRUSES,RABIES,phylogenetically distant RABIES VIRUSES,73-90-98-105,160-167-175,RABIES related viruses,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 22:27:33,,1323874565,7/15/2014 22:27:11,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,98,160,,,112,166,RABIES VIRUSES,RABIES,RABIES VIRUSES,98-105,160-175-167,RABIES related viruses,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 22:29:18,,1323875483,7/15/2014 22:29:12,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,98,160,,,112,166,RABIES VIRUSES,RABIES,the phylogenetically distant RABIES VIRUSES from silver haired,69-73-90-98-105-113-118-125,148-152-156-160-167-175-183,"bat and the RABIES related viruses Mokola,","This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 22:37:07,,1323879530,7/15/2014 22:36:57,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,98,160,,,112,166,RABIES VIRUSES,RABIES,the phylogenetically distant RABIES VIRUSES from silver haired,69-73-90-98-105-113-118-125,148-152-156-160-167-175-183,"bat and the RABIES related viruses Mokola,","This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 23:16:03,,1323899839,7/15/2014 23:15:49,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,98,160,,,112,166,RABIES VIRUSES,RABIES,the phylogenetically distant RABIES VIRUSES from silver haired,69-73-90-98-105-113-118-125,148-152-156-160-167-175-183,"bat and the RABIES related viruses Mokola,","This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 23:18:45,,1323901487,7/15/2014 23:18:28,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,98,160,,,112,166,RABIES VIRUSES,RABIES,phylogenetically distant RABIES VIRUSES silver haired,73-90-98-105-118-125,148-152-156-160-167-175-183,"bat and the RABIES related viruses Mokola,","This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 23:22:19,,1323903327,7/15/2014 23:21:50,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,98,160,,,112,166,RABIES VIRUSES,RABIES,phylogenetically distant RABIES VIRUSES,73-90-98-105,160-167-175,RABIES related viruses,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 23:23:51,,1323904343,7/15/2014 23:23:20,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,98,160,,,112,166,RABIES VIRUSES,RABIES,RABIES VIRUSES,98-105,160,RABIES,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350573,7/15/2014 23:26:51,,1323905970,7/15/2014 23:25:51,clixsense,1.0,23272697,GBR,F6,Romford,94.11.43.229,98,160,,,112,166,RABIES VIRUSES,RABIES,phylogenetically distant RABIES VIRUSES,73-98-105-90,160-183-191-202-206-212,"RABIES Mokola, Duvenhage, and Lagos bat.","This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat.",98 105,160,98,160,112,166,-1,RO-has_causative_agent,903814,"This antigen-detecting procedure has also been used to identify both the phylogenetically distant rabies viruses from silver-haired bat and vampire bat and the rabies-related viruses Mokola, Duvenhage, and Lagos bat",rabies viruses,rabies
503350574,7/15/2014 21:58:49,,1323861482,7/15/2014 21:58:29,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"HYPERCORTISOLISM,",239,199-239,"DEXAMETHASONE hypercortisolism,","The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:00:01,,1323862086,7/15/2014 21:59:47,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"latent HYPERCORTISOLISM,",232-239,199,DEXAMETHASONE,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:05:53,,1323864669,7/15/2014 22:05:29,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"HYPERCORTISOLISM,",239,199,DEXAMETHASONE,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:06:00,,1323864722,7/15/2014 22:05:48,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"latent HYPERCORTISOLISM,",232-239,199,DEXAMETHASONE,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:08:09,,1323865844,7/15/2014 22:07:39,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"latent HYPERCORTISOLISM,",232-239,185-189-199-213,1mg overnight DEXAMETHASONE test,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:19:44,,1323871010,7/15/2014 22:19:25,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"latent HYPERCORTISOLISM,",232-239,199-213,DEXAMETHASONE test,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:26:19,,1323873995,7/15/2014 22:25:57,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"latent HYPERCORTISOLISM,",232-239,199,DEXAMETHASONE,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:34:59,,1323878452,7/15/2014 22:34:40,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"latent HYPERCORTISOLISM,",232-239,199-213,DEXAMETHASONE test,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:35:46,,1323878896,7/15/2014 22:35:25,instagc,1.0,13763729,USA,"","",75.182.89.225,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"latent HYPERCORTISOLISM,",232-239,189-199-213,overnight DEXAMETHASONE test,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350574,7/15/2014 22:37:45,,1323879866,7/15/2014 22:37:22,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,239,199,,,255,212,HYPERCORTISOLISM,DEXAMETHASONE,"latent HYPERCORTISOLISM,",232-239,181-185-189-199,the 1mg overnight DEXAMETHASONE,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas.",239,199,239,199,255,212,1,RO-may_diagnose,906699,"The crucial points of the French consensus are: the usefulness of CT-scanning evaluation of adrenal incidentalomas, the systematic screening for pheochromocytoma, the usefulness of the 1mg overnight dexamethasone test to screen for latent hypercortisolism, the difficulty to interpret mild biological abnormalities of the HPA axis, the consensus to remove surgically most of tumours greater than 4cm, the necessity to follow clinically glucorticoid tissular targets in the follow-up of non operated benign adrenocortical incidentalomas",hypercortisolism,dexamethasone
503350575,7/15/2014 22:03:33,,1323863632,7/15/2014 22:03:10,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,189,116,,,197,127,DEMENTIA,RISPERIDONE,psychosis of DEMENTIA.,176-186-189,88-95-96-107-113-116,placebo - controlled trial of RISPERIDONE,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:05:42,,1323864606,7/15/2014 22:05:30,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,189,116,,,197,127,DEMENTIA,RISPERIDONE,DEMENTIA.,189,116-189,RISPERIDONE dementia.,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:09:22,,1323866293,7/15/2014 22:09:13,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,189,116,,,197,127,DEMENTIA,RISPERIDONE,psychosis of DEMENTIA.,176-186-189,116,RISPERIDONE,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:32:36,,1323877064,7/15/2014 22:32:33,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,189,116,,,197,127,DEMENTIA,RISPERIDONE,and psychosis of DEMENTIA.,172-176-186-189,96-107-113-116-128-132-136,controlled trial of RISPERIDONE for the treatment,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:33:28,,1323877552,7/15/2014 22:33:14,instagc,1.0,13763729,USA,"","",75.182.89.225,189,116,,,197,127,DEMENTIA,RISPERIDONE,DEMENTIA.,189,116,RISPERIDONE,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:34:54,,1323878388,7/15/2014 22:34:44,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,189,116,,,197,127,DEMENTIA,RISPERIDONE,DEMENTIA.,189,116,RISPERIDONE,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:37:06,,1323879526,7/15/2014 22:36:52,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,189,116,,,197,127,DEMENTIA,RISPERIDONE,"treatment of aggression, agitation, and psychosis of DEMENTIA.",136-146-149-172-176-186-189-161,96-107-113-116-128-132-136-146-149-161-172-176-186-189,"controlled trial of RISPERIDONE for the treatment of aggression, agitation, and psychosis of dementia.","1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:39:01,,1323880538,7/15/2014 22:38:51,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,189,116,,,197,127,DEMENTIA,RISPERIDONE,and psychosis of DEMENTIA.,172-176-186-189,96-107-113-116-128-132-136-88,placebo controlled trial of RISPERIDONE for the treatment,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:42:05,,1323881905,7/15/2014 22:42:02,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,189,116,,,197,127,DEMENTIA,RISPERIDONE,and psychosis of DEMENTIA.,172-176-186-189,96-107-113-116-128-132-136,controlled trial of RISPERIDONE for the treatment,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350575,7/15/2014 22:47:59,,1323884519,7/15/2014 22:47:33,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,189,116,,,197,127,DEMENTIA,RISPERIDONE,DEMENTIA.,189,116,RISPERIDONE,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.",189,116,189,116,197,127,1,RO-may_treat,907928,"1]  Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, et al A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia",dementia,risperidone
503350576,7/15/2014 22:09:34,,1323866389,7/15/2014 22:09:23,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,AMYLOID DEPOSITION,94-102,170-178-187-190,amyloid proteins in AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 22:42:19,,1323882051,7/15/2014 22:41:57,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,AMYLOID DEPOSITION,94-102,190,AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 23:10:10,,1323896723,7/15/2014 23:09:50,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,AMYLOID DEPOSITION,94-102,190,AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 23:16:49,,1323900246,7/15/2014 23:16:46,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,and degrees of AMYLOID DEPOSITION in the skeletal,79-83-91-94-102-113-116-120,170-178-187-190,amyloid proteins in AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 23:22:33,,1323903443,7/15/2014 23:22:07,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,AMYLOID DEPOSITION,94-102,190,AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 23:23:07,,1323903827,7/15/2014 23:22:55,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,degrees of AMYLOID DEPOSITION in the skeletal muscles,83-91-94-102-113-116-120-129,170-178-187-190,amyloid proteins in AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 23:25:25,,1323905213,7/15/2014 23:25:14,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,AMYLOID DEPOSITION,94-102,190,AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 23:28:27,,1323906806,7/15/2014 23:27:53,clixsense,1.0,23272697,GBR,F6,Romford,94.11.43.229,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,AMYLOID DEPOSITION,94-102,190,AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 23:31:04,,1323908260,7/15/2014 23:30:24,clixsense,1,17121874,GBR,U9,Falkirk,80.192.66.214,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,AMYLOID DEPOSITION,94-102,190,AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350576,7/15/2014 23:31:42,,1323908552,7/15/2014 23:31:28,instagc,1,19636746,USA,NY,Andover,192.182.216.225,94,190,,,112,201,AMYLOID DEPOSITION,AMYLOIDOSIS,AMYLOID DEPOSITION,94-102,190,AMYLOIDOSIS.,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis.,94 102,190,94,190,112,201,-1,RO-disease_has_finding,901568,Our observations and descriptions in the literature indicate that the presence and degrees of amyloid deposition in the skeletal muscles would be related to the types of amyloid proteins in amyloidosis,amyloid deposition,amyloidosis
503350577,7/15/2014 21:59:41,,1323861861,7/15/2014 21:59:05,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,dog HYPERSENSITIVITY SYMPTOMS,93-110-89,149-153,dog HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 22:34:39,,1323878261,7/15/2014 22:33:47,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,HYPERSENSITIVITY SYMPTOMS,93-110,153,HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 22:42:48,,1323882283,7/15/2014 22:42:07,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,dog HYPERSENSITIVITY SYMPTOMS,93-110-89,149-153,dog HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 22:57:16,,1323889212,7/15/2014 22:56:38,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,dog HYPERSENSITIVITY SYMPTOMS,89-93-110,149-153,dog HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 23:04:51,,1323893582,7/15/2014 23:04:32,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,HYPERSENSITIVITY SYMPTOMS,93-110,153,HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 23:15:57,,1323899789,7/15/2014 23:15:36,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,HYPERSENSITIVITY SYMPTOMS,93-110,153,HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 23:20:58,,1323902715,7/15/2014 23:20:27,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,dog HYPERSENSITIVITY SYMPTOMS,89-93-110,149-153,dog HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 23:24:49,,1323904915,7/15/2014 23:24:27,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,HYPERSENSITIVITY SYMPTOMS,93-110,153,HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 23:24:54,,1323904935,7/15/2014 23:24:34,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,childhood developed dog HYPERSENSITIVITY SYMPTOMS,69-79-89-93-110,153-170-179-184,HYPERSENSITIVITY slightly more often,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350577,7/15/2014 23:24:53,,1323904944,7/15/2014 23:24:30,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,93,153,,,118,169,HYPERSENSITIVITY SYMPTOMS,HYPERSENSITIVITY,dog HYPERSENSITIVITY SYMPTOMS,89-93-110,149-153,dog HYPERSENSITIVITY,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog.",93 110,153,93,153,118,169,-1,RO-cause_of,900138,"However, the children who were exposed to a dog at home during early childhood developed dog hypersensitivity symptoms significantly earlier and had dog hypersensitivity slightly more often than the subjects with a later exposure or no exposure to dog",hypersensitivity symptoms,hypersensitivity
503350578,7/15/2014 22:01:50,,1323862928,7/15/2014 22:01:35,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,81 patients with VASOSPASTIC ANGINA pectoris induced by,150-153-162-167-179-186-195-203,186-195-203-206,pectoris induced by ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 22:18:05,,1323870269,7/15/2014 22:17:26,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,VASOSPASTIC ANGINA,167-179,206,ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 22:23:39,,1323872812,7/15/2014 22:23:22,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,VASOSPASTIC ANGINA,167-179,206,ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 22:33:08,,1323877349,7/15/2014 22:33:01,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,81 patients with VASOSPASTIC ANGINA pectoris induced by,150-153-162-167-179-186-195-203,186-195-203-206,pectoris induced by ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 22:39:17,,1323880687,7/15/2014 22:39:11,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,81 patients with VASOSPASTIC ANGINA pectoris induced by,150-153-162-167-179-186-195-203,186-195-203-206,pectoris induced by ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 22:41:13,,1323881545,7/15/2014 22:40:51,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,VASOSPASTIC ANGINA pectoris,167-179-186,206,ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 22:57:52,,1323889480,7/15/2014 22:57:25,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,VASOSPASTIC ANGINA pectoris,167-179-186,206,ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 23:13:34,,1323898596,7/15/2014 23:13:16,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,VASOSPASTIC ANGINA pectoris,167-179-186,206,ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 23:16:45,,1323900203,7/15/2014 23:16:42,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,81 patients with VASOSPASTIC ANGINA pectoris induced by,150-153-162-167-179-186-195-203,186-195-203-206,pectoris induced by ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350578,7/15/2014 23:24:09,,1323904480,7/15/2014 23:23:49,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,167,206,,,185,216,VASOSPASTIC ANGINA,ERGONOVINE,VASOSPASTIC ANGINA,167-179,206,ERGONOVINE.,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine.",167 179,206,167,206,185,216,1,RO-may_diagnose,906561,"For clarification of the characteristic features of ventricular arrhythmias during acute myocardial ischemia, ventricular arrhythmias were studied in 81 patients with vasospastic angina pectoris induced by ergonovine",vasospastic angina,ergonovine
503350579,7/15/2014 22:00:26,,1323862278,7/15/2014 22:00:19,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,severe HYPOGLYCAEMIA,95-102,136,GLUCOSE,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 22:10:42,,1323866962,7/15/2014 22:10:28,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,"severe HYPOGLYCAEMIA (SH,",95-102-116,136-144,GLUCOSE i.v.,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 22:34:24,,1323878127,7/15/2014 22:33:35,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,HYPOGLYCAEMIA,102,136,GLUCOSE,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 22:36:26,,1323879225,7/15/2014 22:36:21,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,levels and severe HYPOGLYCAEMIA treatment with,84-91-95-102-121-131,116-121-131-136-144,"(SH, treatment with GLUCOSE i.v.","The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 22:37:54,,1323879969,7/15/2014 22:37:46,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,levels and severe HYPOGLYCAEMIA treatment with,84-91-95-102-121-131,116-121-131-136-144,"(SH, treatment with GLUCOSE i.v.","The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 22:38:59,,1323880531,7/15/2014 22:38:43,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,"severe HYPOGLYCAEMIA (SH,",95-102-116,136-144,GLUCOSE i.v.,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 23:03:55,,1323892904,7/15/2014 23:03:35,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,"severe HYPOGLYCAEMIA (SH, treatment with glucose i.v.",95-102-121-131-136-144-116,116-121-131-136-144,"(SH, treatment with GLUCOSE i.v.","The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 23:10:58,,1323897197,7/15/2014 23:10:38,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,HYPOGLYCAEMIA,102,136,GLUCOSE,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 23:17:01,,1323900411,7/15/2014 23:16:58,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,levels and severe HYPOGLYCAEMIA treatment with,84-91-95-102-121-131,116-121-131-136-144,"(SH, treatment with GLUCOSE i.v.","The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350579,7/15/2014 23:21:29,,1323902992,7/15/2014 23:21:07,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,102,136,,,115,143,HYPOGLYCAEMIA,GLUCOSE,severe HYPOGLYCAEMIA,95-102,136-144,GLUCOSE i.v.,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v.",102,136,102,136,115,143,1,RO-may_treat,908138,"The objectives of the present analyses were to assess the association between HbA1c levels and severe hypoglycaemia (SH, treatment with glucose i.v",hypoglycaemia,glucose
503350580,7/15/2014 22:06:43,,1323865120,7/15/2014 22:06:21,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,LEVODOPA.,176,104-113-123,LEVODOPA CARBIDOPA preparations,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 22:16:11,,1323869354,7/15/2014 22:15:41,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,LEVODOPA.,176,104-113,LEVODOPA CARBIDOPA,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 22:32:43,,1323877111,7/15/2014 22:32:26,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,LEVODOPA.,176,104-113,LEVODOPA CARBIDOPA,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 22:35:24,,1323878764,7/15/2014 22:35:09,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,LEVODOPA.,176,104-113,LEVODOPA CARBIDOPA,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 22:35:38,,1323878869,7/15/2014 22:35:28,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,LEVODOPA.,176,104-113-123,LEVODOPA CARBIDOPA preparations,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 22:36:12,,1323879084,7/15/2014 22:35:55,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,of carbidopa to LEVODOPA.,160-163-173-176,79-89-101-104-113,carbidopa preparation or LEVODOPA CARBIDOPA,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 22:39:10,,1323880596,7/15/2014 22:39:06,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,of carbidopa to LEVODOPA.,160-163-173-176,79-89-101-104-113-123-136-147,carbidopa preparation or LEVODOPA CARBIDOPA preparations containing a,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 22:42:30,,1323882116,7/15/2014 22:42:00,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,LEVODOPA.,176,104-113,LEVODOPA CARBIDOPA,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 22:43:44,,1323882708,7/15/2014 22:43:13,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,LEVODOPA.,176,104-112-113-123,LEVODOPA - CARBIDOPA preparations,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350580,7/15/2014 23:10:37,,1323897009,7/15/2014 23:10:11,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,176,104,,,184,122,LEVODOPA,LEVODOPA-CARBIDOPA,LEVODOPA.,176,104-113-147,LEVODOPA CARBIDOPA a,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa.,176,104 113,176,104,184,122,1,RO-has_ingredient,905727,8  No information on transferring patients receiving extended-release levodopa-carbidopa preparation or levodopa-carbidopa preparations containing a 1:10 ratio of carbidopa to levodopa,levodopa,levodopa-carbidopa
503350581,7/15/2014 22:15:43,,1323869148,7/15/2014 22:15:30,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,venous THROMBOEMBOLISM.,128-135,73-82,WARFARIN therapy,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 22:16:12,,1323869361,7/15/2014 22:15:56,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,recurrent venous THROMBOEMBOLISM.,118-128-135,50-63-73-82,conventional intensity WARFARIN therapy,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 22:18:27,,1323870434,7/15/2014 22:17:30,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,venous THROMBOEMBOLISM.,135-128,50-63-73-82,conventional intensity WARFARIN therapy,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 22:32:14,,1323876873,7/15/2014 22:32:00,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,recurrent venous THROMBOEMBOLISM.,118-128-135,50-63-73-82,conventional intensity WARFARIN therapy,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 22:33:24,,1323877501,7/15/2014 22:32:37,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,recurrent venous THROMBOEMBOLISM.,118-128-135,50-63-73,conventional intensity WARFARIN,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 22:51:06,,1323886111,7/15/2014 22:49:36,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,recurrent venous THROMBOEMBOLISM.,118-128-135,73-82,WARFARIN therapy,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 23:04:23,,1323893238,7/15/2014 23:03:56,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,recurrent venous THROMBOEMBOLISM.,118-128-135,50-63-73-82,conventional intensity WARFARIN therapy,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 23:17:36,,1323900695,7/15/2014 23:17:33,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,of recurrent venous THROMBOEMBOLISM.,115-118-128-135,45-50-63-73-82-90-94,with conventional intensity WARFARIN therapy for long,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 23:17:40,,1323900741,7/15/2014 23:17:11,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,venous THROMBOEMBOLISM.,128-135,50-63-73-82,conventional intensity WARFARIN therapy,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350581,7/15/2014 23:19:06,,1323901674,7/15/2014 23:18:46,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,135,73,,,150,81,THROMBOEMBOLISM,WARFARIN,recurrent venous THROMBOEMBOLISM.,118-128-135,45-50-63-73-82-90-94-99-104,with conventional intensity WARFARIN therapy for long term prevention,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.,135,73,135,73,150,81,1,RO-may_prevent,907299,Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism,thromboembolism,warfarin
503350582,7/15/2014 21:59:00,,1323861559,7/15/2014 21:58:50,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",102-111,132-139,ATOPIC dermatitis.,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 22:07:12,,1323865290,7/15/2014 22:07:03,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",102-111,132-139,ATOPIC dermatitis.,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 22:20:31,,1323871285,7/15/2014 22:19:10,fusioncash,1.0,19963999,USA,IL,Springfield,108.243.49.56,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS, asthma, or atopic",102-111-121-129-132,111-121-129-132-139-102,"allergic rhinitis, asthma, or ATOPIC dermatitis.","Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 22:33:15,,1323877423,7/15/2014 22:33:09,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"disease, such as ALLERGIC RHINITIS, asthma, or atopic",85-94-99-102-111-121-129-132,111-121-129-132-139,"rhinitis, asthma, or ATOPIC dermatitis.","Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 22:36:07,,1323879047,7/15/2014 22:35:58,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"disease, such as ALLERGIC RHINITIS, asthma, or atopic",85-94-99-102-111-121-129-132,111-121-129-132-139,"rhinitis, asthma, or ATOPIC dermatitis.","Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 22:37:16,,1323879646,7/15/2014 22:37:04,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",102-111,132-139,ATOPIC dermatitis.,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 22:38:45,,1323880418,7/15/2014 22:38:36,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",102-111,132,ATOPIC,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 22:50:38,,1323885801,7/15/2014 22:49:22,prizerebel,1.0,21325389,USA,NY,Queens Village,108.30.3.50,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",102-111,132-139,ATOPIC dermatitis.,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 22:54:46,,1323888071,7/15/2014 22:54:17,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",102-111,111-121-129-132-139,"rhinitis, asthma, or ATOPIC dermatitis.","Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350582,7/15/2014 23:06:10,,1323894344,7/15/2014 23:05:59,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,102,132,,,119,138,ALLERGIC RHINITIS,ATOPIC,"ALLERGIC RHINITIS,",102-111,132-139,ATOPIC dermatitis.,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis.",102 111,132,102,132,119,138,-1,RO-cause_of,900482,"Approximately 70% of patients with allergic conjunctivitis have an associated atopic disease, such as allergic rhinitis, asthma, or atopic dermatitis",allergic rhinitis,atopic
503350583,7/15/2014 22:02:04,,1323863046,7/15/2014 22:01:48,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,30,40,,,36,49,CARIES,FLUORIDES,CARIES,30,30-40,caries FLUORIDES,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 22:11:28,,1323867389,7/15/2014 22:11:04,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,30,40,,,36,49,CARIES,FLUORIDES,CARIES,30,40,FLUORIDES,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 22:19:53,,1323871052,7/15/2014 22:19:25,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,30,40,,,36,49,CARIES,FLUORIDES,inhibition of CARIES,16-27-30,40,FLUORIDES,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 22:28:47,,1323875197,7/15/2014 22:28:31,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,30,40,,,36,49,CARIES,FLUORIDES,CARIES,30,40,FLUORIDES,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 22:31:55,,1323876650,7/15/2014 22:31:52,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,30,40,,,36,49,CARIES,FLUORIDES,the inhibition of CARIES by fluorides was,12-16-27-30-37-40-50,27-30-37-40-50-54-63,of caries by FLUORIDES was ascribed to,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 22:37:21,,1323879672,7/15/2014 22:37:14,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,30,40,,,36,49,CARIES,FLUORIDES,the inhibition of CARIES by fluorides was,12-16-27-30-37-40-50,27-30-37-40-50-54-63,of caries by FLUORIDES was ascribed to,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 22:39:05,,1323880569,7/15/2014 22:39:02,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,30,40,,,36,49,CARIES,FLUORIDES,the inhibition of CARIES by fluorides was,12-16-27-30-37-40-50,27-30-37-40-50-54-63,of caries by FLUORIDES was ascribed to,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 22:39:36,,1323880865,7/15/2014 22:39:25,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,30,40,,,36,49,CARIES,FLUORIDES,CARIES,30,40,FLUORIDES,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 22:41:28,,1323881622,7/15/2014 22:41:04,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,30,40,,,36,49,CARIES,FLUORIDES,CARIES,30,40,FLUORIDES,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350583,7/15/2014 23:02:56,,1323892186,7/15/2014 23:02:36,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,30,40,,,36,49,CARIES,FLUORIDES,CARIES,30,40,FLUORIDES,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral.,30,40,30,40,36,49,1,RO-may_prevent,907302,In the past the inhibition of caries by fluorides was ascribed to the reduced solubility of enamel due to the incorporation of F- into the enamel mineral,caries,fluorides
503350584,7/15/2014 21:58:29,,1323861233,7/15/2014 21:58:23,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,30,38,,,34,47,PAIN,CAUSALGIA,PAIN,30,38,CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 22:02:51,,1323863426,7/15/2014 22:02:40,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,30,38,,,34,47,PAIN,CAUSALGIA,PAIN as causalgia.,30-35-38,30-35-38,pain as CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 22:08:01,,1323865730,7/15/2014 22:07:49,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,30,38,,,34,47,PAIN,CAUSALGIA,PAIN causalgia.,30-38,30-38,pain CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 22:25:38,,1323873664,7/15/2014 22:25:22,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,30,38,,,34,47,PAIN,CAUSALGIA,PAIN,30,38,CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 22:33:28,,1323877507,7/15/2014 22:33:19,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,30,38,,,34,47,PAIN,CAUSALGIA,PAIN,30,38,CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 22:33:44,,1323877694,7/15/2014 22:33:31,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,30,38,,,34,47,PAIN,CAUSALGIA,PAIN,30,38,CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 22:35:28,,1323878801,7/15/2014 22:35:11,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,30,38,,,34,47,PAIN,CAUSALGIA,PAIN causalgia.,30-38,38,CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 22:38:15,,1323880160,7/15/2014 22:38:10,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,30,38,,,34,47,PAIN,CAUSALGIA,patients characterized the PAIN as causalgia.,3-12-26-30-35-38,26-30-35-38,the pain as CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 22:44:36,,1323883095,7/15/2014 22:44:18,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,30,38,,,34,47,PAIN,CAUSALGIA,PAIN causalgia.,30-38,26-30-35-38,the pain as CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350584,7/15/2014 23:03:09,,1323892325,7/15/2014 23:02:18,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,30,38,,,34,47,PAIN,CAUSALGIA,PAIN as causalgia.,30-35-38,30-35-38,pain as CAUSALGIA.,92 patients characterized the pain as causalgia.,30,38,30,38,34,47,-1,RO-has_definitional_manifestation,904664,92 patients characterized the pain as causalgia,pain,causalgia
503350585,7/15/2014 22:01:04,,1323862569,7/15/2014 22:00:56,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,209,HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:07:53,,1323865636,7/15/2014 22:07:28,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,209,HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:18:20,,1323870384,7/15/2014 22:18:06,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,209,HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:18:39,,1323870482,7/15/2014 22:18:23,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,209,HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:21:54,,1323871882,7/15/2014 22:21:21,fusioncash,1.0,19963999,USA,IL,Springfield,108.243.49.56,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,209,HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:22:06,,1323871978,7/15/2014 22:21:51,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,209,HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:22:38,,1323872290,7/15/2014 22:22:26,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,209,HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:24:20,,1323873072,7/15/2014 22:24:05,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"with Cts prevents BLOOD PRESSURE ELEVATION,",119-124-128-137-143-152,191-195-198-209,Cts in preventing HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:27:29,,1323874551,7/15/2014 22:27:07,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,209,HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350585,7/15/2014 22:56:38,,1323888891,7/15/2014 22:56:21,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,137,209,,,161,221,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION,",137-143-152,183-191-195-198-209-188,role of Cts in preventing HYPERTENSION.,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension.",137 143 152,209,137,209,161,221,-1,RO-has_definitional_manifestation,904540,"Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pretreatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension",blood pressure elevation,hypertension
503350586,7/15/2014 21:56:53,,1323860558,7/15/2014 21:56:24,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,"butyrylcholinesterase (BCHE, EC 3.1.1.8)",68-90-97-100,68-97-100-90,"BUTYRYLCHOLINESTERASE (BChE, EC 3.1.1.8)","Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 22:14:47,,1323868718,7/15/2014 22:14:24,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,"butyrylcholinesterase (BCHE, EC 3.1.1.8) enzymes",68-90-97-100-109,68,BUTYRYLCHOLINESTERASE,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 22:15:43,,1323869151,7/15/2014 22:15:06,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,"butyrylcholinesterase (BCHE, EC 3.1.1.8) enzymes",68-90-100-109-97,68-90-97-100-109,"BUTYRYLCHOLINESTERASE (BChE, EC 3.1.1.8) enzymes","Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 22:33:14,,1323877415,7/15/2014 22:32:57,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,butyrylcholinesterase enzymes,68-109,68,BUTYRYLCHOLINESTERASE,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 22:35:44,,1323878885,7/15/2014 22:35:39,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,"and butyrylcholinesterase (BCHE, EC 3.1.1.8) enzymes",64-68-90-97-100-109,52-55-64-68-97-100,EC 3.1.1.7) and BUTYRYLCHOLINESTERASE EC 3.1.1.8),"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 22:47:56,,1323884492,7/15/2014 22:47:48,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,"and butyrylcholinesterase (BCHE, EC 3.1.1.8) enzymes",64-68-90-97-100-109,52-55-64-68-90-97-100-109,"EC 3.1.1.7) and BUTYRYLCHOLINESTERASE (BChE, EC 3.1.1.8) enzymes","Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 22:52:01,,1323886658,7/15/2014 22:51:08,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,butyrylcholinesterase enzymes,68-109,68,BUTYRYLCHOLINESTERASE,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 22:59:12,,1323890029,7/15/2014 22:58:54,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,"butyrylcholinesterase (BCHE, EC 3.1.1.8) enzymes",68-90-97-100-109,68-90-97-100-109,"BUTYRYLCHOLINESTERASE (BChE, EC 3.1.1.8) enzymes","Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 23:03:33,,1323892619,7/15/2014 23:02:57,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,"butyrylcholinesterase (BCHE, EC 3.1.1.8) enzymes",68-90-97-100-109,68-90-97-100-109,"BUTYRYLCHOLINESTERASE (BChE, EC 3.1.1.8) enzymes","Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350586,7/15/2014 23:09:30,,1323896313,7/15/2014 23:07:56,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,91,68,,,95,89,BCHE,BUTYRYLCHOLINESTERASE,"butyrylcholinesterase (BCHE, EC 3.1.1.8)",68-90-97-100,68-90-97-100,"BUTYRYLCHOLINESTERASE (BChE, EC 3.1.1.8)","Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE.",,68,91,68,95,89,-1,RO-has_manifestation,906111,"Compounds 1-2 inhibited acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) enzymes in a concentration-dependent manner with percent inhibition ranging between 4.24% and 6.94 % and 79.1 % and 82.75 % for AChE and BChE, respectively indicating that compounds 1 and 2 are about thirteen times more specific to BChE than AChE",BChE,butyrylcholinesterase
503350587,7/15/2014 21:58:07,,1323861076,7/15/2014 21:57:53,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,142,180,,,149,188,SEIZURE,EPILEPSY,predicting SEIZURE prognosis,131-142-150,180-189,EPILEPSY prepregnancy.,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 22:01:00,,1323862548,7/15/2014 22:00:40,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,142,180,,,149,188,SEIZURE,EPILEPSY,SEIZURE prognosis,142-150,180,EPILEPSY,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 22:17:27,,1323869926,7/15/2014 22:17:13,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,142,180,,,149,188,SEIZURE,EPILEPSY,SEIZURE prognosis,142-150,180-189,EPILEPSY prepregnancy.,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 22:24:33,,1323873140,7/15/2014 22:24:17,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,142,180,,,149,188,SEIZURE,EPILEPSY,SEIZURE,142,180,EPILEPSY,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 22:28:57,,1323875264,7/15/2014 22:28:50,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,142,180,,,149,188,SEIZURE,EPILEPSY,factor for predicting SEIZURE prognosis was the,120-127-131-142-150-160-164,164-168-177-180-189,the severity of EPILEPSY prepregnancy.,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 22:33:04,,1323877318,7/15/2014 22:32:47,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,142,180,,,149,188,SEIZURE,EPILEPSY,SEIZURE,142,180,EPILEPSY,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 22:34:30,,1323878183,7/15/2014 22:34:05,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,142,180,,,149,188,SEIZURE,EPILEPSY,SEIZURE prognosis,142-150,180,EPILEPSY,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 22:37:12,,1323879606,7/15/2014 22:36:31,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,142,180,,,149,188,SEIZURE,EPILEPSY,SEIZURE,142,180,EPILEPSY,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 22:40:23,,1323881223,7/15/2014 22:40:21,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,142,180,,,149,188,SEIZURE,EPILEPSY,factor for predicting SEIZURE prognosis was the,120-127-131-142-150-160-164,164-168-177-180-189,the severity of EPILEPSY prepregnancy.,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350587,7/15/2014 23:02:00,,1323891531,7/15/2014 23:01:43,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,142,180,,,149,188,SEIZURE,EPILEPSY,SEIZURE,142,180,EPILEPSY,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy.,142,180,142,180,149,188,-1,RO-has_definitional_manifestation,904923,Epileptic women were found to have a 26.1% risk of seizure deterioration during pregnancy and the single most important factor for predicting seizure prognosis was the severity of epilepsy prepregnancy,seizure,epilepsy
503350588,7/15/2014 21:57:59,,1323861020,7/15/2014 21:57:27,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"age of onset of the SEIZURES,",57-61-64-70-73-77,112-127-131-139-142-152-121,cerebral palsy and subtype of EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:04:24,,1323864000,7/15/2014 22:03:59,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES, cerebral palsy",77-112-121,112-121-142-152,cerebral palsy EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:05:28,,1323864482,7/15/2014 22:04:46,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",77,142-152,EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:16:08,,1323869333,7/15/2014 22:15:53,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",77,142-152,EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:36:24,,1323879210,7/15/2014 22:36:13,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",77,142-152,EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:37:03,,1323879514,7/15/2014 22:36:50,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",77,142-152,EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:40:14,,1323881177,7/15/2014 22:39:35,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"onset of the SEIZURES, the clinical subgroup",64-70-73-77-87-91-100,127-131-139-142-152,and subtype of EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:46:11,,1323883711,7/15/2014 22:45:45,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",77,142-152,EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:57:49,,1323889453,7/15/2014 22:57:28,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",77,142-152,EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350588,7/15/2014 22:59:42,,1323890239,7/15/2014 22:59:32,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,77,142,,,85,160,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",77,142-152,EPILEPTIC SEIZURES.,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures.",77,142 152,77,142,85,160,-1,RO-has_definitional_manifestation,904933,"The examined parameters included: the prevalence and the age of onset of the seizures, the clinical subgroup of cerebral palsy and subtype of epileptic seizures",seizures,epileptic seizures
503350589,7/15/2014 22:03:53,,1323863799,7/15/2014 22:03:35,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,atypical migraine HEADACHES,75-84-93,6-15-22-30-39,Anteovin caused CLASSIC MIGRAINE headaches,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:18:51,,1323870561,7/15/2014 22:18:40,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,atypical migraine HEADACHES,75-84-93,22-30-39,CLASSIC MIGRAINE headaches,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:19:27,,1323870812,7/15/2014 22:18:57,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,HEADACHES,93,22-30,CLASSIC MIGRAINE,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:29:14,,1323875454,7/15/2014 22:28:40,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,atypical migraine HEADACHES,75-84-93,22-30,CLASSIC MIGRAINE,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:33:52,,1323877798,7/15/2014 22:33:36,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,migraine HEADACHES,93-84,22-30-39,CLASSIC MIGRAINE headaches,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:34:12,,1323878018,7/15/2014 22:33:55,instagc,1.0,13763729,USA,"","",75.182.89.225,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,atypical migraine HEADACHES,75-84-93,22-30-39,CLASSIC MIGRAINE headaches,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:34:47,,1323878354,7/15/2014 22:34:21,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,and atypical migraine HEADACHES,71-75-84-93,0-6-15-22-30-39,While Anteovin caused CLASSIC MIGRAINE headaches,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:36:55,,1323879463,7/15/2014 22:36:38,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,HEADACHES,93,6-22-30-39-49-52,Anteovin CLASSIC MIGRAINE headaches on 0.98%,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:39:26,,1323880747,7/15/2014 22:39:24,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,and atypical migraine HEADACHES on 2.3% for,71-75-84-93-103-106-111,0-6-15-22-30-39-49-52,While Anteovin caused CLASSIC MIGRAINE headaches on 0.98%,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350589,7/15/2014 22:40:57,,1323881421,7/15/2014 22:40:14,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,93,22,,,102,38,HEADACHES,CLASSIC MIGRAINE,migraine HEADACHES,84-93,22-30-39,CLASSIC MIGRAINE headaches,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon.",93,22 30,93,22,102,38,-1,RO-has_definitional_manifestation,904971,"While Anteovin caused classic migraine headaches on 0.98% of the women and atypical migraine headaches on 2.3% for the women, the figures were only 0.7% and 1.4% for women on Rigevidon",headaches,classic migraine
503350590,7/15/2014 21:59:52,,1323861982,7/15/2014 21:59:46,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,stromal tumors,17-25,0-17-25,GASTROINTESTINAL STROMAL TUMORS,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 22:03:39,,1323863674,7/15/2014 22:03:28,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,Gastrointestinal stromal tumors (GISTS),0-17-25-32,0-17-25,GASTROINTESTINAL STROMAL TUMORS,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 22:06:18,,1323864865,7/15/2014 22:06:08,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,Gastrointestinal stromal tumors (GISTS),0-17-25-32,0-17-25-32,GASTROINTESTINAL STROMAL TUMORS (GISTs),Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 22:34:18,,1323878072,7/15/2014 22:34:03,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,Gastrointestinal stromal tumors,0-17-25,0-17-25,GASTROINTESTINAL STROMAL TUMORS,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 22:35:30,,1323878808,7/15/2014 22:34:48,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,stromal tumors (GISTS) form an interesting group of sarcomas,17-25-32-40-45-48-60-66-69,0-17-25-32,GASTROINTESTINAL STROMAL TUMORS (GISTs),Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 22:36:39,,1323879324,7/15/2014 22:36:34,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,stromal tumors (GISTS) form an interesting,17-25-32-40-45-48,0-17-25-40-45,GASTROINTESTINAL STROMAL TUMORS form an,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 22:39:02,,1323880540,7/15/2014 22:38:52,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,Gastrointestinal stromal tumors (GISTS),0-17-25-32,0-17-25-32,GASTROINTESTINAL STROMAL TUMORS (GISTs),Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 22:46:30,,1323883840,7/15/2014 22:46:07,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,stromal tumors (GISTS),17-25-32,0-17-25-40,GASTROINTESTINAL STROMAL TUMORS form,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 22:55:16,,1323888286,7/15/2014 22:54:54,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,stromal tumors (GISTS),17-25-32,0-17-25-32,GASTROINTESTINAL STROMAL TUMORS (GISTs),Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350590,7/15/2014 23:07:32,,1323895118,7/15/2014 23:07:02,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,33,0,,,38,31,GISTS,GASTROINTESTINAL STROMAL TUMORS,(GISTS),32,0-17-25,GASTROINTESTINAL STROMAL TUMORS,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare.,,0 17 25,33,0,38,31,-1,RO-has_manifestation,906065,Gastrointestinal stromal tumors (GISTs) form an interesting group of sarcomas whose unique pathobiology provides a model of how molecularly targeted therapeutics can have a major impact on patient welfare,GISTs,Gastrointestinal stromal tumors
503350591,7/15/2014 21:58:07,,1323861055,7/15/2014 21:57:57,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,0,87,,,6,100,BREAST,BREAST CANCER,BREAST epithelial stem cells,0-7-18-23,87-94,BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 21:59:32,,1323861788,7/15/2014 21:59:25,clixsense,1,27871219,NLD,07,Amsterdam,87.210.207.223,0,87,,,6,100,BREAST,BREAST CANCER,BREAST epithelial stem cells,0-7-18-23,87-94,BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 22:04:07,,1323863877,7/15/2014 22:03:54,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,0,87,,,6,100,BREAST,BREAST CANCER,BREAST epithelial stem cells,0-7-18-23,74-84-87-94,aetiology of BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 22:04:31,,1323864043,7/15/2014 22:04:24,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,0,87,,,6,100,BREAST,BREAST CANCER,BREAST epithelial stem cells,0-7-18-23,74-84-87-94,aetiology of BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 22:06:20,,1323864890,7/15/2014 22:06:06,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,0,87,,,6,100,BREAST,BREAST CANCER,BREAST epithelial stem cells,0-7-18-23,87-94,BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 22:06:36,,1323865038,7/15/2014 22:06:17,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,0,87,,,6,100,BREAST,BREAST CANCER,BREAST,0,87-94,BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 22:19:53,,1323871053,7/15/2014 22:19:45,elite,1,28503042,USA,OK,Watonga,65.255.78.241,0,87,,,6,100,BREAST,BREAST CANCER,BREAST epithelial stem cells,0-7-18-23,87-94,BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 22:21:05,,1323871562,7/15/2014 22:20:49,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,0,87,,,6,100,BREAST,BREAST CANCER,BREAST epithelial stem cells,0-7-18-23,87-94,BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 22:26:45,,1323874241,7/15/2014 22:26:34,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,0,87,,,6,100,BREAST,BREAST CANCER,BREAST,0,87-94,BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350591,7/15/2014 22:30:12,,1323875879,7/15/2014 22:29:56,instagc,1.0,13763729,USA,"","",75.182.89.225,0,87,,,6,100,BREAST,BREAST CANCER,BREAST epithelial stem cells,0-7-18-23,87-94,BREAST CANCER.,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer.,0,87 94,0,87,6,100,1,RO-disease_has_primary_anatomic_site,902071,Breast epithelial stem cells are thought to be the primary targets in the aetiology of breast cancer,Breast,breast cancer
503350592,7/15/2014 21:58:38,,1323861348,7/15/2014 21:58:27,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,44,ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 21:59:54,,1323861985,7/15/2014 21:59:36,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,4-44,hypersensitivity ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 22:29:05,,1323875336,7/15/2014 22:28:52,instagc,1.0,13763729,USA,"","",75.182.89.225,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,44,ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 22:29:40,,1323875677,7/15/2014 22:29:22,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,44,ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 22:31:31,,1323876496,7/15/2014 22:31:15,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,44,ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 22:33:33,,1323877591,7/15/2014 22:32:46,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,The HYPERSENSITIVITY proved to be,0-4-21-28-31,34-38-41-44-52-55-57,due to an ALLERGY to a reaction,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 22:35:46,,1323878901,7/15/2014 22:35:23,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,44,ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 22:42:54,,1323882325,7/15/2014 22:42:36,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,44,ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 23:03:35,,1323892624,7/15/2014 23:03:16,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,44,ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350592,7/15/2014 23:07:01,,1323894868,7/15/2014 23:06:44,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,4,44,,,20,51,HYPERSENSITIVITY,ALLERGY,HYPERSENSITIVITY,4,44,ALLERGY,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",4,44,4,44,20,51,1,RO-cause_of,900099,"The hypersensitivity proved to be due to an allergy to a reaction product, and the simultaneous presence of the preservatives 1,3,5-trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction",hypersensitivity,allergy
503350593,7/15/2014 22:01:42,,1323862884,7/15/2014 22:01:17,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,46,59,,,51,70,LUNGS,LUNG CANCER,bodies in the LUNGS,32-39-42-46,59-64,LUNG CANCER,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:13:35,,1323868139,7/15/2014 22:13:03,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,46,59,,,51,70,LUNGS,LUNG CANCER,ferruginous bodies in the LUNGS,20-32-39-46-42,59-64,LUNG CANCER,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:25:00,,1323873368,7/15/2014 22:24:43,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,46,59,,,51,70,LUNGS,LUNG CANCER,LUNGS,46,59-64,LUNG CANCER,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:25:09,,1323873448,7/15/2014 22:23:02,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,46,59,,,51,70,LUNGS,LUNG CANCER,LUNGS,46,52-59-64,of LUNG CANCER,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:33:33,,1323877593,7/15/2014 22:33:26,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,46,59,,,51,70,LUNGS,LUNG CANCER,bodies in the LUNGS of ten lung,32-39-42-46-52-55-59,46-52-55-59-64-71-80-85,lungs of ten LUNG CANCER patients with definite,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:38:01,,1323880023,7/15/2014 22:37:46,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,46,59,,,51,70,LUNGS,LUNG CANCER,LUNGS,46,59-64,LUNG CANCER,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:38:43,,1323880398,7/15/2014 22:38:28,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,46,59,,,51,70,LUNGS,LUNG CANCER,LUNGS,46,59-64,LUNG CANCER,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:39:24,,1323880735,7/15/2014 22:39:06,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,46,59,,,51,70,LUNGS,LUNG CANCER,LUNGS,46,59-64,LUNG CANCER,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:40:17,,1323881189,7/15/2014 22:40:14,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,46,59,,,51,70,LUNGS,LUNG CANCER,bodies in the LUNGS of ten lung,32-39-42-46-52-55-59,46-52-55-59-64-71-80-85,lungs of ten LUNG CANCER patients with definite,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350593,7/15/2014 22:49:19,,1323885098,7/15/2014 22:48:52,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,46,59,,,51,70,LUNGS,LUNG CANCER,LUNGS,46,59-64,LUNG CANCER,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated.,46,59 64,46,59,51,70,1,RO-disease_has_primary_anatomic_site,902200,The distribution of ferruginous bodies in the lungs of ten lung cancer patients with definite occupational history of asbestos exposure and the kind of core fibers in the center of the ferruginous bodies were evaluated,lungs,lung cancer
503350594,7/15/2014 22:14:49,,1323868737,7/15/2014 22:14:35,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,71,14,,,81,24,DEPRESSION,SERTRALINE,DEPRESSION Medication augmentation,71-83-94,0-10-14,"Bupropion SR, SERTRALINE,","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 22:23:55,,1323872891,7/15/2014 22:23:34,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,71,14,,,81,24,DEPRESSION,SERTRALINE,DEPRESSION,71,14,"SERTRALINE,","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 22:25:09,,1323873454,7/15/2014 22:24:58,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,71,14,,,81,24,DEPRESSION,SERTRALINE,of SSRIs for DEPRESSION Medication augmentation,58-61-67-71-83-94,0-10-14-26-29-41,"Bupropion SR, SERTRALINE, or venlafaxine XR","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 22:35:15,,1323878629,7/15/2014 22:35:00,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,71,14,,,81,24,DEPRESSION,SERTRALINE,DEPRESSION Medication augmentation,71-83-94,14,"SERTRALINE,","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 22:36:56,,1323879468,7/15/2014 22:36:39,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.170,71,14,,,81,24,DEPRESSION,SERTRALINE,DEPRESSION,71,14,"SERTRALINE,","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 22:37:55,,1323879978,7/15/2014 22:37:51,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,71,14,,,81,24,DEPRESSION,SERTRALINE,of SSRIs for DEPRESSION Medication augmentation after,58-61-67-71-83-94-107,0-10-14-26-29-41,"Bupropion SR, SERTRALINE, or venlafaxine XR","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 22:39:11,,1323880600,7/15/2014 22:39:03,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,71,14,,,81,24,DEPRESSION,SERTRALINE,of SSRIs for DEPRESSION Medication augmentation,58-61-67-71-83-94,0-10-14-26-29-41,"Bupropion SR, SERTRALINE, or venlafaxine XR","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 23:12:43,,1323898082,7/15/2014 23:12:25,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,71,14,,,81,24,DEPRESSION,SERTRALINE,DEPRESSION,71,14,"SERTRALINE,","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 23:12:48,,1323898095,7/15/2014 23:12:30,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,71,14,,,81,24,DEPRESSION,SERTRALINE,DEPRESSION,71,14,"SERTRALINE,","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350594,7/15/2014 23:18:07,,1323901005,7/15/2014 23:17:50,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,71,14,,,81,24,DEPRESSION,SERTRALINE,of SSRIs for DEPRESSION Medication augmentation after,58-61-67-71-83-94-107,0-10-14-26-29-41,"Bupropion SR, SERTRALINE, or venlafaxine XR","Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression.",71,14,71,14,81,24,1,RO-may_treat,907692,"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for depression",depression,sertraline
503350595,7/15/2014 22:13:28,,1323868084,7/15/2014 22:13:10,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,MELANOMA pan,159-168,60-70,"MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:16:49,,1323869650,7/15/2014 22:16:28,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,MELANOMA,159,60-70,"MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:25:55,,1323873797,7/15/2014 22:25:30,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,MELANOMA pan,159-168,60-70,"MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:25:58,,1323873841,7/15/2014 22:25:22,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,MELANOMA pan,159-168,60-70,"MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:32:17,,1323876908,7/15/2014 22:32:04,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,"S 100 protein, MELANOMA pan and vimentin.",144-146-150-159-168-172-176,40-49-58-60-70-80-86-90,"specimen revealed a MALIGNANT MELANOMA, which was confirmed","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:34:38,,1323878248,7/15/2014 22:34:24,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,MELANOMA pan,159-168,60-70,"MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:35:45,,1323878890,7/15/2014 22:33:53,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,MELANOMA pan,159-168,60-70,"MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:36:11,,1323879105,7/15/2014 22:35:56,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.170,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,MELANOMA - pan,159-167-168,60-70,"MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:38:27,,1323880234,7/15/2014 22:38:09,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,MELANOMA pan,159-168,60-70,"MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350595,7/15/2014 22:39:42,,1323880940,7/15/2014 22:39:33,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,159,60,,,167,78,MELANOMA,MALIGNANT MELANOMA,"S 100 protein, MELANOMA pan and vimentin.",144-146-150-159-168-172-176,40-49-58-60-70,"specimen revealed a MALIGNANT MELANOMA,","Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin.",159,60 70,159,60,167,78,-1,RO-has_manifestation,906345,"Microscopic examination of the resected specimen revealed a malignant melanoma, which was confirmed by immunohistochemical staining for HMB-45, S-100 protein, melanoma-pan and vimentin",melanoma,malignant melanoma
503350596,7/15/2014 22:00:35,,1323862343,7/15/2014 22:00:27,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,TREPONEMA PALLIDUM,76-86,133,SYPHILIS,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:05:35,,1323864522,7/15/2014 22:05:20,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,antibodies to TREPONEMA PALLIDUM,62-73-76-86,133,SYPHILIS,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:08:43,,1323866063,7/15/2014 22:08:26,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,TREPONEMA PALLIDUM,76-86,133,SYPHILIS,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:21:38,,1323871775,7/15/2014 22:21:18,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,TREPONEMA PALLIDUM,76-86,133,SYPHILIS,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:22:52,,1323872369,7/15/2014 22:22:37,fusioncash,1.0,19963999,USA,IL,Springfield,108.243.49.56,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,TREPONEMA PALLIDUM,76-86,133,SYPHILIS,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:31:50,,1323876622,7/15/2014 22:31:32,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,TREPONEMA PALLIDUM,76-86,133,SYPHILIS,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:32:16,,1323876904,7/15/2014 22:32:05,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,TREPONEMA PALLIDUM,76-86,133,SYPHILIS,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:35:31,,1323878820,7/15/2014 22:35:25,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,of antibodies to TREPONEMA PALLIDUM was evaluated as,59-62-73-76-86-95-99-109,114-124-129-133-142-145-156,screening test for SYPHILIS in comparison with,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:41:46,,1323881749,7/15/2014 22:41:43,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,of antibodies to TREPONEMA PALLIDUM was evaluated as,59-62-73-76-86-95-99-109,114-124-129-133-142-145-156,screening test for SYPHILIS in comparison with,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350596,7/15/2014 22:47:31,,1323884315,7/15/2014 22:46:31,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,76,133,,,94,141,TREPONEMA PALLIDUM,SYPHILIS,TREPONEMA PALLIDUM,76-86,124-129-133-142-145-156-114,screening test for SYPHILIS in comparison with,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test.,76 86,133,76,133,94,141,1,RO-has_causative_agent,903820,The CAPTIA Syphilis-G enzyme immunoassay for the detection of antibodies to Treponema pallidum was evaluated as a screening test for syphilis in comparison with the standard rapid plasma reagin (RPR) test,Treponema pallidum,syphilis
503350597,7/15/2014 22:37:28,,1323879710,7/15/2014 22:37:22,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"cryoprotein induced diseases, MONOCLONAL GAMMOPATHY, Waldenstrom's macroglobulinemia, hyperviscosity",36-48-56-66-77-89-103-122,66-77-89-103-122-137-147,"monoclonal gammopathy, Waldenstrom's MACROGLOBULINEMIA, hyperviscosity syndrome, multiple","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 22:39:14,,1323880649,7/15/2014 22:39:03,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"MONOCLONAL GAMMOPATHY,",66-77,89-103,"Waldenstrom's MACROGLOBULINEMIA,","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 22:44:19,,1323882950,7/15/2014 22:44:00,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"MONOCLONAL GAMMOPATHY,",66-77,89-103,"Waldenstrom's MACROGLOBULINEMIA,","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 22:59:44,,1323890259,7/15/2014 22:59:15,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"MONOCLONAL GAMMOPATHY,",66-77,103,"MACROGLOBULINEMIA,","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 22:59:47,,1323890302,7/15/2014 22:59:13,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"MONOCLONAL GAMMOPATHY, Waldenstrom's macroglobulinemia, hyperviscosity",66-77-89-103-122,89-103,"Waldenstrom's MACROGLOBULINEMIA,","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 23:04:33,,1323893339,7/15/2014 23:04:18,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"MONOCLONAL GAMMOPATHY,",66-77,103,"MACROGLOBULINEMIA,","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 23:14:27,,1323899077,7/15/2014 23:14:01,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"MONOCLONAL GAMMOPATHY,",66-77,89-103,"Waldenstrom's MACROGLOBULINEMIA,","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 23:18:12,,1323901049,7/15/2014 23:18:08,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"cryoprotein induced diseases, MONOCLONAL GAMMOPATHY, Waldenstrom's macroglobulinemia, hyperviscosity",36-48-56-66-77-89-103-122,66-77-89-103-122-137-147,"monoclonal gammopathy, Waldenstrom's MACROGLOBULINEMIA, hyperviscosity syndrome, multiple","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 23:21:10,,1323902809,7/15/2014 23:20:55,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"cryoprotein induced diseases, MONOCLONAL GAMMOPATHY, Waldenstrom's macroglobulinemia, hyperviscosity",36-48-56-66-77-89-103-122,66-77-89-103-122-137,"monoclonal gammopathy, Waldenstrom's MACROGLOBULINEMIA, hyperviscosity syndrome,","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350597,7/15/2014 23:22:42,,1323903540,7/15/2014 23:21:31,clixsense,1,25399403,GBR,"","",94.196.240.121,66,103,,,87,120,MONOCLONAL GAMMOPATHY,MACROGLOBULINEMIA,"MONOCLONAL GAMMOPATHY,",66-77,103,"MACROGLOBULINEMIA,","Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",66 77,103,66,103,87,120,-1,RO-disease_has_finding,901594,"Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis",monoclonal gammopathy,macroglobulinemia
503350598,7/15/2014 22:02:15,,1323863097,7/15/2014 22:02:07,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,131,201,,,136,213,COLON,COLON CANCER,mice COLON,126-131,201-207,"COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 22:09:46,,1323866517,7/15/2014 22:09:34,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,131,201,,,136,213,COLON,COLON CANCER,COLON,131,201-207,"COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 22:13:31,,1323868093,7/15/2014 22:13:11,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,131,201,,,136,213,COLON,COLON CANCER,"COLON cancer,",131-207,201-207,"COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 22:15:04,,1323868838,7/15/2014 22:14:44,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,131,201,,,136,213,COLON,COLON CANCER,COLON,131,191-195-201-207,"end point COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 22:18:25,,1323870428,7/15/2014 22:18:12,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,131,201,,,136,213,COLON,COLON CANCER,mice COLON,126-131,191-195-201-207,"end point COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 22:29:47,,1323875757,7/15/2014 22:29:40,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,131,201,,,136,213,COLON,COLON CANCER,Focus) in mice COLON after IQ or,116-123-126-131-137-143-147,187-191-195-201-207-215-219-224,"the end point COLON CANCER, and thus supports","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 22:33:13,,1323877375,7/15/2014 22:32:57,instagc,1.0,13763729,USA,"","",75.182.89.225,131,201,,,136,213,COLON,COLON CANCER,COLON,131,191-195-201-207,"end point COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 22:38:19,,1323880186,7/15/2014 22:37:47,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,131,201,,,136,213,COLON,COLON CANCER,COLON,131,201-207,"COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 22:55:55,,1323888569,7/15/2014 22:55:35,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,131,201,,,136,213,COLON,COLON CANCER,COLON,131,201-207,"COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350598,7/15/2014 23:08:43,,1323895811,7/15/2014 23:08:25,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,131,201,,,136,213,COLON,COLON CANCER,COLON,131,201-207,"COLON CANCER,","In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome.",131,201 207,131,201,136,213,1,RO-disease_has_primary_anatomic_site,902086,"In conclusion, this finding suggests that the detection of a high number of ACF with low crypt multiplicity (1-3 AC/Focus) in mice colon after IQ- or PhIP-treatment is not indicative for the end-point colon cancer, and thus supports the hypothesis that only the presence of a high number of ACF with high crypt multiplicity is predictive for tumor outcome",colon,colon cancer
503350599,7/15/2014 22:05:57,,1323864697,7/15/2014 22:05:42,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"severe HYPERTENSION,",39-46,92-101-104-110-123,syndrome of acute HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:08:25,,1323865949,7/15/2014 22:08:10,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"HYPERTENSION,",46,110-123,HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:10:09,,1323866697,7/15/2014 22:10:00,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"severe HYPERTENSION,",39-46,104-110-123,acute HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:23:21,,1323872633,7/15/2014 22:23:06,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"HYPERTENSION,",46,110-123,HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:32:24,,1323876975,7/15/2014 22:32:09,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"HYPERTENSION,",46,110-123,HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:33:59,,1323877867,7/15/2014 22:33:49,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"severe HYPERTENSION,",39-46,104-110-123,acute HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:36:11,,1323879112,7/15/2014 22:35:59,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"HYPERTENSION,",46,104-110-123,acute HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:36:59,,1323879503,7/15/2014 22:36:53,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"caused by severe HYPERTENSION, which may also",29-36-39-46-60-66-70,92-101-104-110-123,syndrome of acute HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:39:23,,1323880719,7/15/2014 22:39:21,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"caused by severe HYPERTENSION, which may also",29-36-39-46-60-66-70,92-101-104-110-123,syndrome of acute HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350599,7/15/2014 22:46:44,,1323883939,7/15/2014 22:46:16,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,46,110,,,58,137,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,"severe HYPERTENSION,",39-46,110-123-104,acute HYPERTENSIVE ENCEPHALOPATHY.,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy.",46,110 123,46,110,58,137,1,RO-disease_has_finding,901623,"Headache may occasionally be caused by severe hypertension, which may also lead to the rare syndrome of acute hypertensive encephalopathy",hypertension,hypertensive encephalopathy
503350600,7/15/2014 21:59:16,,1323861664,7/15/2014 21:58:53,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"RESPIRATORY DISTRESS,",68-80,92-96-101,WET LUNG appearance,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 22:00:10,,1323862158,7/15/2014 22:00:01,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"RESPIRATORY DISTRESS,",68-80,92-96-101,WET LUNG appearance,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 22:13:04,,1323867950,7/15/2014 22:12:46,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"RESPIRATORY DISTRESS,",68-80,92-96,WET LUNG,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 22:23:22,,1323872627,7/15/2014 22:22:53,fusioncash,1.0,19963999,USA,IL,Springfield,108.243.49.56,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"RESPIRATORY DISTRESS,",68-80,92-96,WET LUNG,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 22:25:23,,1323873563,7/15/2014 22:25:10,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"meconium may precipitate RESPIRATORY DISTRESS, a wet lung appearance and respiratory failure.",43-52-56-68-80-90-92-96-101-112-116-128,68-80-90-92-96-101-112-116-128,"respiratory distress, a WET LUNG appearance and respiratory failure.","Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 22:29:04,,1323875322,7/15/2014 22:28:59,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"meconium may precipitate RESPIRATORY DISTRESS, a wet lung",43-52-56-68-80-90-92-96,68-80-90-92-96-101-112-116,"respiratory distress, a WET LUNG appearance and respiratory","Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 22:35:22,,1323878745,7/15/2014 22:34:21,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"RESPIRATORY DISTRESS,",68-80,92-96-101,WET LUNG appearance,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 23:04:46,,1323893526,7/15/2014 23:04:34,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"RESPIRATORY DISTRESS,",68-80,92-96,WET LUNG,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 23:11:22,,1323897348,7/15/2014 23:11:01,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"RESPIRATORY DISTRESS,",68-80,92-96,WET LUNG,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350600,7/15/2014 23:16:40,,1323900167,7/15/2014 23:16:37,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,68,92,,,88,100,RESPIRATORY DISTRESS,WET LUNG,"meconium may precipitate RESPIRATORY DISTRESS, a wet lung",43-52-56-68-80-90-92-96,68-80-90-92-96-101-112-116,"respiratory distress, a WET LUNG appearance and respiratory","Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure.",68 80,92 96,68,92,88,100,-1,RO-disease_has_finding,901567,"Tracheobronchial saline lavage to dislodge meconium may precipitate respiratory distress, a wet lung appearance and respiratory failure",respiratory distress,wet lung
503350601,7/15/2014 22:00:39,,1323862392,7/15/2014 22:00:17,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7,OXYGEN,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:09:52,,1323866575,7/15/2014 22:08:40,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7,OXYGEN,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:10:30,,1323866849,7/15/2014 22:10:15,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7,OXYGEN,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:18:05,,1323870265,7/15/2014 22:17:48,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7,OXYGEN,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:23:40,,1323872815,7/15/2014 22:23:23,fusioncash,1.0,19963999,USA,IL,Springfield,108.243.49.56,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7-17,OXYGEN too,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:28:31,,1323875088,7/15/2014 22:27:54,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7,OXYGEN,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:29:39,,1323875675,7/15/2014 22:29:34,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,the incidence of DECOMPRESSION SICKNESS increases; if the,26-30-40-43-57-66-77-80,0-3-7-14-17-21,"If the OXYGEN is too low,","If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:32:56,,1323877270,7/15/2014 22:32:29,instagc,1.0,13763729,USA,"","",75.182.89.225,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7,OXYGEN,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:37:32,,1323879747,7/15/2014 22:37:21,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7,OXYGEN,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350601,7/15/2014 22:39:01,,1323880539,7/15/2014 22:38:46,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,43,7,,,65,13,DECOMPRESSION SICKNESS,OXYGEN,DECOMPRESSION SICKNESS,43-57,7,OXYGEN,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem.",43 57,7,43,7,65,13,1,RO-may_treat,908185,"If the oxygen is too low, the incidence of decompression sickness increases; if the oxygen is too high, oxygen poisoning becomes a problem",decompression sickness,oxygen
503350602,7/15/2014 21:58:29,,1323861225,7/15/2014 21:58:25,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,13,53,,,17,69,PAIN,CLUSTER HEADACHE,Although the PAIN in both disorders,0-9-13-18-21-26,26-36-39-53-61-70-75-78,"disorders is excruciating, CLUSTER HEADACHE pain is episodic","Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 22:00:55,,1323862528,7/15/2014 22:00:46,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,13,53,,,17,69,PAIN,CLUSTER HEADACHE,PAIN,13,53-61,CLUSTER HEADACHE,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 22:03:29,,1323863607,7/15/2014 22:02:46,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,13,53,,,17,69,PAIN,CLUSTER HEADACHE,PAIN trigeminal neuralgia,13-173-184,53-61-173-184,CLUSTER HEADACHE trigeminal neuralgia,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 22:35:54,,1323878939,7/15/2014 22:35:29,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,13,53,,,17,69,PAIN,CLUSTER HEADACHE,PAIN,13,53-61,CLUSTER HEADACHE,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 22:38:06,,1323880052,7/15/2014 22:37:53,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,13,53,,,17,69,PAIN,CLUSTER HEADACHE,PAIN,13,53-61,CLUSTER HEADACHE,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 22:41:42,,1323881703,7/15/2014 22:41:15,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,13,53,,,17,69,PAIN,CLUSTER HEADACHE,Although the PAIN in both disorders,0-9-13-18-21-26,26-36-39-53-61-70-75-78,"disorders is excruciating, CLUSTER HEADACHE pain is episodic","Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 22:41:52,,1323881795,7/15/2014 22:41:32,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,13,53,,,17,69,PAIN,CLUSTER HEADACHE,PAIN,13,53-61-70,CLUSTER HEADACHE pain,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 23:01:00,,1323890910,7/15/2014 23:00:40,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,13,53,,,17,69,PAIN,CLUSTER HEADACHE,PAIN in both disorders,13-18-21-26,53-61-70-75-78,CLUSTER HEADACHE pain is episodic,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 23:16:26,,1323899985,7/15/2014 23:16:05,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,13,53,,,17,69,PAIN,CLUSTER HEADACHE,PAIN,13,53-61-70,CLUSTER HEADACHE pain,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350602,7/15/2014 23:18:20,,1323901122,7/15/2014 23:18:17,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,13,53,,,17,69,PAIN,CLUSTER HEADACHE,Although the PAIN in both disorders,0-9-13-18-21-26,26-36-39-53-61-70-75-78,"disorders is excruciating, CLUSTER HEADACHE pain is episodic","Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve.",13,53 61,13,53,17,69,-1,RO-has_definitional_manifestation,904783,"Although the pain in both disorders is excruciating, cluster headache pain is episodic and unilateral, typically surrounds the eye, and lasts 15 to 180 minutes; the pain of trigeminal neuralgia lasts just seconds and is usually limited to the tissues overlying the maxillary and mandibular divisions of the trigeminal nerve",pain,cluster headache
503350603,7/15/2014 22:00:58,,1323862537,7/15/2014 22:00:46,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,56,112,,,60,127,SKIN,DERMATOPHYTOSES,"feather, hair and SKIN specimens from a",38-47-52-56-61-71-76,89-97-102-112-128-133-142,"animals with suspected DERMATOPHYTOSES were studied, of","Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 22:01:46,,1323862920,7/15/2014 22:01:27,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,56,112,,,60,127,SKIN,DERMATOPHYTOSES,SKIN dermatophytoses,56-112,112,DERMATOPHYTOSES,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 22:02:39,,1323863319,7/15/2014 22:02:23,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,56,112,,,60,127,SKIN,DERMATOPHYTOSES,"feather, hair and SKIN specimens",38-47-52-56-61,89-97-102-112,animals with suspected DERMATOPHYTOSES,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 22:05:19,,1323864425,7/15/2014 22:05:07,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,56,112,,,60,127,SKIN,DERMATOPHYTOSES,SKIN,56,112-128,DERMATOPHYTOSES were,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 22:23:58,,1323872918,7/15/2014 22:23:42,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,56,112,,,60,127,SKIN,DERMATOPHYTOSES,SKIN,56,112,DERMATOPHYTOSES,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 22:35:58,,1323878977,7/15/2014 22:35:42,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,56,112,,,60,127,SKIN,DERMATOPHYTOSES,SKIN,56,112,DERMATOPHYTOSES,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 22:51:35,,1323886351,7/15/2014 22:51:13,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,56,112,,,60,127,SKIN,DERMATOPHYTOSES,SKIN,56,112,DERMATOPHYTOSES,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 22:57:27,,1323889263,7/15/2014 22:56:53,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,56,112,,,60,127,SKIN,DERMATOPHYTOSES,SKIN,56,112,DERMATOPHYTOSES,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 22:58:36,,1323889756,7/15/2014 22:58:15,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,56,112,,,60,127,SKIN,DERMATOPHYTOSES,"feather, hair and SKIN specimens",38-47-52-56-61,89-97-102-112,animals with suspected DERMATOPHYTOSES,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350603,7/15/2014 23:04:51,,1323893580,7/15/2014 23:04:38,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,56,112,,,60,127,SKIN,DERMATOPHYTOSES,SKIN,56,112,DERMATOPHYTOSES,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes.",56,112,56,112,60,127,1,RO-disease_has_primary_anatomic_site,902135,"Between 1994 and 1998, a total of 790 feather, hair and skin specimens from a variety of animals with suspected dermatophytoses were studied, of which 248 (31.4%) yielded dermatophytes",skin,dermatophytoses
503350604,7/15/2014 22:14:29,,1323868552,7/15/2014 22:14:15,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,Mycobacterium TUBERCULOSIS,124-138,180-186-191-208,first line ANTITUBERCULOSIS drugs.,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 22:29:29,,1323875595,7/15/2014 22:29:25,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,isolates of Mycobacterium TUBERCULOSIS susceptible or resistant,110-119-124-138-152-164-167,177-180-186-191-208,to first line ANTITUBERCULOSIS drugs.,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 22:31:59,,1323876668,7/15/2014 22:31:14,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,Mycobacterium TUBERCULOSIS,124-138,191,ANTITUBERCULOSIS,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 22:35:14,,1323878588,7/15/2014 22:34:39,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,Mycobacterium TUBERCULOSIS,124-138,191-208,ANTITUBERCULOSIS drugs.,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 22:38:02,,1323880024,7/15/2014 22:37:57,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,isolates of Mycobacterium TUBERCULOSIS susceptible or resistant,110-119-124-138-152-164-167,177-180-186-191-208,to first line ANTITUBERCULOSIS drugs.,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 22:39:51,,1323880990,7/15/2014 22:39:17,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,Mycobacterium TUBERCULOSIS,124-138,180-186-191-208,first line ANTITUBERCULOSIS drugs.,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 22:40:35,,1323881292,7/15/2014 22:40:33,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,isolates of Mycobacterium TUBERCULOSIS susceptible or resistant,110-119-124-138-152-164-167,177-180-186-191-208,to first line ANTITUBERCULOSIS drugs.,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 22:45:39,,1323883498,7/15/2014 22:45:07,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,Mycobacterium TUBERCULOSIS,124-138,191,ANTITUBERCULOSIS,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 23:02:12,,1323891646,7/15/2014 23:01:46,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,Mycobacterium TUBERCULOSIS,124-138,191,ANTITUBERCULOSIS,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350604,7/15/2014 23:06:42,,1323894664,7/15/2014 23:06:14,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,138,191,,,150,207,TUBERCULOSIS,ANTITUBERCULOSIS,Mycobacterium TUBERCULOSIS,124-138,191-208,ANTITUBERCULOSIS drugs.,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs.",138,191,138,191,150,207,1,RO-may_treat,907849,"Ruiz-Serrano MJ, Alcala L, Martinez L et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of   Mycobacterium tuberculosis  susceptible or resistant to first-line antituberculosis drugs",tuberculosis,antituberculosis
503350605,7/15/2014 22:00:20,,1323862232,7/15/2014 22:00:07,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,colitis (5 without DYSPLASIA and 10 with,164-172-175-183-193-197-200,200-205-217-220-228-239-243-246,"with dysplasia), 25 TUBULAR ADENOMAS], and 25 adenocarcinoma","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 22:31:30,,1323876469,7/15/2014 22:31:16,instagc,1.0,13763729,USA,"","",75.182.89.225,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,DYSPLASIA,183,220-228,"TUBULAR ADENOMAS],","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 22:35:26,,1323878770,7/15/2014 22:35:12,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.170,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,DYSPLASIA,183,220-228,"TUBULAR ADENOMAS],","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 22:37:28,,1323879711,7/15/2014 22:37:17,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,(5 without DYSPLASIA and 10 with,172-175-183-193-197-200,220-228,"TUBULAR ADENOMAS],","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 22:38:07,,1323880071,7/15/2014 22:37:53,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,DYSPLASIA,183,220-228,"TUBULAR ADENOMAS],","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 22:39:27,,1323880750,7/15/2014 22:39:06,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,"colitis (5 without DYSPLASIA and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",164-172-175-183-193-197-200-205-217-220-228-239-243-246-261,200-205-217-220-228-239-243-246-261,"with dysplasia), 25 TUBULAR ADENOMAS], and 25 adenocarcinoma cases.","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 22:39:32,,1323880800,7/15/2014 22:39:23,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,colitis (5 without DYSPLASIA and 10 with,164-172-175-183-193-197-200,200-205-217-220-228-239-243-246,"with dysplasia), 25 TUBULAR ADENOMAS], and 25 adenocarcinoma","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 22:41:55,,1323881810,7/15/2014 22:41:29,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,DYSPLASIA,183,220-228,"TUBULAR ADENOMAS],","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 23:01:02,,1323890939,7/15/2014 23:00:33,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,DYSPLASIA,183,220-228,"TUBULAR ADENOMAS],","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350605,7/15/2014 23:05:47,,1323894158,7/15/2014 23:05:11,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,183,220,,,192,236,DYSPLASIA,TUBULAR ADENOMAS,DYSPLASIA,183,220-228,"TUBULAR ADENOMAS],","We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases.",183,220 228,183,220,192,236,-1,RO-disease_has_finding,901521,"We studied the expression of Gal-GalNAc by GOS reaction, lectin reactivity and immunocytochemistry in 10 normal, .45 precancerous [5 Crohn's disease, 15 ulcerative colitis (5 without dysplasia and 10 with dysplasia), 25 tubular adenomas], and 25 adenocarcinoma cases",dysplasia,tubular adenomas
503350606,7/15/2014 21:58:57,,1323861545,7/15/2014 21:58:48,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,and develop thromboembOLISM AFTER MAJor abdominal,144-148-156-172-178-184,119-124-132-144-148-156,dose heparin prOPHYLAXis and develop thromboembolism,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:00:08,,1323862137,7/15/2014 21:59:55,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,156,thromboembolism,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:02:30,,1323863217,7/15/2014 22:02:16,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,115-118-119-124-132,low - dose heparin prOPHYLAXis,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:10:36,,1323866889,7/15/2014 22:10:10,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,115-119-124-132,low dose heparin prOPHYLAXis,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:14:34,,1323868582,7/15/2014 22:14:11,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,115-119-124-132,low dose heparin prOPHYLAXis,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:17:24,,1323869913,7/15/2014 22:16:50,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,124,heparin,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:25:06,,1323873420,7/15/2014 22:24:40,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,124-132,heparin prOPHYLAXis,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:26:34,,1323874083,7/15/2014 22:26:11,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,124-132,heparin prOPHYLAXis,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:28:10,,1323874925,7/15/2014 22:27:49,instagc,1.0,13763729,USA,"","",75.182.89.225,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,119-124,dose heparin,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350606,7/15/2014 22:30:41,,1323876132,7/15/2014 22:30:16,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,166,134,,,181,141,THROMBOEMBOLISM,HEPARIN,thromboembOLISM,156,115-119-124-132,low dose heparin prOPHYLAXis,"The object of the present investigation was to identify those who, among high-risk patients, would ""break through"" low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery.",,,166,134,181,141,1,RO-may_prevent,907131,"The object of the present investigation was to identify those who, among high-risk patients, would &quot;break through&quot; low-dose heparin prophylaxis and develop thromboembolism after major abdominal surgery",thromboembolism,heparin
503350607,7/15/2014 22:17:39,,1323870035,7/15/2014 22:17:14,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,102,47,,,108,55,NUMBER,EPILEPSY,NUMBER,102,47,"EPILEPSY,","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 22:24:20,,1323873067,7/15/2014 22:23:57,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,102,47,,,108,55,NUMBER,EPILEPSY,NUMBER of seizures,102-109-112,47,"EPILEPSY,","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 22:27:53,,1323874685,7/15/2014 22:27:08,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,102,47,,,108,55,NUMBER,EPILEPSY,NUMBER of seizures,102-109-112,47,"EPILEPSY,","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 22:40:06,,1323881115,7/15/2014 22:39:26,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,102,47,,,108,55,NUMBER,EPILEPSY,high lifetime NUMBER of seizures,88-93-102-109-112,47,"EPILEPSY,","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 22:40:19,,1323881195,7/15/2014 22:40:11,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,102,47,,,108,55,NUMBER,EPILEPSY,NUMBER of seizures and,102-109-112-121,33-36-42-47-57-68-71,"in women with EPILEPSY, especially in the","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 22:42:13,,1323881999,7/15/2014 22:41:53,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,102,47,,,108,55,NUMBER,EPILEPSY,NUMBER,102,47,"EPILEPSY,","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 23:06:55,,1323894808,7/15/2014 23:06:42,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,102,47,,,108,55,NUMBER,EPILEPSY,NUMBER of seizures,102-109-112,47,"EPILEPSY,","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 23:12:05,,1323897789,7/15/2014 23:11:45,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,102,47,,,108,55,NUMBER,EPILEPSY,NUMBER,102,47,"EPILEPSY,","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 23:20:07,,1323902266,7/15/2014 23:19:44,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,102,47,,,108,55,NUMBER,EPILEPSY,NUMBER of seizures,102-109-112,47,"EPILEPSY,","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350607,7/15/2014 23:20:43,,1323902577,7/15/2014 23:20:23,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,102,47,,,108,55,NUMBER,EPILEPSY,high lifetime NUMBER of seizures,88-93-102-109-112,36-47-57,"women EPILEPSY, especially","Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs.",102,47,102,47,108,55,-1,RO-has_definitional_manifestation,904527,"Menopause tends to occur earlier in women with epilepsy, especially in the setting of a high lifetime number of seizures and lifetime use of multiple enzyme-inducing AEDs",number,epilepsy
503350608,7/15/2014 22:14:24,,1323868480,7/15/2014 22:14:10,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 22:14:43,,1323868645,7/15/2014 22:14:21,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 22:22:07,,1323871982,7/15/2014 22:21:51,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 22:33:15,,1323877420,7/15/2014 22:33:01,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 22:33:35,,1323877613,7/15/2014 22:33:21,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 22:38:46,,1323880419,7/15/2014 22:38:25,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 22:38:57,,1323880530,7/15/2014 22:38:55,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,in patients with HYPERCHOLESTEROLEMIA CURVES study.,145-148-157-162-188-195,85-92-104-117-129-133-145,"versus lovastatin, pravastatin, LOVASTATIN, and fluvastatin in","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 22:40:16,,1323881179,7/15/2014 22:40:03,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 22:59:14,,1323890045,7/15/2014 22:58:44,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350608,7/15/2014 23:18:30,,1323901234,7/15/2014 23:18:12,prodege,1,12537159,USA,MI,Sterling Heights,68.60.146.55,162,117,,,182,127,HYPERCHOLESTEROLEMIA,LOVASTATIN,HYPERCHOLESTEROLEMIA,162,117,"LOVASTATIN,","Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study.",162,117,162,117,182,127,1,RO-may_treat,907513,"Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin versus lovastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study",hypercholesterolemia,lovastatin
503350609,7/15/2014 22:02:22,,1323863155,7/15/2014 22:01:43,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,malabsorption of the xylose in the SMALL INTESTINE,57-71-74-78-85-88-92-98,46-54-57-71-74-78,leading to MALABSORPTION of the xylose,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:04:43,,1323864178,7/15/2014 22:04:26,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,SMALL INTESTINE,92-98,57-71-74-78,MALABSORPTION of the xylose,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:04:52,,1323864229,7/15/2014 22:04:25,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,SMALL INTESTINE colonic metabolism,92-98-123-131,57-123-131,MALABSORPTION colonic metabolism,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:14:09,,1323868360,7/15/2014 22:13:52,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,SMALL INTESTINE,92-98,57,MALABSORPTION,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:18:24,,1323870425,7/15/2014 22:18:08,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,SMALL INTESTINE,92-98,57-71-74-78,MALABSORPTION of the xylose,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:21:35,,1323871757,7/15/2014 22:21:23,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,SMALL INTESTINE colonic,92-98-123,57,MALABSORPTION,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:29:25,,1323875568,7/15/2014 22:27:38,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,SMALL INTESTINE,92-98,57,MALABSORPTION,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:29:33,,1323875648,7/15/2014 22:29:30,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,xylose in the SMALL INTESTINE and subsequent colonic,78-85-88-92-98-108-112-123,37-46-54-57-71-74-78,"transit, leading to MALABSORPTION of the xylose","Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:31:09,,1323876320,7/15/2014 22:29:54,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,SMALL INTESTINE,92-98,57,MALABSORPTION,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350609,7/15/2014 22:31:15,,1323876366,7/15/2014 22:30:58,instagc,1.0,13763729,USA,"","",75.182.89.225,92,57,,,107,70,SMALL INTESTINE,MALABSORPTION,SMALL INTESTINE,92-98,57,MALABSORPTION,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose.",92 98,57,92,57,107,70,1,RO-has_finding_site,905415,"Gastrografin accelerated small bowel transit, leading to malabsorption of the xylose in the small intestine and subsequent colonic metabolism of the xylose",small intestine,malabsorption
503350610,7/15/2014 22:07:38,,1323865500,7/15/2014 22:07:10,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,history of POSTMENOPAUSAL BLEEDING.,150-158-161-176,93-98-101-112-124,TVUS in diagnosing ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 22:11:57,,1323867558,7/15/2014 22:11:39,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,112-124,ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 22:19:55,,1323871092,7/15/2014 22:19:41,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,112-124,ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 22:20:21,,1323871211,7/15/2014 22:20:07,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,112-124,ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 22:23:28,,1323872713,7/15/2014 22:23:12,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,93-98-101-112-124-131-134-143-161-176,TVUS in diagnosing ENDOMETRIAL CANCER in patients with postmenopausal bleeding.,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 22:29:25,,1323875578,7/15/2014 22:29:08,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,112-124,ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 22:34:23,,1323878125,7/15/2014 22:34:12,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,112-124,ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 23:02:18,,1323891721,7/15/2014 23:02:07,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,112-124,ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 23:02:31,,1323891894,7/15/2014 23:02:19,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,112-124,ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350610,7/15/2014 23:18:06,,1323901004,7/15/2014 23:17:47,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,161,112,,,184,130,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER,POSTMENOPAUSAL BLEEDING.,161-176,112-124,ENDOMETRIAL CANCER,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding.,161 176,112 124,161,112,184,130,-1,RO-disease_may_have_finding,902513,? A prospective study was done to evaluate the role of three-dimensional vs. two-dimensional TVUS in diagnosing endometrial cancer in patients with a history of postmenopausal bleeding,postmenopausal bleeding,endometrial cancer
503350611,7/15/2014 21:58:42,,1323861395,7/15/2014 21:58:36,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,of erythromycin resistant S. AUREUS varied widely nationwide.,115-118-131-141-144-151-158-165,33-37-50-60-75-82-86-95,"and levofloxacin resistant STAPHYLOCOCCUS AUREUS was similar, while","The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 22:05:16,,1323864406,7/15/2014 22:05:00,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin resistant S. AUREUS,118-131-141-144,37-50-60-75,levofloxacin resistant STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 22:05:20,,1323864438,7/15/2014 22:04:34,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin resistant S. AUREUS,118-131-141-144,18-31-33-37-50-60-75-49,ciprofloxacin - and levofloxacin - resistant STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 22:09:12,,1323866249,7/15/2014 22:08:58,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin resistant S. AUREUS,118-131-141-144,37-50-60-75,levofloxacin resistant STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 22:11:09,,1323867202,7/15/2014 22:10:56,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin resistant S. AUREUS,118-131-141-144,37-50-60-75,levofloxacin resistant STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 22:21:20,,1323871626,7/15/2014 22:20:32,fusioncash,1.0,19963999,USA,IL,Springfield,108.243.49.56,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin resistant S. AUREUS,118-131-141-144,33-37-50-60-75,and levofloxacin resistant STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 22:31:17,,1323876369,7/15/2014 22:28:38,clixsense,1,8133967,AUS,02,Sydney,14.200.47.168,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin - resistant S. AUREUS,118-130-141-144-131,37-50-60-75,levofloxacin resistant STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 22:41:59,,1323881839,7/15/2014 22:41:27,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin resistant S. AUREUS,118-131-141-144,37-50-60-75,levofloxacin resistant STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 22:53:56,,1323887654,7/15/2014 22:53:41,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin resistant S. AUREUS,118-131-141-144,37-50-60-75,levofloxacin resistant STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350611,7/15/2014 23:17:45,,1323900796,7/15/2014 23:17:10,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,141,60,,,150,81,S. AUREUS,STAPHYLOCOCCUS AUREUS,erythromycin resistant S. AUREUS,118-131-141-144,60-75,STAPHYLOCOCCUS AUREUS,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide.",141 144,60 75,141,60,150,81,-1,RO-has_causative_agent,903640,"The occurrence of ciprofloxacin- and levofloxacin-resistant Staphylococcus aureus was similar, while the frequency of erythromycin-resistant S. aureus varied widely nationwide",S. aureus,Staphylococcus aureus
503350612,7/15/2014 22:10:27,,1323866823,7/15/2014 22:10:18,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,Tension type HEADACHE,0-8-13,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 22:10:54,,1323867089,7/15/2014 22:10:31,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,HEADACHE,13,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 22:32:14,,1323876871,7/15/2014 22:31:58,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,Tension - type HEADACHE headache,7-8-13-35-0,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 22:34:50,,1323878360,7/15/2014 22:34:36,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,Tension type HEADACHE,0-8-13,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 22:36:08,,1323879073,7/15/2014 22:35:59,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,Tension type HEADACHE,0-8-13,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 22:36:39,,1323879322,7/15/2014 22:36:25,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,Tension - type HEADACHE,0-7-8-13,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 22:37:09,,1323879560,7/15/2014 22:36:42,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,Tension type HEADACHE migraine headache,0-8-13-26-35,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 22:40:20,,1323881211,7/15/2014 22:40:18,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,Tension type HEADACHE and migraine headache,0-8-13-22-26-35,8-13-22-26-35-44-58-65,"type headache and MIGRAINE HEADACHE predominantly affect women,","Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 22:43:24,,1323882555,7/15/2014 22:42:58,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,Tension type HEADACHE,0-13-8,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350612,7/15/2014 23:17:08,,1323900457,7/15/2014 23:16:28,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,13,26,,,21,43,HEADACHE,MIGRAINE HEADACHE,HEADACHE,13,26-35,MIGRAINE HEADACHE,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men.",13,26 35,13,26,21,43,-1,RO-has_definitional_manifestation,904962,"Tension-type headache and migraine headache predominantly affect women, whereas cluster headache predominantly affects men",headache,migraine headache
503350613,7/15/2014 22:04:21,,1323863968,7/15/2014 22:03:56,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77,ANXIETY DISORDER,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 22:12:38,,1323867835,7/15/2014 22:12:21,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77,ANXIETY DISORDER,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 22:13:50,,1323868244,7/15/2014 22:13:29,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77-86,"ANXIETY DISORDER patients,","In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 22:31:14,,1323876361,7/15/2014 22:30:56,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77,ANXIETY DISORDER,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 22:38:35,,1323880343,7/15/2014 22:37:13,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.170,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77,ANXIETY DISORDER,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 23:04:37,,1323893379,7/15/2014 23:04:24,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77,ANXIETY DISORDER,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 23:05:20,,1323893899,7/15/2014 23:04:52,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77,ANXIETY DISORDER,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 23:17:18,,1323900547,7/15/2014 23:17:15,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,"In addition, only ANXIETY had a direct",0-3-13-18-26-30-32,49-57-66-69-77-86-96-104,"somatic symptoms in ANXIETY DISORDER patients, whereas both","In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 23:21:20,,1323902905,7/15/2014 23:20:58,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77,ANXIETY DISORDER,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350613,7/15/2014 23:23:22,,1323903974,7/15/2014 23:22:59,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,18,69,,,25,85,ANXIETY,ANXIETY DISORDER,ANXIETY,18,69-77,ANXIETY DISORDER,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients.",18,69 77,18,69,25,85,-1,RO-has_definitional_manifestation,904601,"In addition, only anxiety had a direct effect on somatic symptoms in anxiety disorder patients, whereas both anxiety and depression had direct effects on somatic symptoms in somatoform disorder patients",anxiety,anxiety disorder
503350614,7/15/2014 22:06:44,,1323865108,7/15/2014 22:06:20,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,Selenium (Se) deficiency ENDEMIC GOITER,0-14-94-102-9,0-9-14,Selenium (Se) DEFICIENCY,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:08:31,,1323865998,7/15/2014 22:08:11,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,ENDEMIC GOITER areas,94-102-109,0-9-14,Selenium (Se) DEFICIENCY,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:17:54,,1323870121,7/15/2014 22:17:38,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,Selenium (Se) deficiency gland in certain ENDEMIC GOITER areas in Africa.,0-9-77-83-86-94-102-109-115-118-14,0-9-14-25-28-33,Selenium (Se) DEFICIENCY is said to,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:19:05,,1323870644,7/15/2014 22:18:53,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,ENDEMIC GOITER areas,94-102-109,0-9-14,Selenium (Se) DEFICIENCY,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:24:48,,1323873251,7/15/2014 22:24:34,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,ENDEMIC GOITER,94-102,0-9-14,Selenium (Se) DEFICIENCY,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:27:10,,1323874433,7/15/2014 22:26:51,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,ENDEMIC GOITER,94-102,0-14,Selenium DEFICIENCY,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:32:52,,1323877241,7/15/2014 22:32:46,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,gland in certain ENDEMIC GOITER areas in Africa.,77-83-86-94-102-109-115-118,0-9-14-25-28-33,Selenium (Se) DEFICIENCY is said to,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:35:10,,1323878562,7/15/2014 22:34:54,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,ENDEMIC GOITER,94-102,0-9-14,Selenium (Se) DEFICIENCY,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:39:34,,1323880834,7/15/2014 22:39:31,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,gland in certain ENDEMIC GOITER areas in Africa.,77-83-86-94-102-109-115-118,0-9-14-25-28-33,Selenium (Se) DEFICIENCY is said to,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350614,7/15/2014 22:42:00,,1323881856,7/15/2014 22:41:29,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,94,14,,,108,24,ENDEMIC GOITER,DEFICIENCY,ENDEMIC GOITER,94-102,14-0,Selenium DEFICIENCY,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa.,94 102,14,94,14,108,24,1,RO-cause_of,900255,Selenium (Se) deficiency is said to contribute to the atrophy of the thyroid gland in certain endemic goiter areas in Africa,endemic goiter,deficiency
503350615,7/15/2014 22:05:08,,1323864326,7/15/2014 22:04:53,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,HISTOPLASMOSIS,39,39-66,histoplasmosis HISTOPLASMIN,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:17:47,,1323870073,7/15/2014 22:17:28,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,HISTOPLASMOSIS,39,66-79-84,HISTOPLASMIN skin tests.,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:29:56,,1323875809,7/15/2014 22:29:26,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,HISTOPLASMOSIS,39,66,HISTOPLASMIN,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:34:20,,1323878077,7/15/2014 22:33:26,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,HISTOPLASMOSIS,39,66-79-84,HISTOPLASMIN skin tests.,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:34:20,,1323878097,7/15/2014 22:34:08,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,HISTOPLASMOSIS,39,66,HISTOPLASMIN,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:37:50,,1323879926,7/15/2014 22:37:43,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,15 cases of HISTOPLASMOSIS with strong histoplasmin,27-30-36-39-54-59-66,39-54-59-66-79-84,histoplasmosis with strong HISTOPLASMIN skin tests.,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:38:54,,1323880510,7/15/2014 22:38:51,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,15 cases of HISTOPLASMOSIS with strong histoplasmin,27-30-36-39-54-59-66,39-54-59-66-79-84,histoplasmosis with strong HISTOPLASMIN skin tests.,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:39:22,,1323880721,7/15/2014 22:39:12,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,15 cases of HISTOPLASMOSIS with strong histoplasmin skin tests.,27-30-36-39-54-59-66-84-79,39-54-59-66-79-84,histoplasmosis with strong HISTOPLASMIN skin tests.,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:40:02,,1323881079,7/15/2014 22:39:50,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,HISTOPLASMOSIS,39,66,HISTOPLASMIN,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350615,7/15/2014 22:58:07,,1323889572,7/15/2014 22:57:44,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,39,66,,,53,78,HISTOPLASMOSIS,HISTOPLASMIN,HISTOPLASMOSIS,39,66,HISTOPLASMIN,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests.,39,66,39,66,53,78,1,RO-may_diagnose,906592,The second was composed of 15 cases of histoplasmosis with strong histoplasmin skin tests,histoplasmosis,histoplasmin
503350619,7/15/2014 22:23:57,,1323872919,7/15/2014 22:23:41,fusioncash,1,19963999,USA,IL,Springfield,108.243.49.56,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,in ARRHYTHMIA,159-181,135,ANTIARRHYTHMIC,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 22:32:46,,1323877228,7/15/2014 22:32:29,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,adrenaline induced ARRHYTHMIA,162-173-181,122-135-150,prophylactic ANTIARRHYTHMIC activity,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 22:44:17,,1323882939,7/15/2014 22:43:39,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,adrenaline induced ARRHYTHMIA,162-173-181,122-135-150,prophylactic ANTIARRHYTHMIC activity,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 22:45:58,,1323883650,7/15/2014 22:45:40,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,adrenaline induced ARRHYTHMIA,162-173-181,122-135-150,prophylactic ANTIARRHYTHMIC activity,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 22:53:17,,1323887289,7/15/2014 22:51:46,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,adrenaline induced ARRHYTHMIA,162-173-181,122-135-150,prophylactic ANTIARRHYTHMIC activity,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 23:16:53,,1323900289,7/15/2014 23:16:50,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,in adrenaline induced ARRHYTHMIA in anesthetized rats.,159-162-173-181-192-195-208,115-118-122-135-150-159-162,in the prophylactic ANTIARRHYTHMIC activity in adrenaline,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 23:22:04,,1323903246,7/15/2014 23:21:21,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,adrenaline induced ARRHYTHMIA,162-173-181,135-150-122,prophylactic ANTIARRHYTHMIC activity,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 23:23:47,,1323904288,7/15/2014 23:23:24,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,in ARRHYTHMIA,159-181,135,ANTIARRHYTHMIC,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 23:25:55,,1323905490,7/15/2014 23:25:40,instagc,1,18531561,CAN,ON,Mississauga,99.229.185.45,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,adrenaline induced ARRHYTHMIA,162-173-181,122-135-150,prophylactic ANTIARRHYTHMIC activity,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350619,7/15/2014 23:27:50,,1323906475,7/15/2014 23:26:54,clixsense,1,23272697,GBR,F6,Romford,94.11.43.229,181,135,,,191,149,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA,181,135-162-173-181,ANTIARRHYTHMIC adrenaline induced arrhythmia,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats.",181,135,181,135,191,149,1,RO-may_prevent,907226,"Among the compounds tested, 1-(2-hydroxy-3-(4-phenylpiperidin-1-yl)-propylpyrrolidin-2-one (5) was the most active in the prophylactic antiarrhythmic activity in adrenaline induced arrhythmia in anesthetized rats",arrhythmia,antiarrhythmic
503350620,7/15/2014 22:08:26,,1323865968,7/15/2014 22:07:50,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,histologically prominent MICROVASCULAR PROLIFERATION,23-33-47-8,86-99,"GLIOBLASTOMA multiforme,","Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:12:08,,1323867629,7/15/2014 22:11:49,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,histologically prominent MICROVASCULAR PROLIFERATION,8-23-33-47,86-99,"GLIOBLASTOMA multiforme,","Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:18:57,,1323870602,7/15/2014 22:18:41,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,MICROVASCULAR PROLIFERATION,33-47,86,GLIOBLASTOMA,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:23:59,,1323872921,7/15/2014 22:23:47,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,MICROVASCULAR PROLIFERATION,33-47,86-99,"GLIOBLASTOMA multiforme,","Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:32:07,,1323876741,7/15/2014 22:31:49,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,MICROVASCULAR PROLIFERATION,33-47,86,GLIOBLASTOMA,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:34:19,,1323878112,7/15/2014 22:33:53,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,"Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present in glioblastoma multiforme,",0-8-23-33-47-61-64-75-86-99-83,33-47-64-75-83-86-99-61,"microvascular proliferation is frequently present in GLIOBLASTOMA multiforme,","Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:36:15,,1323879127,7/15/2014 22:35:56,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,histologically prominent MICROVASCULAR PROLIFERATION,8-23-33-47,86-99,"GLIOBLASTOMA multiforme,","Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:37:06,,1323879525,7/15/2014 22:37:01,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,Because histologically prominent MICROVASCULAR PROLIFERATION is frequently present,0-8-23-33-47-61-64-75,64-75-83-86-99-111-114,"frequently present in GLIOBLASTOMA multiforme, it has","Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:39:21,,1323880713,7/15/2014 22:38:51,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,MICROVASCULAR PROLIFERATION,33-47,86-99,"GLIOBLASTOMA multiforme,","Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350620,7/15/2014 22:40:34,,1323881276,7/15/2014 22:40:17,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,33,86,,,60,98,MICROVASCULAR PROLIFERATION,GLIOBLASTOMA,MICROVASCULAR PROLIFERATION,33-47,86-99,"GLIOBLASTOMA multiforme,","Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful.",33 47,86,33,86,60,98,1,RO-disease_has_finding,901556,"Because histologically prominent microvascular proliferation is frequently present in glioblastoma multiforme, it has been hypothesized that this neoplasm is particularly dependent on neovascularization for its continued growth and that antiangiogenic therapy might be especially useful",microvascular proliferation,glioblastoma
503350621,7/15/2014 22:24:17,,1323873056,7/15/2014 22:24:01,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224,ERGONOVINE,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 22:26:50,,1323874278,7/15/2014 22:26:35,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224,ERGONOVINE,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 22:31:26,,1323876427,7/15/2014 22:31:10,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224,ERGONOVINE,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 22:31:32,,1323876507,7/15/2014 22:30:59,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224,ERGONOVINE,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 22:33:48,,1323877744,7/15/2014 22:33:28,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224-235,ERGONOVINE administration,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 22:53:42,,1323887514,7/15/2014 22:53:25,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"11 patients with VARIANT ANGINA PECTORIS, whereas no significant change in the Q T interval",123-126-135-140-148-155-165-173-176-188-195-198-202-206-204,204-206-215-224-235-250-253-202,Q T interval followed ERGONOVINE administration in 27,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 22:53:54,,1323887651,7/15/2014 22:53:28,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224,ERGONOVINE,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 22:55:44,,1323888497,7/15/2014 22:55:04,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224-235,ERGONOVINE administration,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 23:11:36,,1323897556,7/15/2014 23:11:13,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224,ERGONOVINE,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350621,7/15/2014 23:13:20,,1323898432,7/15/2014 23:13:03,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,140,224,,,163,234,VARIANT ANGINA PECTORIS,ERGONOVINE,"VARIANT ANGINA PECTORIS,",140-148-155,224,ERGONOVINE,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm.",140 148 155,224,140,224,163,234,1,RO-may_diagnose,906938,"Transient prolongation of the corrected Q-T interval preceded spontaneous or ergonovine maleate-provoked coronary spasm in 11 patients with variant angina pectoris, whereas no significant change in the Q-T interval followed ergonovine administration in 27 control patients with atypical chest pain who did not have coronary spasm",variant angina pectoris,ergonovine
503350622,7/15/2014 21:58:51,,1323861489,7/15/2014 21:58:40,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,21,0,,,24,12,ONE,PREECLAMPSIA,ONE,21,0,PREECLAMPSIA,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 22:09:09,,1323866220,7/15/2014 22:08:32,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,21,0,,,24,12,ONE,PREECLAMPSIA,ONE of the most severe complications of pregnancy.,21-25-28-32-37-44-58-61,0-13,PREECLAMPSIA (PE),Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 22:15:40,,1323869120,7/15/2014 22:15:16,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,21,0,,,24,12,ONE,PREECLAMPSIA,ONE,21,0,PREECLAMPSIA,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 22:23:01,,1323872453,7/15/2014 22:20:32,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,21,0,,,24,12,ONE,PREECLAMPSIA,ONE,21,0-18,PREECLAMPSIA is,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 22:31:12,,1323876338,7/15/2014 22:31:00,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,21,0,,,24,12,ONE,PREECLAMPSIA,Preeclampsia (PE) is ONE of the most,0-13-18-21-25-28-32,0-18-21,PREECLAMPSIA is one,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 22:35:00,,1323878482,7/15/2014 22:34:51,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,21,0,,,24,12,ONE,PREECLAMPSIA,Preeclampsia (PE) is ONE of the most,0-13-18-21-25-28-32,0-18-21,PREECLAMPSIA is one,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 22:36:37,,1323879301,7/15/2014 22:35:58,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,21,0,,,24,12,ONE,PREECLAMPSIA,ONE,21,0,PREECLAMPSIA,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 22:38:49,,1323880448,7/15/2014 22:38:46,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,21,0,,,24,12,ONE,PREECLAMPSIA,Preeclampsia (PE) is ONE of the most,0-13-18-21-25-28-32,0-18-21,PREECLAMPSIA is one,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 22:48:10,,1323884613,7/15/2014 22:47:27,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,21,0,,,24,12,ONE,PREECLAMPSIA,ONE,21,0,PREECLAMPSIA,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350622,7/15/2014 23:03:15,,1323892387,7/15/2014 23:02:14,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,21,0,,,24,12,ONE,PREECLAMPSIA,Preeclampsia (PE) ONE,0-21-13,0,PREECLAMPSIA,Preeclampsia (PE) is one of the most severe complications of pregnancy.,21,0,21,0,24,12,-1,RO-disease_has_finding,901754,Preeclampsia (PE) is one of the most severe complications of pregnancy,one,Preeclampsia
503350623,7/15/2014 22:07:49,,1323865611,7/15/2014 22:07:27,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,HYPERTENSION.,98,73,PROPRANOLOL,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:11:07,,1323867182,7/15/2014 22:10:55,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,HYPERTENSION.,98,73,PROPRANOLOL,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:11:31,,1323867397,7/15/2014 22:11:10,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,essential HYPERTENSION.,98-88,73,PROPRANOLOL,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:25:01,,1323873364,7/15/2014 22:24:47,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,essential HYPERTENSION.,88-98,73,PROPRANOLOL,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:32:58,,1323877283,7/15/2014 22:32:45,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,HYPERTENSION.,98,73,PROPRANOLOL,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:34:42,,1323878275,7/15/2014 22:34:31,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,HYPERTENSION.,98,73,PROPRANOLOL,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:38:46,,1323880420,7/15/2014 22:38:34,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,propranolol in essential HYPERTENSION.,73-85-88-98,56-59-69-73-85-88-98,of enalapril and PROPRANOLOL in essential hypertension.,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:39:11,,1323880601,7/15/2014 22:39:02,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,HYPERTENSION.,98,73,PROPRANOLOL,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:45:03,,1323883301,7/15/2014 22:44:38,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,HYPERTENSION.,98,73-98,PROPRANOLOL hypertension.,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350623,7/15/2014 22:45:39,,1323883500,7/15/2014 22:45:25,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,98,73,,,110,84,HYPERTENSION,PROPRANOLOL,essential HYPERTENSION.,98-88,73,PROPRANOLOL,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension.",98,73,98,73,110,84,1,RO-may_treat,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and propranolol in essential hypertension",hypertension,propranolol
503350624,7/15/2014 22:01:21,,1323862705,7/15/2014 22:01:12,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"PRINZMETAL VARIANT ANGINA,",44-55-63,0,ERGOMETRINE,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:13:09,,1323867983,7/15/2014 22:12:56,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"PRINZMETAL VARIANT ANGINA,",44-55-63,0,ERGOMETRINE,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:21:22,,1323871681,7/15/2014 22:21:06,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"PRINZMETAL VARIANT ANGINA,",44-55-63,0,ERGOMETRINE,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:23:37,,1323872795,7/15/2014 22:23:12,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"PRINZMETAL VARIANT ANGINA,",44-55-63,0,ERGOMETRINE,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:32:28,,1323877012,7/15/2014 22:32:15,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"PRINZMETAL VARIANT ANGINA,",44-55-63,0,ERGOMETRINE,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:35:37,,1323878850,7/15/2014 22:35:33,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"a test for PRINZMETAL VARIANT ANGINA, causing specifically a",33-35-40-44-55-63-71-79-92,0-12-15-25,ERGOMETRINE is currently used,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:38:35,,1323880342,7/15/2014 22:38:25,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"PRINZMETAL VARIANT ANGINA,",44-55-63,0,ERGOMETRINE,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:48:44,,1323884814,7/15/2014 22:48:25,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"a test for PRINZMETAL VARIANT ANGINA, causing specifically a coronary artery spasm",33-35-40-44-55-63-71-79-92-94-103-110,0-12-15-25-44-55-63,"ERGOMETRINE is currently used Prinzmetal variant angina,","Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:52:38,,1323886984,7/15/2014 22:52:03,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"PRINZMETAL VARIANT ANGINA,",44-55-63,0,ERGOMETRINE,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350624,7/15/2014 22:55:40,,1323888472,7/15/2014 22:53:56,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,44,0,,,69,11,PRINZMETAL VARIANT ANGINA,ERGOMETRINE,"PRINZMETAL VARIANT ANGINA,",44-55-63,0,ERGOMETRINE,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear.",44 55 63,0,44,0,69,11,1,RO-may_diagnose,906617,"Ergometrine is currently used as a test for Prinzmetal variant angina, causing specifically a coronary artery spasm in these patients, even if the mechanism of this drug on coronaries is still unclear",Prinzmetal variant angina,Ergometrine
503350625,7/15/2014 22:01:26,,1323862742,7/15/2014 22:01:10,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82-138-144,INDOCYANINE GREEN liver disease.,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 22:01:35,,1323862861,7/15/2014 22:01:29,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82,INDOCYANINE GREEN,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 22:07:05,,1323865265,7/15/2014 22:06:37,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82,INDOCYANINE GREEN,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 22:16:42,,1323869616,7/15/2014 22:16:20,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82-88-94-101-111,INDOCYANINE GREEN (ICG) uptake excretion mechanism,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 22:29:56,,1323875808,7/15/2014 22:29:40,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82,INDOCYANINE GREEN,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 22:34:40,,1323878271,7/15/2014 22:34:15,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82-88-94-100-101-111,INDOCYANINE GREEN (ICG) uptake - excretion mechanism,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 22:36:52,,1323879444,7/15/2014 22:36:38,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82-94-100-101,INDOCYANINE GREEN uptake - excretion,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 22:55:47,,1323888532,7/15/2014 22:55:17,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82-88-94-101-111,INDOCYANINE GREEN (ICG) uptake excretion mechanism,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 23:06:29,,1323894567,7/15/2014 23:06:11,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,LIVER DISEASE.,138-144,70-82-88,INDOCYANINE GREEN (ICG),The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350625,7/15/2014 23:15:41,,1323899660,7/15/2014 23:15:38,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,138,70,,,151,87,LIVER DISEASE,INDOCYANINE GREEN,in patients with LIVER DISEASE.,121-124-133-138-144,51-63-66-70-82-94-101,disturbance of the INDOCYANINE GREEN uptake excretion,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease.,138 144,70 82,138,70,151,87,1,RO-may_diagnose,906957,The purpose of the present paper is to clarify the disturbance of the indocyanine green (ICG) uptake-excretion mechanism in patients with liver disease,liver disease,indocyanine green
503350626,7/15/2014 22:02:22,,1323863156,7/15/2014 22:01:53,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,174,107,,,186,112,BINGE EATING,BINGE,the BINGE EATING episodes,160-174-180-187,70-79-88-96-106-85,"Severity Index of Bulimic Condition (BINGE),","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 22:14:34,,1323868581,7/15/2014 22:12:14,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,174,107,,,186,112,BINGE EATING,BINGE,BINGE EATING,174-180,88-96,Bulimic Condition,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 22:19:01,,1323870608,7/15/2014 22:18:40,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,174,107,,,186,112,BINGE EATING,BINGE,BINGE EATING episodes,174-180-187,70-79-88-96-106-85,"Severity Index of Bulimic Condition (BINGE),","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 22:36:13,,1323879104,7/15/2014 22:36:08,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,174,107,,,186,112,BINGE EATING,BINGE,the number of BINGE EATING episodes per week.,160-164-171-174-180-187-196-200,88-96-106-115-124-131,"Bulimic Condition (BINGE), Clinical Global Impression","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 23:05:05,,1323893774,7/15/2014 23:04:47,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,174,107,,,186,112,BINGE EATING,BINGE,BINGE EATING,174-180,96-106-88,"Bulimic Condition (BINGE),","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 23:13:46,,1323898679,7/15/2014 23:13:21,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,174,107,,,186,112,BINGE EATING,BINGE,BINGE EATING,174-180,88-96-106,"Bulimic Condition (BINGE),","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 23:16:32,,1323900050,7/15/2014 23:16:27,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,174,107,,,186,112,BINGE EATING,BINGE,the number of BINGE EATING episodes per week.,160-164-171-174-180-187-196-200,88-96-106-115-124-131,"Bulimic Condition (BINGE), Clinical Global Impression","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 23:17:09,,1323900449,7/15/2014 23:16:27,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,174,107,,,186,112,BINGE EATING,BINGE,BINGE EATING,174-180,88-96-106,"Bulimic Condition (BINGE),","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 23:23:59,,1323904376,7/15/2014 23:23:37,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,174,107,,,186,112,BINGE EATING,BINGE,BINGE EATING episodes per week.,174-180-187-196-200,88-96-106-115-124-131,"Bulimic Condition (BINGE), Clinical Global Impression","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350626,7/15/2014 23:24:42,,1323904815,7/15/2014 23:22:08,clixsense,1.0,23272697,GBR,F6,Romford,94.11.43.229,174,107,,,186,112,BINGE EATING,BINGE,Bulimic Condition BINGE EATING,88-174-180-96,88-96-106,"Bulimic Condition (BINGE),","Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week.",174 180,,174,107,186,112,-1,RO-has_definitional_manifestation,904730,"Primary end-points included the Eating Disorders Inventory (EDI), the Severity Index of Bulimic Condition (BINGE), Clinical Global Impression (CGI) scores, and the number of binge eating episodes per week",binge eating,BINGE
503350627,7/15/2014 22:00:43,,1323862435,7/15/2014 22:00:29,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,DIARRHOEA,18,74-81-96-99,BLOODY DIARRHOEA 44 to,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 22:04:05,,1323863861,7/15/2014 22:03:54,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,DIARRHOEA,18,74-81,BLOODY DIARRHOEA,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 22:15:11,,1323868877,7/15/2014 22:14:50,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,DIARRHOEA,18,60-71-74-81,prevalence of BLOODY DIARRHOEA,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 22:20:33,,1323871307,7/15/2014 22:20:12,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,DIARRHOEA,18,74-81,BLOODY DIARRHOEA,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 22:38:51,,1323880479,7/15/2014 22:38:39,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,DIARRHOEA,18,74-81,BLOODY DIARRHOEA,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 22:43:37,,1323882658,7/15/2014 22:43:03,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,DIARRHOEA,18,74-81,BLOODY DIARRHOEA,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 22:57:52,,1323889474,7/15/2014 22:57:33,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,The prevalence of DIARRHOEA,4-15-18-0,56-60-71-74-81,the prevalence of BLOODY DIARRHOEA,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 23:01:23,,1323891108,7/15/2014 23:01:03,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,DIARRHOEA,18,74-81,BLOODY DIARRHOEA,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 23:16:25,,1323899967,7/15/2014 23:16:04,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,The prevalence of DIARRHOEA was reduced from,0-4-15-18-28-32-40,56-60-71-74-81-91-96-99,the prevalence of BLOODY DIARRHOEA from 44 to,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350627,7/15/2014 23:18:56,,1323901613,7/15/2014 23:18:31,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,18,74,,,27,90,DIARRHOEA,BLOODY DIARRHOEA,DIARRHOEA,18,74-81,BLOODY DIARRHOEA,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%.",18,74 81,18,74,27,90,-1,RO-has_definitional_manifestation,904989,"The prevalence of diarrhoea was reduced from 55 to 29%, the prevalence of bloody diarrhoea from 44 to 11% and the prevalence of abdominal discomfort from 66 to 41%",diarrhoea,bloody diarrhoea
503350628,7/15/2014 22:01:09,,1323862632,7/15/2014 22:00:47,instagc,1.0,28301350,GBR,O4,Torquay,89.241.101.166,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,78-88-158,"malignant hyperthermia, HALOTHANE","In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:02:45,,1323863356,7/15/2014 22:02:08,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"characterizing subjects with MALIGNANT HYPERTHERMIA, it is suggested",49-64-73-78-88-102-108-105,145-151-154-158-168-172-181,added to the HALOTHANE and caffeine tests,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:03:04,,1323863488,7/15/2014 22:02:52,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,158,HALOTHANE,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:03:40,,1323863682,7/15/2014 22:03:13,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,158,HALOTHANE,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:17:19,,1323869876,7/15/2014 22:17:08,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,158,HALOTHANE,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:32:28,,1323877006,7/15/2014 22:32:15,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,158,HALOTHANE,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:36:49,,1323879405,7/15/2014 22:36:36,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,158,HALOTHANE,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:37:12,,1323879624,7/15/2014 22:36:58,bitcoinget,1.0,24792414,USA,WI,Juneau,166.181.83.170,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,158,HALOTHANE,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:54:21,,1323887866,7/15/2014 22:53:55,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,158,HALOTHANE,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350628,7/15/2014 22:58:57,,1323889923,7/15/2014 22:58:30,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,78,158,,,100,167,MALIGNANT HYPERTHERMIA,HALOTHANE,"MALIGNANT HYPERTHERMIA,",78-88,158,HALOTHANE,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease.",78 88,158,78,158,100,167,1,RO-may_diagnose,906943,"In view of the wide spectrum of drug sensitivity characterizing subjects with malignant hyperthermia, it is suggested that exposure to A23187 be added to the halothane and caffeine tests currently used to detect this disease",malignant hyperthermia,halothane
503350629,7/15/2014 21:59:46,,1323861937,7/15/2014 21:59:35,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,42,LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 22:05:07,,1323864334,7/15/2014 22:04:46,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,42,LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 22:06:22,,1323864944,7/15/2014 22:05:58,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,30-39-42,addition of LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 22:14:20,,1323868445,7/15/2014 22:14:08,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,42,LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 22:17:09,,1323869763,7/15/2014 22:16:56,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,42,LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 22:19:18,,1323870747,7/15/2014 22:19:03,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,42,LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 22:22:47,,1323872357,7/15/2014 22:22:16,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,42,LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 22:27:06,,1323874411,7/15/2014 22:26:49,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,42,LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 22:44:53,,1323883211,7/15/2014 22:44:33,onestopgpt,1.0,21275875,CAN,ON,Hamilton,216.209.129.155,78,42,,,82,51,PAIN,LIDOCAINE,PAIN,78,42,LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350629,7/15/2014 23:00:39,,1323890752,7/15/2014 23:00:21,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,78,42,,,82,51,PAIN,LIDOCAINE,lidocaine significantly reduced the PAIN,52-66-74-78-42,30-39-42,addition of LIDOCAINE,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol.,78,42,78,42,82,51,1,RO-may_prevent,907174,This study concluded that the addition of lidocaine significantly reduced the pain felt in the circulatory tract selected for the injection of propofol,pain,lidocaine
503350630,7/15/2014 22:06:15,,1323864844,7/15/2014 22:06:01,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,64,18,,,68,26,LENS,CATARACT,LENS transparency,64-69,18-27,CATARACT formation,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 22:07:05,,1323865254,7/15/2014 22:06:44,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,64,18,,,68,26,LENS,CATARACT,LENS transparency,64-69,18-27,CATARACT formation,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 22:23:33,,1323872756,7/15/2014 22:23:10,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,64,18,,,68,26,LENS,CATARACT,LENS,64,18-27,CATARACT formation,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 22:33:18,,1323877453,7/15/2014 22:33:06,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,64,18,,,68,26,LENS,CATARACT,LENS transparency,64-69,18,CATARACT,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 22:33:20,,1323877470,7/15/2014 22:33:09,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,64,18,,,68,26,LENS,CATARACT,LENS,64,18,CATARACT,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 22:38:19,,1323880180,7/15/2014 22:37:55,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,64,18,,,68,26,LENS,CATARACT,The last stage of cataract formation results in loss of LENS transparency and leakage,0-4-9-15-18-27-37-45-56-61-64-69-82-86,4-9-15-18-27-37-45-48-50-56-61-64-69-82-86,last stage of CATARACT formation results in a total loss of lens transparency and leakage,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 22:48:51,,1323884888,7/15/2014 22:48:26,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,64,18,,,68,26,LENS,CATARACT,total loss of LENS transparency and leakage,50-56-61-64-69-82-86,18,CATARACT,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 22:58:15,,1323889628,7/15/2014 22:57:53,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,64,18,,,68,26,LENS,CATARACT,loss of LENS transparency,56-61-64-69,4-9-15-18-27,last stage of CATARACT formation,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 23:02:50,,1323892137,7/15/2014 23:02:33,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,64,18,,,68,26,LENS,CATARACT,LENS transparency,64-69,18-27,CATARACT formation,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350630,7/15/2014 23:12:29,,1323897956,7/15/2014 23:12:08,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,64,18,,,68,26,LENS,CATARACT,LENS,64,18,CATARACT,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins.,64,18,64,18,68,26,1,RO-has_finding_site,905456,The last stage of cataract formation results in a total loss of lens transparency and leakage of lens proteins,lens,cataract
503350631,7/15/2014 22:05:42,,1323864602,7/15/2014 22:05:19,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,ALUMINUM,96,0-9,ALUMINUM INTOXICATION,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 22:11:48,,1323867525,7/15/2014 22:11:33,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,absorption of ALUMINUM,82-93-96,0-9,ALUMINUM INTOXICATION,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 22:15:29,,1323869021,7/15/2014 22:15:09,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,intoxication ALUMINUM,96-9,0-9,ALUMINUM INTOXICATION,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 22:27:48,,1323874655,7/15/2014 22:27:32,instagc,1.0,13763729,USA,"","",75.182.89.225,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,ALUMINUM,96,0-9,ALUMINUM INTOXICATION,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 22:35:12,,1323878573,7/15/2014 22:35:00,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,ALUMINUM,96,0-9,ALUMINUM INTOXICATION,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 22:38:13,,1323880154,7/15/2014 22:38:03,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,ALUMINUM,96,0-9,ALUMINUM INTOXICATION,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 23:17:14,,1323900483,7/15/2014 23:17:11,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,of absorption of ALUMINUM during dialysis from,79-82-93-96-105-112-121,0-9-22-25-32,ALUMINUM INTOXICATION is common in,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 23:22:06,,1323903258,7/15/2014 23:21:44,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,ALUMINUM,96,0-9,ALUMINUM INTOXICATION,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 23:22:53,,1323903680,7/15/2014 23:22:39,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,absorption of ALUMINUM during dialysis,82-93-96-105-112,0-9,ALUMINUM INTOXICATION,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350631,7/15/2014 23:22:54,,1323903689,7/15/2014 23:22:42,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,96,0,,,104,21,ALUMINUM,ALUMINUM INTOXICATION,absorption ALUMINUM during dialysis from,82-96-105-112-121,0-9-22-25,ALUMINUM INTOXICATION is common,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum.,96,0 9,96,0,104,21,1,RO-has_causative_agent,903967,Aluminum intoxication is common in patients with chronic renal failure because of absorption of aluminum during dialysis from aluminum-containing dyalysate water and ingestion of phosphate binders containing aluminum,aluminum,Aluminum intoxication
503350632,7/15/2014 22:01:10,,1323862645,7/15/2014 22:00:59,instagc,1.0,26706653,USA,IL,Elk Grove Village,99.99.9.247,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,of the,309-306,213-280-280,of ms) ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 22:20:01,,1323871137,7/15/2014 22:17:01,clixsense,1.0,23585686,GBR,H9,London,31.51.221.173,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,41,-1,64-280-81,ventriculoatrial block ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 22:24:46,,1323873226,7/15/2014 22:24:15,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,41,-1,280,ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 22:31:48,,1323876607,7/15/2014 22:30:50,clixsense,1.0,21034659,AUS,04,Brisbane,49.189.2.107,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,ventriculoatrial block,64-81,280--1,41 ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 22:35:23,,1323878755,7/15/2014 22:35:17,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,of the,309-306,213-280-280,of ms) ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 22:39:05,,1323880578,7/15/2014 22:38:19,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,41 of the,306-309--1,213-280-280,of ms) ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 22:40:25,,1323881229,7/15/2014 22:39:29,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,41,-1,280,ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 23:20:22,,1323902394,7/15/2014 23:19:08,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,41,-1,-1,41,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 23:23:19,,1323903945,7/15/2014 23:22:29,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,41,-1,280,ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350632,7/15/2014 23:24:29,,1323904704,7/15/2014 23:22:53,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,313,226,,,324,265,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,41,-1,280,ms),In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia.,,,313,226,324,265,-1,RO-has_definitional_manifestation,904966,In the other four the ventricular paced cycle lengths producing ventriculoatrial block (318 +/- 41 ms) and effective refractory period of retrograde fast pathway (320 +/- 28 ms) were shorter than the cycle length of reinduced paroxysmal supraventricular tachycardia (367.5 +/- 35 ms) allowing perpetuation of the tachycardia,tachycardia,paroxysmal supraventricular tachycardia
503350633,7/15/2014 22:08:39,,1323866029,7/15/2014 22:06:27,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,PAIN by,146-158,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 22:08:57,,1323866132,7/15/2014 22:08:21,clixsense,1.0,15189335,GBR,H9,London,188.29.165.113,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,PAIN,146,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 22:09:55,,1323866594,7/15/2014 22:09:04,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,"PAIN caused by somatosensory system disease or damage (neuropathic pain),",146-151-158-161-175-182-190-193-200-213,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 22:15:22,,1323868952,7/15/2014 22:15:05,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,PAIN,146,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 22:27:52,,1323874672,7/15/2014 22:27:35,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,PAIN,146,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 22:33:52,,1323877787,7/15/2014 22:33:38,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,"(nociceptive pain), (2) PAIN caused by somatosensory",122-135-142-146-151-158-161,200-213-220-228,"(NEUROPATHIC PAIN), and pain","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 22:37:12,,1323879632,7/15/2014 22:35:24,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,"PAIN (neuropathic pain),",146-200-213,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 22:38:37,,1323880372,7/15/2014 22:38:25,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,PAIN caused by somatosensory,146-151-158-161,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 22:58:43,,1323889798,7/15/2014 22:58:16,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,PAIN caused by somatosensory system disease,146-151-158-161-175-182,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350633,7/15/2014 23:02:35,,1323891930,7/15/2014 23:02:19,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,146,201,,,150,217,PAIN,NEUROPATHIC PAIN,PAIN,146,200-213,"(NEUROPATHIC PAIN),","Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background.",146,213,146,201,150,217,1,RO-has_definitional_manifestation,904937,"Essentially, the classification of chronic pain falls into 3 broad categories: (1) pain owing to tissue disease or damage (nociceptive pain), (2) pain caused by somatosensory system disease or damage (neuropathic pain), and (3) pain without a known somatic background",pain,neuropathic pain
503350634,7/15/2014 22:02:06,,1323863053,7/15/2014 22:01:55,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,47,11,,,54,25,TENDONS,TENDON RUPTURE,TENDONS,47,11-18,TENDON RUPTURE,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 22:12:24,,1323867763,7/15/2014 22:12:09,instagc,1.0,27770607,USA,TX,El Paso,72.183.248.75,47,11,,,54,25,TENDONS,TENDON RUPTURE,TENDONS,47,11-18,TENDON RUPTURE,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 22:16:53,,1323869679,7/15/2014 22:16:44,elite,1.0,28503042,USA,OK,Watonga,65.255.78.241,47,11,,,54,25,TENDONS,TENDON RUPTURE,TENDONS,47,11-18,TENDON RUPTURE,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 22:29:37,,1323875665,7/15/2014 22:29:25,instagc,1.0,13763729,USA,"","",75.182.89.225,47,11,,,54,25,TENDONS,TENDON RUPTURE,TENDONS,47,11-18,TENDON RUPTURE,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 22:38:22,,1323880191,7/15/2014 22:38:17,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,47,11,,,54,25,TENDONS,TENDON RUPTURE,minimal and even TENDONS found to be,30-38-42-47-55-61-64,0-11-18-26-30-38,Subsequent TENDON RUPTURE was minimal and,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 22:38:47,,1323880435,7/15/2014 22:38:16,neodev,1.0,13525941,AUS,02,Sydney,14.200.47.168,47,11,,,54,25,TENDONS,TENDON RUPTURE,minimal even TENDONS,30-47-42,11-18,TENDON RUPTURE,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 22:40:26,,1323881234,7/15/2014 22:40:24,coinworker,1.0,26727958,USA,OH,Cleveland,99.108.68.152,47,11,,,54,25,TENDONS,TENDON RUPTURE,minimal and even TENDONS found to be,30-38-42-47-55-61-64,0-11-18-26-30-38,Subsequent TENDON RUPTURE was minimal and,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 22:46:12,,1323883733,7/15/2014 22:45:59,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,47,11,,,54,25,TENDONS,TENDON RUPTURE,TENDONS,47,11-18,TENDON RUPTURE,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 23:05:57,,1323894224,7/15/2014 23:05:29,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,47,11,,,54,25,TENDONS,TENDON RUPTURE,TENDONS,47,11-18,TENDON RUPTURE,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350634,7/15/2014 23:17:49,,1323900814,7/15/2014 23:17:45,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,47,11,,,54,25,TENDONS,TENDON RUPTURE,minimal and even TENDONS found to be,30-38-42-47-55-61-64,0-11-18-26-30-38,Subsequent TENDON RUPTURE was minimal and,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact.,47,11 18,47,11,54,25,1,RO-has_finding_site,905252,Subsequent tendon rupture was minimal and even tendons found to be thinned out at the time of surgery remained intact,tendons,tendon rupture
503350635,7/15/2014 22:29:24,,1323875563,7/15/2014 22:29:19,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,lymphocytic choriomeningitis (LCM) VIRUS.,198-210-227-233,178-183-186-198-210-233,dose of neurotropic LYMPHOCYTIC CHORIOMENINGITIS virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 22:33:08,,1323877348,7/15/2014 22:32:55,clixsense,1.0,16827630,GBR,A7,Birmingham,86.146.169.103,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,neurotropic lymphocytic choriomeningitis VIRUS.,198-210-233-186,186-198-210-233,neurotropic LYMPHOCYTIC CHORIOMENINGITIS virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 22:34:29,,1323878182,7/15/2014 22:32:33,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,lymphocytic choriomeningitis (LCM) VIRUS.,198-210-227-233,198-210-227-233,LYMPHOCYTIC CHORIOMENINGITIS (LCM) virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 22:40:49,,1323881376,7/15/2014 22:40:26,instagc,1.0,24252915,GBR,B7,Bristol,77.98.139.82,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,neurotropic lymphocytic choriomeningitis (LCM) VIRUS.,198-210-227-233-186,186-198-210-233-227,neurotropic LYMPHOCYTIC CHORIOMENINGITIS (LCM) virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 22:44:36,,1323883102,7/15/2014 22:44:20,bitcoinget,1.0,24792414,USA,"","",166.181.81.170,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,neurotropic lymphocytic choriomeningitis (LCM) VIRUS.,198-210-227-233-186,186-198-210-233-227,neurotropic LYMPHOCYTIC CHORIOMENINGITIS (LCM) virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 23:00:12,,1323890508,7/15/2014 22:59:48,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,neurotropic lymphocytic choriomeningitis (LCM) VIRUS.,198-210-227-233-186,186-198-210-227-233,neurotropic LYMPHOCYTIC CHORIOMENINGITIS (LCM) virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 23:10:56,,1323897172,7/15/2014 23:10:16,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,neurotropic lymphocytic choriomeningitis (LCM) VIRUS.,198-210-227-233-186,186-198-210-233-227,neurotropic LYMPHOCYTIC CHORIOMENINGITIS (LCM) virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 23:17:22,,1323900573,7/15/2014 23:17:20,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,lymphocytic choriomeningitis (LCM) VIRUS.,198-210-227-233,178-183-186-198-210-233,dose of neurotropic LYMPHOCYTIC CHORIOMENINGITIS virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 23:21:48,,1323903122,7/15/2014 23:21:11,clixsense,1.0,26770238,CAN,ON,London,209.183.157.27,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,"large, not small, dose VIRUS.",156-171-178-233-167,178-183-186-198-210,dose of neurotropic LYMPHOCYTIC CHORIOMENINGITIS,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350635,7/15/2014 23:25:38,,1323905323,7/15/2014 23:25:14,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,228,198,,,238,226,LCM) VIRUS,LYMPHOCYTIC CHORIOMENINGITIS,(LCM) VIRUS.,227-233,198-210-233,LYMPHOCYTIC CHORIOMENINGITIS virus.,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus.",233,198 210,228,198,238,226,-1,RO-has_causative_agent,903721,"Adoptively transferred immune spleen cells induce fatal neurological disease in cyclophosphamide-suppressed recipients injected intracerebrally (ic) with a large, but not small, dose of neurotropic lymphocytic choriomeningitis (LCM) virus",LCM) virus,lymphocytic choriomeningitis
503350636,7/15/2014 22:00:00,,1323862077,7/15/2014 21:59:53,tremorgames,1.0,24449707,CAN,QC,Laval,96.21.249.72,100,69,,,107,79,ASCITES,FUROSEMIDE,ASCITES:,100,69,FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 22:05:03,,1323864298,7/15/2014 22:04:41,clixsense,1.0,25595227,CAN,SK,North Battleford,24.72.96.119,100,69,,,107,79,ASCITES,FUROSEMIDE,ASCITES:,100,69,FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 22:06:27,,1323864978,7/15/2014 22:06:16,neodev,1.0,28175665,CAN,ON,Brampton,99.228.31.59,100,69,,,107,79,ASCITES,FUROSEMIDE,ASCITES:,100,69,FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 22:08:09,,1323865830,7/15/2014 22:07:51,pedtoclick,1.0,20864559,GBR,B8,Bromley,213.106.94.78,100,69,,,107,79,ASCITES,FUROSEMIDE,ASCITES:,100,69,FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 22:29:04,,1323875331,7/15/2014 22:28:48,elite,1.0,28466071,CAN,AB,Edmonton,68.150.39.46,100,69,,,107,79,ASCITES,FUROSEMIDE,ASCITES:,100,69,FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 22:38:32,,1323880292,7/15/2014 22:38:24,clixsense,1.0,7265596,USA,IA,Neola,199.120.116.136,100,69,,,107,79,ASCITES,FUROSEMIDE,the treatment of ASCITES: cooperative study.,83-87-97-100-109-121,51-54-65-69-80-83-87,of bumetanide and FUROSEMIDE in the treatment,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 23:00:32,,1323890661,7/15/2014 23:00:12,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,100,69,,,107,79,ASCITES,FUROSEMIDE,ASCITES:,100,69,FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 23:00:48,,1323890816,7/15/2014 23:00:35,prodege,1.0,22124564,GBR,N5,Lowestoft,90.220.97.157,100,69,,,107,79,ASCITES,FUROSEMIDE,ASCITES:,100,69,FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 23:04:17,,1323893174,7/15/2014 23:04:05,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,100,69,,,107,79,ASCITES,FUROSEMIDE,ASCITES:,100,69,FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350636,7/15/2014 23:06:23,,1323894534,7/15/2014 23:05:48,instagc,1.0,23149109,USA,NC,Durham,75.189.206.205,100,69,,,107,79,ASCITES,FUROSEMIDE,treatment of ASCITES:,87-97-100,54-65-69,bumetanide and FUROSEMIDE,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study.",100,69,100,69,107,79,1,RO-may_treat,907842,"Herlong HF, Hunter FM, Koff RS et al. A comparison of bumetanide and furosemide in the treatment of ascites: cooperative study",ascites,furosemide
503350637,7/15/2014 22:16:55,,1323869693,7/15/2014 22:16:31,prodege,1.0,28255346,GBR,L9,Sheffield,2.125.183.137,91,79,,,101,87,ISLET CELL,DIABETES,ISLET CELL neogenesis,91-97-102,79,DIABETES,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 22:32:45,,1323877170,7/15/2014 22:32:38,bitcoinget,1.0,28377798,GBR,"","",195.166.117.126,91,79,,,101,87,ISLET CELL,DIABETES,curing diabetes by ISLET CELL neogenesis may be,72-79-88-91-97-102-113-117,62-69-72-79-88-91-97,hurdle to curing DIABETES by islet cell,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 22:35:45,,1323878897,7/15/2014 22:35:15,clixsense,1.0,13648721,GBR,K9,Saltburn-by-the-sea,86.19.175.51,91,79,,,101,87,ISLET CELL,DIABETES,ISLET CELL neogenesis,91-97-102,79-88-91-97,DIABETES by islet cell,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 22:38:25,,1323880222,7/15/2014 22:38:07,tremorgames,1.0,26860817,NLD,06,Boxmeer,84.29.157.221,91,79,,,101,87,ISLET CELL,DIABETES,ISLET CELL neogenesis,91-97-102,79,DIABETES,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 22:48:55,,1323884914,7/15/2014 22:48:46,sendearnings,1.0,20717796,USA,CA,San Jose,99.27.90.128,91,79,,,101,87,ISLET CELL,DIABETES,curing diabetes by ISLET CELL neogenesis may be,72-79-88-91-97-102-113-117,62-69-72-79-88-91-97-102,hurdle to curing DIABETES by islet cell neogenesis,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 22:56:51,,1323888986,7/15/2014 22:56:18,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,91,79,,,101,87,ISLET CELL,DIABETES,diabetes by ISLET CELL neogenesis,79-88-91-97-102,79-88-91-97-102,DIABETES by islet cell neogenesis,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 22:59:13,,1323890050,7/15/2014 22:58:58,tremorgames,1.0,21788954,GBR,E3,Enfield,82.45.226.44,91,79,,,101,87,ISLET CELL,DIABETES,ISLET CELL neogenesis,91-97-102,79,DIABETES,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 23:07:54,,1323895337,7/15/2014 23:07:15,elite,1.0,28397222,GBR,Y4,Usk,31.50.223.75,91,79,,,101,87,ISLET CELL,DIABETES,ISLET CELL neogenesis,91-97-102,79,DIABETES,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 23:09:48,,1323896545,7/15/2014 23:09:22,instagc,1.0,21551272,GBR,E6,Chipping Campden,78.145.193.123,91,79,,,101,87,ISLET CELL,DIABETES,ISLET CELL,91-97,79,DIABETES,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
503350637,7/15/2014 23:15:48,,1323899711,7/15/2014 23:15:42,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,91,79,,,101,87,ISLET CELL,DIABETES,curing diabetes by ISLET CELL neogenesis may be,72-79-88-91-97-102-113-117,62-69-72-79-88-91-97,hurdle to curing DIABETES by islet cell,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome.",91 97,79,91,79,101,87,1,RO-disease_has_primary_anatomic_site,902134,"If islet cell tolerance could be re-induced, a major clinical hurdle to curing diabetes by islet cell neogenesis may be overcome",islet cell,diabetes
